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Communication between cells is a crucial process in multicellular organisms. One 
prominent communication pathway is the signal transduction between nerve cells. Here, an 
electrical impulse is translated into a chemical signal, which transfers information from one 
neuron to another. An important part of this transmission is the neuronal exocytosis. 
Synaptic vesicles fuse with the presynaptic membrane and release the stored 
neurotransmitters into the synaptic cleft.[1,2] During this process, two separate membranes 
have to overcome an energy barrier to facilitate fusion. This complex task can be achieved 
by the evolutionary conserved SNARE (soluble N-ethylmaleimide-sensitive factor 
attachment protein receptor) family.[3–5] The vesicle membrane contains synaptobrevin 2, 
the acceptor membrane syntaxin 1A and the 25 kDa synaptosome-associated protein SNAP 
25.[6] The interaction between these proteins is thought to start N-terminally and proceed 
in a zipper-like manner toward the C-termini.[7–9] The membranes are brought in close 
proximity so that they ultimately fuse together. The strong interaction between the proteins, 
which is needed for the mechanism, is a result of the formation of a four-helical 
bundle.[10,11] Each of the involved proteins contributes its motif to form this structure. In 
case of synaptobrevin 2 and syntaxin 1A, the motif is attached via a small flexible linker 
sequence to a transmembrane domain (TMD) which anchors the protein into the 
membrane.[12,13] Since the discovery of the SNAREs in the late 1980s, the protein family 
has been studied extensively.[14–16] Different synthetic models have been developed to 
mimic the function of the SNAREs to even further improve the understanding of the 
underlying mechanism.[17–20]  
 
One of these SNARE mimetics consists of a dimeric peptide system, which is designed to 
keep the main three domains as close to the natural system as possible. The linker and TMD 
are the native sequences of synaptobrevin 2 (Syb) and syntaxin 1A (Sx). The natural parts 
are attached to an artificial motif which consists of the coiled coil pair E3 and K3.[21] 
Initially, this system was developed to be synthesized via solid phase peptide synthesis 




Furthermore, the natural peptidic backbone was kept to reduce unnatural structural changes. 
The pair of E3-Syb and K3-Sx peptides has already been verified to be capable of fusing 
large unilamellar vesicles (LUVs) in bulk fusion assays.[22] One of the advantages of this 
system is its peptidic character which can be modified easily and can therefore be used to 
address specific questions regarding the fusion mechanism or peptide structure.  
In fact, one of the objectives of this work is to investigate the fusion mechanism of the 
E3/K3-TMD model system and to connect the results to the natural SNARE fusion process. 
This is achieved by precisely stopping the fusion process after the coiled coil formation of 
the motifs and starting it again after a specific trigger. To accomplish this, a photocleavable 
protecting group was introduced into the linker of one of the peptides. Using Förster 
resonance energy transfer (FRET) based bulk fusion assays the inhibitory effect of the 
group was tested. For this purpose the position of the group in the peptide has been 
evaluated via the x-ray data of the natural SNARE complex.[23] Additionally, the 
predetermined positions have been investigated regarding their effect on fusion efficiency 
of the system. Peptide variants with substituted amino acids have been synthesized and 
tested in this regard. 
 
Another focus of this work targets a deeper understanding of the role of the linker sequence 
in the fusion mechanism. To achieve this, the E3/K3-TMD systems sequences are 
selectively modified and the resulting changes of vesicle sizes and fusion behavior are 
monitored. The modifications are aimed at three properties of the linker. First, the effect of 
the linker length is tested. Here, the particular connection between the artificial motif and 
natural linker is of interested. Second, the charge of the polybasic area in syntaxins linker, 
which has been investigated by research groups for years.[24–26] In this regard, the 
interaction with charged lipids was also investigated in this work. Especially PIP2 
(phosphatidyl 4,5-bisphosphate) is known for its interactions with syntaxins linker.[27,28] 
Third, a ring of aromatic amino acids is believed to be responsible for the insertion depth 
of adjacent lysines,[29] the stiffness of synaptobrevins linker,[23] and plays a role in the fusion 
process itself.[30] To test whether these amino acids are important for the E3/K3-TMD 
model systems ability to fuse vesicles, alterations in the peptide sequence have been 





 Membranes and their Fusion 
Behavior 
This chapter focusses on the properties of biological membranes and on proteins which 
have the ability to fuse two separate lipid bilayers. Chapter 2.1 and 2.2 give an introduction 
in today’s knowledge about biological membranes and their main building block lipids. 
The next two chapters (2.3 and 2.4) deal with membrane fusion and describe the neuronal 
exocytosis pathway. Sections 2.5 and 2.6 present proteins which are capable of performing 
the task of fusing separate lipid bilayers in nature. Finally, chapter 2.7 is dedicated to model 
systems, which are developed to mimic SNARE protein structure and/or imitate their fusion 
mechanism. 
2.1 Biological Membranes 
Biological membranes are an essential structure for cells and cell organelles to maintain 
their functional capabilities.[31] Many different processes vital for life are occurring in or at 
membranes. The reason for this is the high number of different lipids, proteins, sugars and 
other molecules and cell organelles which are associated to the membrane (see Figure 2.1). 
The structural foundation of biological membranes are lipids (see chapter 2.2).[32] These 
molecules have an amphipathic character due to their polar head groups and hydrophobic 
acyl tail chains and are therefore prone to form lipid bilayers in an aqueous environment.[33] 
The driving force of this behavior is the hydrophobic interaction between the acyl chains.[34] 
 
A key feature of these membranes is the separation of different cells and compartments.[35] 
This opens up the possibility for diverse biochemical reaction environments and specialized 
domains within a cell. These domains provide a foundation for proteins and other molecules 
for important cellular tasks like proton gradient generation or signaling cascades.[36] The 
bilayer can also act as a barrier to protect the cell against toxins or oxidation, as well as 
maintain an electrochemical gradient which is important for multiple other cell activities.[37] 
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Membrane proteins are responsible for many processes such as enzymatic activity, particle 
transport across the membrane, communication between cells and signal transduction.[38] 
Classification of these proteins can be done via the type of attachment to the membrane. 
Integral proteins are embedded into the lipid bilayer via specific protein structures. They 
have been identified to contain -helical and/or -barrel structures, which contain 
hydrophobic domains to stay inside the bilayer.[39,40] Peripheral membrane proteins, on the 
other hand, are attached to the outside of the membrane. The proteins are mostly acting in 
the lipid-water interface and are fully water soluble. They can interact with the bilayer 
reversibly through electrostatic interactions, hydrophobic interactions or attachment to lipid 
anchors.[41,42]  
 
Figure 2.1: Schematic model of the different components located at cell 
membranes. The bilayer consists of various lipids (phospholipids, glycolipids, 
sphingolipids, etc.), proteins, sugars and other molecules. The components are 
usually not distributed evenly and are known to form specialized areas, where the 
local concentration of specific lipids or proteins is higher compared to the rest of 
the membrane. 
Membranes are highly asymmetric regarding the lipid and protein composition between the 
two sides of the bilayer.[43,44] Processes like ion pumping and signaling cascades have to be 
directional to serve a purpose for the cell. This asymmetric feature is vital for many cell 
activities and has for example been correlated with cell apoptosis.[45]  
 
In 1972 SINGER and NICOLSON introduced the fluid mosaic model which contributed to a 
better understanding of lipid membranes and proteins at the time.[46] Biological membranes 
are described as a two dimensional matrix, which is made up of a fluid bilayer of 
2.2 Membrane Lipids 
________________________________________________________________________ 
5 
phospholipids in which mobile integral globular proteins are embedded. These proteins are 
distributed evenly throughout the fluid membrane but are also able to form aggregates at 
short ranges. The fluid mosaic model replaced the at that time prevalent unit membrane 
model and tri-layer model.[47–49] As research progressed, the fluid mosaic model reached 
its limits and is not generally applicable for the description of membranes anymore. The 
model fails to describe lipid-lipid, lipid-protein, protein-protein, membrane-associated 
cytoskeletal and extracellular matrix interactions.[35] Furthermore, observation of lateral 
membrane heterogeneity lead to the development of a new concept to explain these 
findings. The compartmentalization of the membrane was first discovered in the 1970s and 
led to the concept of lipid rafts.[50–53] Rafts are defined as highly dynamic, heterogeneous 
sterol- and sphingolipid-enriched domains with a size of about 10-200 nm.[54] They are 
proposed to form relatively ordered domains which recruit other proteins and lipids to form 
functionally specialized membrane regions.[50] However, as detection of these rafts is 
difficult and different methodologies often yield contradictory results, lipid rafts have yet 
to be observed in living cells.[52] The ongoing controversy of this model sparked a debate 
about renaming these previous findings into “transient nanodomains” rather than rafts.[55] 
Alongside this model, other alternatives discuss the organization inside the plasma 
membrane.[56–58] Charge-mediated formation of clusters, lipid shells or areas confined by 
cortical actin skeleton may also compartmentalize the plasma membrane.[59]  
2.2 Membrane Lipids 
Lipids are the main building blocks of biological membranes and are essential for every 
organism. For example, about 50 % of the human brains dry weight is accounted for by 
lipids.[60] Plenty proteins rely on their amphoteric nature to form a suitable environment for 
protein activity. Understanding the properties and behavior of lipids is therefore crucial for 
the elucidation of membrane processes. 
Membrane lipids are amphoteric molecules with a polar head group and a lipophilic acyl 
chain. Generally, these lipids can be categorized by their physicochemical properties.[61] 
The chemical diversity can be achieved with different types of headgroups, backbones and 
acyl chains. Phosphatidylethanolamine, phosphatidylcholine and phosphatidylserine are 
prominent head groups. The backbone consists of either glycerol or sphingosine. The acyl 
chain can vary in length as well as in conformation due to possible double bonds. For 
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phosphoglycerolipids a combination of two different acyl chains is also possible, increasing 
the number of available lipids.[32,61] The majority of biological lipids can be classified into 
glycerophospholipids, sphingolipids and sterols.[32] Another important characteristic of 
lipids is their interaction with each other. Due to the high number of lipids inside a lipid 
bilayer, compositional diversity expands the scope of application of membranes even 
further. Depending on the type or mixture of lipids in the membrane, several properties of 
the structure can be changed (see Figure 2.2). Membrane thickness, flexibility or even local 
charge can be modulated with different lipid compositions. As biological membranes 
consist of hundreds of different species (lipids and proteins) the complexity of these 
systems is immense.[62,63] 
 
Figure 2.2: Illustration of membrane properties due to lipid diversity. 
(a) Membrane thickness is modulated by different lipids and cholesterol. 
(b) Depending on the curvature of the membrane, specific types of lipids are 
recruited. (c) DOPE as an example for a cone-shaped lipid and DOPC as a 
cylinder-shaped lipid. Location of cholesterol in between lipids is shown. 
The fluidity and flexibility of lipid bilayers is a result of the interaction between the lipids 
and proteins present at this interface.[61] Lipids have intrinsic shapes which are dependent 
on their hydrophobic acyl chains and hydrophilic head groups. Different geometric shapes 
of the lipids are possible. Cone shaped lipids are a result of headgroups having a smaller 
mean diameter compared to the acyl chains. Unsaturated phosphoethanolamine (PE) and 
phosphatidic acid (PA) lipids are cone shaped, whereas phosphatidylcholine (PC) 
headgroups tend to be cylindrical. The shape determines the side-by-side packing and 
2.3 Membrane Fusion 
________________________________________________________________________ 
7 
therefore, the curvature of the monolayers. The thickness of the bilayer is also an important 
parameter which can determine the properties of a membrane. For example, the activity of 
many proteins is regulated via the thickness of the bilayer.[64] The length of the acyl chains 
of lipids, the amount of cholesterol, as well as proteins itself can modify this property.[64,65]  
Another important lipidic component are sterols, with the most prominent being 
cholesterol.[66] Cholesterol modulates the bilayers fluidity, thickness and curvature, making 
it an essential component in mammalian cells.[65,67][65,ERL It increases the bilayer thickness 
by straightening the acyl chains of adjacent lipids and can be found preferably in negatively 
curved bilayers due to its intrinsic curvature.[65] The molecule is positioned in between the 
acyl chains of the phospholipids with its hydroxyl group at the level of the ester groups.[68,69] 
Furthermore, cholesterol is known to interact with many proteins e.g. SNARE proteins and 
HIV-1 gp41.[70,71]  
2.3 Membrane Fusion 
Fusion of biological membranes is the process in which two separate lipid bilayers 
overcome an energy barrier and merge together, forming one continuous bilayer. In most 
cases, this event also leads to mixing of the two contents which were enclosed by the two 
separate bilayers. There are two main mechanisms for the fusion process which can be 
separated into protein independent and protein dependent fusion. The mechanism for the 
former was first postulated by KOZLOV and MARKIN in 1983.[72] The original theory 
describes a mechanism in which first a hemifusion step has to be passed before full fusion 
occurs (see Figure 2.3). Here, the two membranes are in close proximity when a point-like-
protrusion minimizes the hydration energy so that a hemifusion stalk can be formed 
(1>2>3). In this stage, the outer membrane leaflets are mixed, whereas the inner leaflets 
stay separated. Continuing from the stalk, either a hemifusion diaphragm can be formed 
(3>4),[73] or a direct fusion pore opening occurs (3>5).[74] Either way, the last step includes 
the formation of a fusion pore which enables the exchange of the aqueous contents between 
the formerly separated bilayers. The process of hemifusion stalk formation is generally 
agreed upon, as it has been observed with X-ray diffraction studies.[75,76] Although the 
formation of a hemifusion diaphragm was experimentally observed,[77,78] it is still debated 
whether the process can proceed to the pore formation from this stage.[79] Since the first 
postulation, several improvements and additions on the “stalk model” have been made to 
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describe the process more accurately.[80–82] Recently, the mechanism has been modified and 
adapted even further to accommodate several possible alternative fusion pathways.[83] 
These new pathways are less symmetric than the original mechanism but originate from the 
hemifusion stalk.  
During the first route (3>6>7>8), the stalk grows linearly along a circular path to form an 
inverted micelle (6). From here, two pores need to be opened, with the first leading to the 
formation of a -shaped hemifusion diaphragm (7). This diaphragm is similar to (4), 
however the lipids have been mixed during its formation. 
In an alternative route, the fusion stalk opens transiently and forms the stalk-pore complex 
(9), which closes to form a hemifusion diaphragm before the fusion pore opening 
(3>9>7>8).[84–86] It is also currently debated, that the stalk-pore complex opens during the 
hemifusion diaphragma elongation (3>4>9>7>8).[87] 
 
Figure 2.3: Illustration of several fusion pathways of two lipid bilayers. 
(1) Separate bilayers. (2) Point-like protrusion. (3) Hemifusion stalk. 
(4) Hemifusion diaphragm. (5) Fusion pore. (6) Inverted micelle. (7) -shaped 
hemifusion diaphragm. (8) Fusion pore with mixed lipids. (9) Stalk-pore complex. 
Image based on [83,85,88,89]. 
The second type of membrane fusion includes proteins. Here, many of the previously stated 
concepts are applied for the membrane merger itself. The advantages which result from the 
inclusion of proteins in the fusion process are manifold. The hydration, curvature, lipid 
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composition or stability of the membrane can be altered due to proteins.[90] Furthermore, 
proteins can actively pull membranes together to perform the fusion process.[77] The 
mechanism can therefore be controlled more precisely. Some proteins capable of this task 
are discussed in more detail in the chapters 2.5 and 2.6. 
One important factor for bilayer fusion is the lipid composition of the membrane. During 
the process the shapes of the bilayers change dramatically. This change has to be 
accommodated by the structures of the involved lipids. During stalk formation, a highly 
negatively curved membrane develops in the inner leaflets which has to be stabilized by a 
suitable lipid. As described in section 2.2, lipids with PE headgroups promote this 
formation, whereas lysophosphatidylcholine (LPC) inhibit the process.[91] Conversely, LPC 
is better suited for the outer leaflet than PE lipids. These findings can also be applied to the 
curvature of liposomes. Less curved membranes tend to fuse less readily than highly curved 
membranes.[91] Thus, larger liposomes are less fusogenic, whereas small liposomes, for 
example small unilamellar vesicles (SUVs) are more prone to fuse. 
2.4 Neuronal Exocytosis 
Since the 1960s, when the fundamental understanding about synaptic signal transduction 
was obtained, a lot of research was conducted in this field. Especially the exocytosis of 
synaptic vesicles has been studied intensively, making it one of the best understood 
membrane fusion processes.[2,92–94] 
Transferring information between cells is a fundamental process in many organisms. In 
mammals, the central nervous system is filled with specialized cells to conduct reliable and 
fast information transduction. These so-called neurons consist of different components (see 
Figure 2.4a). The cell body is made of the soma which contains the nucleus and is connected 
to multiple branched dendrites. These dendrites receive information from other cells that is 
processed in the cell body. The information is then transferred via the axon, an elongation 
of the cell, in which electrical pulses can be transmitted over a long distance to the axon 
termini. The speed of the information transfer is further increased by Schwann cells, which 
wrap around the axon to form the myelin sheath. At the terminal points a connection to 
other cells e.g. other neurons form a synapse (see Figure 2.4b). At the synapse the electrical 
information is translated into a chemical signal that is transmitted to the next cell. 
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Figure 2.4: Illustration of neuronal signal transduction synaptic activity. 
(a) Structure of a neuron. (b) Synapse with simplified vesicle trafficking cycle. 
The electrical signal from the axon is translated into chemical information. 
Neurotransmitters are released into the synaptic cleft, where they bind onto 
receptors on the postsynaptic membrane. Based on [94]. 
The underlying principle of the information transfer is a difference in the electrochemical 
potential between the intra- and extracellular area. The composition of ions differs between 
the inside of the neuron and the outside. Consequently, a charge difference across the 
membrane exists. This potential, which is maintained by active ion pumps, can be changed 
in the event of an action potential. An action potential is generated when signals from the 
dendrites arrive in the axon hillock and a specific threshold is exceeded. After that, the 
signal is sent down the axon and induces a change in the resting potential. This is done via 
a set of voltage-gated ion channels which alter the permeability of Na+ and K+-ions of the 
membrane. Upon arrival at the axon terminal region, voltage-gated Ca2+ channels open. 
The previously prevalent low amount of Ca2+-ions increases and triggers multiple events, 
one of which is the fusion of transmitter filled synaptic vesicles with the presynaptic 
membrane. These transmitters are then released into the synaptic cleft and can bind to 
specific receptors on the postsynaptic membrane. 
 
The formation and recycling of synaptic vesicles is a process needed for signal transduction, 
to maintain a readily releasable pool of neurotransmitter filled vesicles (see Figure 2.4b).[2] 
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For the neurotransmitters to be released, they first have to be incorporated inside a vesicle 
via active transport. Filled vesicles form the readily releasable pool of synaptic vesicles 
which are stored inside the cell until needed. [95] In the next step, the filled vesicles dock at 
the active zone near the synaptic membrane and undergo a priming process. After priming, 
the vesicles can be triggered by means of a Ca2+ to take part in the fusion process. 
Subsequent, the empty synaptic vesicle can undergo endocytosis to be recycled via 
endosomes.[2] This whole process is accompanied by a variety of proteins e.g. clathrin, to 
regulate and catalyze the different steps.  
2.5 Fusion Proteins 
Fusion of biological membranes can be performed by different types of proteins. 
Depending on the evolutionary background, the protein structures and fusion mechanisms 
differ quiet substantially. For example, viral fusion proteins facilitate the merger with the 
proteins being present on only one of the membranes.[96] SNARE proteins on the other hand 
are located in both membranes and interact with each other to facilitate fusion.[6] 
Knowledge about natures fusion machinery is important considering e. g. the recent 
outbreak of the SARS-CoV-2 virus. The fusion proteins used by the virus are potential 
targest for drug agents, as they are exposed to the environment.[97] In this chapter, the 
different types of fusion proteins are discussed. 
2.5.1 Viral Fusion 
Viral fusion differs significantly compared to neuronal exocytosis. The acceptor membrane 
does not have proteins specifically designed for the fusion of viral membrane with the host. 
Furthermore, viral fusion proteins do not necessarily have to be recycled after use, as one 
fusion event leads to the desired outcome. Consequently, viruses have developed 
alternative methods of fusing separate membranes.[96] The proteins used by viruses can be 
divided into three main classes.[98,99] Class I fusion proteins are trimers consisting mainly 
of -helical parts. Class II proteins have a -sheet as the most defining feature and class III 
fusion proteins share the features of class I and II.[99]  
One of the best researched virus fusion proteins is hemagglutinin (HA) in the influenza 
virus, which belongs to the class I fusion proteins.[100,101] In the case of HA, a protein trimer 
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is needed for this process. The monomers consist of two domains, the globular head region 
HA1, which contains the receptor-binding site and the HA2 domain, which encloses the 
fusion peptides.[101,102] Both are connected via a disulfide bridge. Briefly, the 
transmembrane viral fusion proteins form a trimer which reside in an inactive state (see 
Figure 2.5 step 1). Upon a specific trigger, which can be the interaction with a receptor or 
pH change, the protein changes its conformation rather drastically. During this change, HA1 
folds towards the outside (2) and the fusion peptide of HA2 is exposed (3). The previously 
unstructured parts form -helices which point toward the target membrane. The fusion 
peptide is inserted into the target membrane (4) and further conformational changes occur, 
leading to a bending of the proteins (5). Meanwhile, the two membranes are pulled toward 
each other, creating disturbances in the bilayers. Consequently, a hemifusion diaphragm is 
formed (6) and the fusion pore opens, completing the process (7).[98]  
 
Figure 2.5: Schematic diagram of viral membrane fusion. (1) Assembled viral 
proteins wait for a trigger. (2) HA1 folds away from HA2 but stays connected the 
whole process (not shown in following steps). (3) The fusion peptide is extended. 
(4) Insertion of the fusion peptide into the target membrane. (5) A conformational 
change of the proteins pulls both membranes toward each other. (6) A fusion 
diaphrama develops. Multiple trimers are involved in the whole process. (7) 
Opening of the fusion pore. Based on [97,103]. 
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One virus which gained worldwide attention in 2019/2020 is the severe acute respiratory 
syndrome coronavirus-2 (SARS-CoV-2). The virus causes the coronavirus disease 2019 
(Covid-19) which can lead to severe respiratory malfunctions.[104] Coronavirus (CoV) 
membrane fusion is achieved by the coronavirus spike protein, which assembles into 
trimers on the surface to form the crown-like (corona) appearance.[105,106] It belongs to the 
class I fusion proteins and is therefore similar to the HA protein in structure and fusion 
mechanism.[103,107] Fusion can be triggered either by the presence of the exogenous protease 
trypsin or the cathepsin L protease.[108,109]  
2.5.2 Mitochondrial Fusion 
In contrast to viral fusion, the mechanism for mitochondrial fusion remains elusive to this 
day. Key proteins involved have been identified but the mechanism is still being 
researched.[110] The outstanding characteristic of mitochondrial fusion is the even more 
complex task of fusing four membranes, as mitochondria consist of an outer- and inner 
mitochondrial membrane, which use a different set of fusion proteins.[111]  
The proteins involved in mitochondrial membrane fusion are part of the dynamin-related 
proteins.[110,112] These proteins are a group of GTPases which main task is to shape 
membranes. The process starts with two MFN1 (mitofusin 1) molecules on opposite 
mitochondria docking to each other. The association triggers conformational changes 
which lead to GTP hydrolysis and induces the fusion of the outer mitochondrial 
membrane.[113] The next step is the fusion of the mitochondrial inner membranes, which is 
achieved by OPa1 (optic atrophy protein 1) and MFN2. Fusion and fission of the 
mitochondrial membrane appears to be an integral part of many essential cell processes like 
cell signaling, apoptosis or mitophagy.[112]  
2.5.3 Cell-cell Fusion 
Fusion of multiple cells is an essential mechanism in mammals. Nevertheless, only a 
limited collection of cells has this ability. For example, fertilization is needed for 
proliferation of the species and includes a cell-cell fusion event. Here, the sperm fuses with 
the oocyte to convey information in form of its DNA. Immune responses also include such 
events and are crucial to maintain health of its host.[98] Macrophages are mononucleate cells 
whose range of tasks is quiet big owing to their high mobility, plasticity and 
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adaptability.[114] In certain conditions, fusion between two macrophages occurs to generate 
a multinucleated osteoclast, which has multiple tasks in bones.[115] Skeletal muscles are also 
a product of cell-cell fusion, in fact, fusion of multiple myoblasts is needed to form a single 
muscle fiber.[116]  
 
Further proteins capable of fusing membranes, have been summarized as FF-Proteins 
(fusion family).[117] These proteins are a superfamily referred to as fusexins and are required 
in both fusing membranes. Upon docking to one another, trimers form during the fusion 
process, where one of the proteins is on the opposing membranes compared to the other 
two. After a relocation process, the two membranes get pulled toward each other and a 
supposedly zippering-like process executes the fusion.[118] The most prominent proteins of 
this family are EFF-1(epithelial fusion failure 1) and AFF-1 (anchor-cell fusion failure 1), 
which are related to membrane glycoproteins found in C. elegans.[119,120]  
2.6 SNARE Proteins 
Beside the previously mentioned membrane fusion proteins, a different family of proteins 
is responsible for membrane fusion in the secretory pathway. SNAREs (soluble 
N-ethylmaleimide-sensitive factor attachment protein receptor) have been studied since the 
late 1980s and identified as a key complex in membrane fusion.[6] Though, a lot of research 
has been conducted already, SNAREs remain a point of interest concerning their fusion 
behavior to this day. In this chapter, the fusion mechanism and structure of the SNARE 
machinery is discussed. Furthermore, important associated and regulative proteins which 
are also involved in SNARE mediated membrane fusion are examined. 
2.6.1 Structure of SNARE Proteins 
For neuronal exocytosis the SNARE machinery consists of synaptobrevin 2, syntaxin 1A 
and SNAP-25 (25 kDa synaptosome-associated protein). Syntaxin 1A and SNAP-25 are 
located at the presynaptic membrane, whereas synaptobrevin 2 can be found on the synaptic 
vesicle. On the basis of the protein location, syntaxin 1A and SNAP-25 were historically 
classified as t-SNAREs (target-membrane) and synaptobrevin 2 as a v-SNARE (vesicle 
membrane). Attachment to the membrane is achieved either through a peptidic TMD (trans 
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membrane domain) or a lipid anchor (see Figure 2.6). For example, SNAP-25 uses 
palmitoyl chains to attach to the membrane whereas synaptobrevin 2 and syntaxin 1A have 
a TMD at the C-terminus.[6]  
 
Figure 2.6: Illustration of the structure of three neuronal SNARE proteins. (a) 
Synaptobrevin 2 and syntaxin 1A have peptidic membrane anchors, whereas 
SNAP-25 has lipids attached to its peptidic backbone. The subunits Qb and Qc are 
connected via a peptide chain. The chain is not part of the motif. (b) X-ray 
structure of the assembled SNARE complex with marked 0-layer. X-ray data from 
STEIN et al.[23] Molecular graphics and analyses were performed with the UCSF 
Chimera package.[121] 
The structure of SNAREs can be divided into domains which serve different functions. The 
most characteristic domain is the SNARE motif which consists of a 60-70 amino acid long 
evolutionary conserved sequence. Four of those motifs form a tetrameric coiled coil, 
yielding the core SNARE complex.[6] In case of the neuronal SNAREs, syntaxin and 
synaptobrevin contribute one -helix each, whereas SNAP-25 contributes two motifs, 
which are connected to each other via a peptidic loop. The core complex consists of 16 
layers of mostly hydrophobic amino acids, which interact with each other to form a stable 
parallel coiled coil. In the center of this bundle, three arginine (R) and one glutamine (Q) 
residue form the so called “zero layer”.[3] These specific residues are highly conserved in 
the SNARE family. Due to this, SNARE proteins are classified as R- or Q-SNAREs (see 
Figure 2.6).[122] The SNARE complex is a remarkably strong structure, which needs 
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multiple ATP molecules for disassembly.[123,124] The energy which is released during the 
formation is used to bring the opposing membranes into close proximity.[77,125,126]  
On the C-terminal end of the motif, a short linker connects it to the TMD. The linker in 
syntaxin 1A and synaptobrevin 2 are a sequence of ten amino acids each which reside in 
the junction between lipid membrane and cytosol.[6,23] The structure of the linker, especially 
its stiffness or flexibility is being discussed in literature extensively as described in section 
2.6.4.[127–130] The TMD is located on the C-terminal end of the proteins and consists of 
about 20 amino acids with mainly hydrophobic side chains.[10,23] These form primarily an 
-helical structure in the membrane. Recent molecular dynamics (MD) simulations 
suggest, that the TMD specifically of synaptobrevin has a flexible glycine kink, which 
modulates the insertion angle.[129] Furthermore, the linker and N-terminal half of 
synaptobrevins TMD (residues 85-99) form a continuous helix which is decoupled from 
the C-terminal part of the TMD (101-116) due to the glycine in position 100.[130] Also, the 
simulations suggest a tilt between 30 ° to 40 ° in a POPC membrane for the TMD of 
synaptobrevin. [129,130]  
 
At the N-terminal end of the proteins, additional domains can be located which serve many 
different functions.[6,131] For example, the N-terminal domain in syntaxin 1A forms an 
antiparallel trimeric helix bundle which interacts with the motif, resulting in two 
conformations.[132] In the closed conformation, the Habc domain is folded onto the 
N-terminal part of the motif. In this conformation, the regulatory protein munc18-1 
(mammalian uncoordinated-18) can bind to syntaxin 1A, inhibiting the formation of the 
SNARE core complex. Upon release of munc18-1, via the help of additional proteins, 
syntaxin converts to the open state, in which the core SNARE-complex formation takes 
place.[133] The question whether the domain is essential for the fusion process can not be 
generally answered. For some SNAREs (Sso1p of yeast) the domain is necessary,[134] 
whereas for others (Vamp3p of yeast) the domain is dispensable.[135] Additionally the 
N-terminal domain can serve as a docking point for different other regulatory proteins.[136]  
2.6.2 Formation of the SNARE Complex 
The assembly of the core SNARE complex and the succeeding membrane fusion have yet 
to be understood in its entirety. Due to the many proteins associated to this process, 
especially for regulation, a generally accepted mechanism remains to be found. 
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Nevertheless, the “zippering” hypothesis of SNARE fusion is the most recognized and 
describes the fusion process to start at the N-termini and proceeding toward the C-termini 
in a zipper-like manner (see Figure 2.7).[7]  
 
Figure 2.7: Illustration of the SNARE zippering mechanism. (1) Syntaxin 1A and 
SNAP-25 pre-assemble on the acceptor membrane. The vesicle with 
synaptobrevin 2 comes into proximity of the other proteins. (2) Formation of the 
half-zippered state at the N-termini of the motif. (3) Zippering continues toward 
the C-termini. (4) Completed zippering leads to pore opening. The SNARE 
proteins are now all in the same membrane and form the cis-SNARE complex. 
Based on [6]. 
Recent studies suggest the zippering to proceed in distinct steps.[9,137,138] It starts with the 
association of the N-terminal domain of the motif, which leads to the formation of a half-
zippered state. This process is slow and believed to be the rate determining step of the 
whole assembly.[139] However, during this stage the readily releasable vesicle pool is build 
which ensures a fast signal transduction between nerve cells. The half-zippered state was 
detected by several research groups with a variety of methods. Using single molecule FRET 
and EPR (electron paramagnetic resonance), the SNAREpin assembly was shown to form 
a helical structure right above the conserved ionic layer, whereas the C-terminal structure 
was determined ambiguous.[140] Another study using magnetic tweezers found similar 
results and also verified the directionality of the complex formation to go from N- to 
C-termini.[141] The intermediate state is believed to be important for the organization of the 
regulatory machinery.[139,142,143] The next step includes the zippering of the C-terminal 
domain which is accompanied by a high energy release.[9] Furthermore, it is believed that 
zippering continues throughout the linker and the TMD to trigger fusion of the 
membranes.[144–146] At this stage, all SNARE proteins are in the same membrane forming 
the cis-SNARE complex. Although, the different energy stages of the assembly were shown 
with multiple methods, it remains unclear if the natural process halts at these positions.[147]  
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2.6.3 Regulation of the SNARE Complex Formation 
Albeit the SNARE proteins resemble the minimal machinery needed to facilitate the fusion 
of the synaptic vesicles and the presynaptic membrane, many more proteins are involved 
in this process. The roles of the regulatory proteins include the priming of the complex, 
activation of proteins, sensing of triggers and many more.[6,148–150] Although, over three 
decades of research have been done in this field, the exact role of each protein has yet to be 
determined.[148,151,152] 
 
Munc18-1 was one of the first proteins found to interact with syntaxin 1A. It is arch-shaped, 
consists of three domains and belongs to the SM (Sec1/Munc18-like) protein family.[153] A 
large central cavity provides the binding surface for the closed state of syntaxin 1A. The 
N-terminal region of syntaxin including the N-peptide and Habc domains as well as the four-
helix bundle are points of contact with munc18-1.[153] The exact role of the SM protein is 
still under debate.[154] One task involves the stabilization of the SNARE complex in a 
primed state.[155] However, recent research supports the idea of munc18-1 remaining 
associated with the SNARE complex during the fusion process, making it an essential 
component of the fusion mechanism.[150,156] Accordingly, a complex between syntaxin 1A 
and munc18-1 rather than with SNAP-25 is currently debated to be the beginning of the 
fusion process (see Figure 2.8).[157]  
 
Another protein associated to the SNARE complex assembly is munc13.[152] This protein 
has a large (~200 kDa) arche-shaped multidomain structure and is involved in the opening 
of the conformation of syntaxin 1A.[158] It is also capable of bridging both involved 
membranes due to its interaction with DAG and PIP2. Furthermore, munc13 assists in the 
formation of the ternary SNARE complex between syntaxin, synaptobrevin and 
SNAP-25.[159] The cooperation of munc18-1 and munc13 ensure the formation of the four-
helix bundle and keep the system in a primed state. 
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Figure 2.8: Schematic illustration of the recent presumed fusion cycle of synaptic 
vesicles. (1) Syntaxin 1A and SNAP-25 are forming a complex which is 
presumably disassembled by NSF and SNAPs. (2) After disassembly, munc18-1 
and syntaxin 1A in its closed state form the starting complex. (3) Munc13 connects 
to both membranes and interacts with the N-terminal domains of syntaxin 1A. 
Synaptobrevin attaches to the munc18-1/syntaxin 1A complex. (4) Munc18-1 acts 
as a template to initiate the motif assembly including SNAP-25. (5) Complexin 
attaches to the four-helical bundle. (6) A calcium trigger activates synaptotagmin, 
which attaches to the motif ensamble to initiate membrane fusion. (7) NSF and 
SNAPs disassemble the fusion machinery post fusion. (8) The proteins are 
recycled and used in consecutive fusions. Mechanism based on [1,152]. 
2 Membranes and their Fusion Behavior 
________________________________________________________________________ 
20 
In neuronal exocytosis Ca2+ influx triggers the release of the neurotransmitters into the 
synaptic cleft. Sensing the change in the concentration is associated with 
synaptotagmins.[160] Synaptotagmin 1 (Syt1) can be classified as an evolutionary conserved 
transmembrane protein which is located in the synaptic vesicle. Beside the transmembrane 
domain it has two connected domains C2A and C2B which are capable of binding multiple 
Ca2+-ions.[161] After calcium binding, synaptotagmin stimulates membrane fusion by 
interacting with the target membrane.[162] However, the proteins task does involve many 
more functions. For example, another task which is associated to synaptotagmin is its 
ability to act as a fusion clamp for the SNARE complex.[160] This topic has been discussed 
controversially over the past years, as other proteins were suspected to perform in the same 
way.[163,164] Nevertheless, recent research appoints this function to the C2B domain of 
synaptotagmin.[165]  
Another protein group involved in the SNARE mediated fusion mechanism are complexins 
(Cpx). Complexins and synaptotagmins have a concurrent binding behavior to the SNARE 
complex. The interplay of the SNARE-Cpx-Syt1 tripartite is specific, as X-ray data of the 
complex showed a high complementarity between the molecules.[166] Collaboration of these 
proteins leads to a successful Ca2+-triggered neurotransmitter release. 
After the membrane fusion process is completed, the SNARE complex is disassembled and 
recycled for further uses. The dismantling of the protein complex is an integral part of the 
whole process as many consecutive fusions have to be performed in a short time. The whole 
procedure is organized by NSF (N-ethylmaleimide-sensitive factor) and SNAPs (soluble 
NSF attachment proteins). NSF is an ATPase that binds together with SNAPs to the 
assembled SNARE proteins to form a supercomplex.[167] ATP hydrolysis provides the 
necessary energy to execute the disassembly. However, the exact mechanism remains 
elusive and is topic of research interest until today.[124] 
2.6.4 Role of the Linker in SNARE mediated Fusion 
The linker connects the characteristic SNARE motif with the transmembrane domain. The 
exact role of the linker during the fusion process is under investigation for years. Most 
research focused on the flexibility of this domain and its ability to direct the energy 
generated by the motif assembly towards the TMD.[6,168] Experiments as well as MD 
simulations indicate an ambivalent characteristic regarding the stiffness, which is necessary 
for efficient fusion.[168] Stiffness is achieved by the formation of an -helix, which 
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compared to a random coil is limited in its flexibility. A stiff linker is needed to ensure a 
force propagation from the motifs to the TMDs.[127] Mechanical stress stored in the linker 
leads to a self-organization which conducts the membrane fusion process. Stress cannot be 
propagated beyond the linker if it is too flexible, MD simulations have shown.[127] 
Furthermore, the X-ray structure of the post-fusion cis-SNARE complex shows a fully 
helical TMD of synaptobrevin and syntaxin, suggesting it to be the end state.[23] The X-ray 
structure of the natural SNARE complex of syntaxin 1A and synaptobrevin 2 shows 
multiple aromatic residues present in the linker (see Figure 2.9). These are arranged in such 
a way, that they wrap around the synaptobrevin linker to form a collar of aromatic residues. 
It is assumed that these aromatic residues stiffen the linker region due to intermolecular 
interactions.[23] Furthermore, they appear to modulate insertion depth of the TMD into the 
membrane.[169]  
 
Figure 2.9: Illustration of the linkers of synaptobrevin 2 and syntaxin 1A. (a) Top 
view from the N-termini; (b) side view with N-termini on the left; (c) amino acid 
sequence of the linker domains of both proteins. X-ray data from STEIN et al.[23] 
Molecular graphics and analyses were performed with the UCSF Chimera 
package.[121] 
As the linkers of syntaxin and synaptobrevin are small, research focused on the specific 
amino acids present in the linkers. For this, different mutations, ranging from amino acid 
substitutions to the insertion of small peptides into the linker have been done. Previous 
deletion experiments of specific amino acids in synaptobrevins linker showed, that fusion 
can still be observed albeit with a loss in the efficiency.[77] Regarding the linker length, 
opposing results were reported with different experimental setups. Thereafter, linker 
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elongation may prolong the time between signal stimulus and exocytosis.[170] Furthermore, 
small changes by adding six additional amino acids does not have significant effects in in 
vivo experiments. Whereas, the addition of eleven or more amino acids to the linker have 
an impact on the growing behavior of Saccharomyces cerevisiae.[25] Unfortunately, there 
is still a lot of controversy regarding the linker. Disrupting the helicity of the linker yielded 
mixed results in literature. While overexpression of a mutant with two proline residues 
shows growth, using endogenous levels of the target protein did not.[25] This phenomenon 
was also observed in hippocampal neurons by addition of twelve and 24 amino acids.[171] 
The polybasic residues are a highly conserved motif in syntaxin 1A.[172] Multiple functions 
and mechanisms have been reported to be linked to this region of the protein, making it 
essential for the fusion process. Especially the high density of positive charges and the 
position in the membrane is important regarding the surrounding lipids.[24] Studies 
conducted with Sso1p showed that substitution of the polybasic area in the juxtamembrane 
region leads to a total loss of function of the protein.[25] Depending on the experiment, a 
substitution of as few as three residue changes showed a complete stop in activity. 
However, the exact reason for this remains unclear, as the results could not be reproduced 
with artificial liposomes.[25] Furthermore, the polybasic area is known to interact with head 
groups of lipids due to its charge and position in the membrane.[172] The recruitment of 
these lipids may therefore also be a feature of these amino acids. 
2.7 Model Systems for SNARE Fusion 
Studying the SNARE machinery can be done with an assortment of approaches. The direct 
way is to examine the proteins by themselves. Another possibility is to use molecules which 
resemble the natural systems function or structural features. Over the years, many different 
model systems have been developed to mimic the membrane fusion capabilities of 
SNAREs. Due to the high complexity of the natural proteins and whole exocytotic pathway, 
a need for more simple assemblies arose to isolate specific parts of the process. The focus 
of these structures varies from being easy to synthesize to maintaining key parts of the 
natural sequences. In the following chapter, some of these SNARE analogs are presented 
and discussed regarding their specific features. 
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2.7.1 Simplified SNARE Complexes 
One way of studying the SNARE machinery is to isolate the proteins and use them in in 
vitro experiments. The advantage of this method is that other proteins and molecules are 
excluded from the experiment while studying the targeted component. The observed results 
can be assigned beyond doubt to the isolated proteins. With this approach, the SNAREs 
were identified to be the minimal machinery needed to perform membrane fusion.[173] 
However, extraction of the proteins from their natural surroundings changes several 
important factors. Due to this, contradicting results were obtained in many studies 
comparing in vitro with in vivo experiments.[174] Especially, the time needed to facilitate 
fusion differed drastically. From the below millisecond fusion times in neurons,[175] to 
several hours until completion arose questions whether this approach is reasonable. These 
concerns were addressed by the introduction of the N-complex, a stabilized 
syntaxin/SNAP25 acceptor assembly which is capable of doing the task of membrane 
fusion in reasonable times (Figure 2.10).[7] A short fragment of synaptobrevins C-terminal 
region (AA 49-96) prevents the formation of the inactive 2:1 complex which consists of 
two syntaxin and one SNAP-25 protein. During the fusion process, the small fragment is 
replaced by the full-length synaptobrevin 2. In comparison to the 1:1 complex, the 
N-complex shows a highly increased liposome fusion rate. 
 
Figure 2.10: Illustration of the assembly pathway of SNAREs. (a) Formation of 
the 2:1 complex which reduces the fusion activity in in vitro experiments. 
(b) Demonstration of the Syb 49-69 fragment stabilizing syntaxin and SNAP-25. 
The N-complex prevents the 2:1 complex formation and improves the fusion 
speed of the system. Based on [7]. 
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2.7.2 Artificial SNARE Analogs 
Although, isolation of the SNARE proteins made research more accessible and easier to 
understand, an alternative approach reduces the complexity even further. Instead of using 
the natural system as a whole, only specific parts are used and combined with artificial 
components. It is also possible to substitute every aspect with a mimetic, to study the 
general mechanism or structure. The key features of the distinct SNARE domains are 
imitated by simpler structures. For example, instead of a four-helical-bundle as the natural 
recognition center, an interaction between only two artificial motifs is used. The approach 
of breaking down the SNAREs key features and substituting them with artificial 
components has previously shown to be successful in mimicking the fusion process.  
The recognition unit can consist of small molecules like melamine and cyanuric acid.[176] 
These are attached to a lipid anchor which are embedded in opposing liposomes. Hydrogen 
bonds between melamine and cyanuric acid are formed, which is enough to facilitate fusion 
between the two liposomes. Similar results could be obtained with the use of boronic acid 
and diols as the recognition unit.[18] In this system, an additional PEG linker was attached 
between the boronic head group and lipid anchor to prevent the recognition unit from being 
buried in the hydration layer. Another example for a fairly simple fusion system was 
developed recently and utilizes a strain-promoted alkyne-azide cycloaddition.[177] A click 
reaction between the alkine and azide fusogenes, which reside in opposing liposomes, 
induces membrane fusion. 
 
A more sophisticated approach of mimicking SNARE recognition utilizes bigger molecules 
which can be programmed to have a high specificity. It has been shown that DNA mediated 
liposome fusion can be achieved by the attachment of two complementary DNA strands in 
the right orientation to a phospholipid anchor.[178] One strand is attached at the 5’-terminus 
and the complementary strand in the opposing liposome is connected at the 3’-terminus to 
the anchor. A similar approach based on DNA as the motif uses a double cholesterol anchor 
(Figure 2.11).[20,179] The strands in the vesicles are already in a duplex formation, with one 
strand being longer and partly not participating in nucleobase pairing.This end is capable 
of interacting with the complementary strand in the other liposome and facilitates fusion in 
a zipper-like manner. The shorter ends also start interacting, leading to the generation of a 
short helix.  
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Figure 2.11: Illustration of the DNA based SNARE analog from STENGEL 
et al.[20] Both liposomes contain different sets of DNA double helices which are 
attached to the membrane by two cholesterol anchors. One of the two DNA strands 
is longer and acts as a sticky end to catch the complementary strand of the opposite 
liposome. The formation of a short and long helix pulls both membranes together, 
which facilitates fusion. 
A DNA alternative has been found to be a good motif for fusogens as well. Peptide nucleic 
acids (PNA) use a peptidic backbone onto which the nucleobases are attached.[180,181] The 
recognition between complementary strands follows the Watson-Crick pairing and can be 
easily modified. Stability and strand orientation can be modulated by exchanging 
nucleobases in the sequence. Recently, PNA was attached to a PEG linker and lipid anchor 
to successfully promote membrane fusion.[182]  
It is also possible to combine both natural and artificial structures into one model system. 
Thereby, more insight about the specific domains of the natural proteins can be gained. An 
example for this approach is the PNA-TMD model system introduced by LYGINA et al (see 
Figure 2.12).[183] PNA was used as the motif and was attached to the TMD of the natural 
proteins syntaxin 1A and synaptobrevin 2. With this system, the effect of the orientation of 
duplex assembly on fusion efficiency was tested. The antiparallel orientation showed a 
lower amount of lipid mixing compared to parallel aligned species. As a result of the 
composition of the model system, the TMD could be investigated regarding several other 
aspects. First, the use of identical or truncated TMDs showed a significant reduction in 
fusion efficiency. Furthermore, the charges at the C-terminus have been altered by 
WEHLAND et al. to inquire into their role during membrane fusion.[184] Normally the 
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C-terminus is negatively charged due to its carboxylic group. However, changing it to a 
neutral amide terminus showed an increased amount of lipid mixing. An increase was also 
observed by the use of the net neutrally charged amino acid lysine at the C-terminal 
position. The introduction of a doubly anionic charge on the other hand reduced the systems 
fusion capabilities.  
 
Figure 2.12: Illustration of the PNA-TMD model system by LYGINA et al.[183] The 
recognition motif consisting of complementary PNA strands which are attached 
to the linker and TMD of synaptobrevin 2 (red) and syntaxin 1A (blue). Watson-
Crick base pairing between the PNA motifs in the opposing membranes ultimately 
leads to fusion of the lipid bilayers. 
The PNA-TMD model system was developed even further to incorporate two types of 
PNA. N-(2-aminoethyl)glycine (aeg-PNA) and alanyl-PNA which differ in their duplex 
formation kinetics and topology.[185] A duplex consisting of aeg-PNA forms a helix, 
whereas alanyl-PNA strands form a linear structure.[186,187] The idea behind the hybrid motif 
was to force a directional zippering of the peptides and draw comparisons to the native 
mechanism. However, the use of only five aeg-PNA building blocks turned out to be the 
most optimal combination for maximal fusion efficiency.[188] Another version of this analog 
uses -peptides and -PNA and was used to modulate the distance between the two 
liposome species.[189] Although the duplex formation was oriented in an antiparallel 
manner, lipid mixing has been observed. 
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2.7.3 E3/K3-PEG-Lipid Model System 
An alternative model system for SNARE mediated membrane fusion was developed by 
MARSDEN et al.[19,190,191] Here, the three key components of the minimal SNARE fusion 
machinery; motif, linker and TMD were substituted by artificial structures. The 
transmembrane region was exchanged with a lipid or cholesterol anchor. A PEG linker with 
varying length was attached to the anchor to connect it to the artificial motif consisting of 
the heterospecific duplex peptides E3/K3. The E/K-coiled coil was first introduced by 
LITOWSKI et al. for the purpose of peptide delivery and as a capture system e.g. in 
purifications (Figure 2.13).[21] Coiled coils are generally designed following a heptad repeat 
pattern denoted abcdefg.[192,193] The residues at the positions a and d are exclusively 
hydrophobic residues which upon coiled coil formation pack into knobs-into-holes to form 
a hydrophobic core.[194] Depending on the type of hydrophobic amino acid (leucine, 
isoleucine, valine, alanine), the formation of two-, three- or four-stranded coiled coils is 
preferred.[195] In case of the E3/K3 coiled coil, positions e and g are occupied either with 
glutamic acids (E) or lysines (K) depending on the peptide species and are hampering the 
formation of homomeric coiled coils. The remaining positions are occupied by alanines or 
a contrarily charged amino acid to reduce the net charge of the peptide. These positions are 
not taking part in the coiled coil interaction and can therefore be modified more forgivingly. 
These heptads are repeated three times each to form the E3 or K3 peptide respectively. 
 
Figure 2.13: Illustration of the E3/K3 coiled coil. (a) Helical wheel depicting a 
heptad repeat of the sequences. (b) E3/K3 coiled coil side view. (c) Top view of 
the peptides. NMR solution structure from LINDHOUT et al.[196] Molecular 
graphics and analyses were performed with the UCSF Chimera package.[121] 
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The E3/K3-PEG-Lipid anchor model system is capable of fusing lipid membranes and has 
been studied extensively regarding the fusion mechanism.[197] As the membrane anchor, 
several lipids have been tested with cholesterol being the most efficient in facilitating 
fusion.[198] However, it has also been observed that the secondary structure of the motif 
changes depending on the type of lipid anchor.[197] Cholesterol bound species showed a 
more pronounced helicity indicating a more extensive interaction with the membrane. The 
effect of the distance between motif and membrane was also tested with this model system 
by attaching different lengths of PEG spacers to the two molecule species. Here, the specific 
mechanism of this analog can be observed, as the different roles of the two molecules 
become more evident. The lack of a spacer prevented fusion, whereas a too long spacer 
lessened the fusion efficiency.[197] More interestingly, the combination of asymmetric 
spacer lengths in the K lipopeptide (LPK) and the E species (LPE) showed that LPK is 
much more sensitive to variations in the linker length and determines the overall fusion 
efficiency. The authors concluded that both lipopeptides serve different functions in the 
process. The E-lipopeptide acts as a handle in such a way, that it extends into the aqueous 
surrounding and offers its motif to bind LPK (see Figure 2.14). This is supported by 
experiments which modulated the membrane pressure and showed that LPE rather forms 
random coils than to interact with the membrane.[199,200] LPE is also forming weak 
homodimeric coiled coils in aqueous environment. On the other hand, LPK showed strong 
interactions with the membrane which was shown by FTIR and temperature dependent CD 
spectroscopy.[201] This observation can be explained by lysines ability to interact with the 
polar headgroups of the lipids by snorkeling into it.[202] This K3 interaction with the 
membrane has a destabilizing effect, as lipids with smaller headgroups e.g. DOPE tend to 
be recruited by this.[197,203–205] Consequently, the membrane is more prone to fuse as the 
destabilization reduces the energy needed for the merger. 
It was concluded, that the LPE motif grabs onto K3 and transfers it to the other membrane. 
The interaction of K3 destabilizes both membranes which leads to the formation of 
protrusions. At this point, the distance between the liposomes is minimal which 
subsequently leads to fusion.[197]  
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Figure 2.14: Schematic representation of the fusion behavior of LPE and LPK by 
DAUDEY et al.[197] (1) E3 acts as a handle to recruit the membrane bound K3. 
(2) Coiled coil formation of E3/K3. (3) K3 is transferred to the opposing 
membrane. Destabilization of both membranes by K3 promotes fusion. (4) E3 is 
also forming weak homodimeric coiled coils. Based on [197]. 
2.7.4 E3/K3-TMD Model System 
With the E3/K3 coiled coil being established as a good alternative motif to the comparably 
big SNARE recognition unit, it was incorporated into a similar SNARE alternative. The 
E3/K3-TMD model system is a combination of two peptides which are designed to mimic 
the function of the natural SNARE core complex.[6] It was first introduced by MEYENBERG 
et al. and tested upon its fusion capabilities.[22,206] Both peptides consist of an artificial motif 
and a native linker and transmembrane domain as illustrated in Figure 2.15. The unique 
feature of this system is the incorporation of the native amino acid sequences into the 
design. Additionally, the artificial part is of peptidic nature which makes the transition 
between the two seamless. In comparison to other SNARE analogs the topology resembles 
more closely the native one. This has the advantage of being able to form -helical 
structures throughout the whole peptide. Both the peptides E3-Syb and K3-Sx contain 30 
amino acids of the natives TMD and linker. Therefore, not all amino acids of the designated 
linker region of the natural proteins are included in this mimetic. 
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Figure 2.15: Illustration of the E3/K3-TMD system by MEYENBERG et al.[22] The 
peptides E3-Syb (orange/red) and K3-Sx (blue) reside in opposite membranes. 
Formation of a coiled coil initiates fusion of both membranes. 
As the artificial motif, the E3/K3 coiled coil pair has been chosen due to its simplicity, high 
stability and it being well characterized.[206] Additionally, the coiled coil was already 
successfully used for vesicle fusion in a similar system (see section 2.7.3).[19] A side effect 
of the artificial motif K3 is its ability to adhere to membranes and destabilize them.[197,202] 
This feature differs from the natural system and has yet to be investigated in more detail. 
 
One advantage of the E3/K3-TMD system is the high potential of modification. In fact, due 
to its peptidic nature and the current state of peptide synthesis methods, alterations are very 
easy and reliable. On the other hand, a disadvantage of the model system is the amphiphilic 
character of the peptides. The hydrophilic motif and the lipophilic TMD make the 
purification quiet challenging. For this reason, up until now, experiments performed with 
this system could not be conducted with high peptide quality.[206,207] 
Nevertheless, the system is capable of performing full fusion as indicated by lipid and 
content mixing assays.[22] Furthermore, an increase of the K3-Sx linker length showed a 
reduction in fusion efficiency and especially lowered the amount of content mixing.[206] 
Similar to the PNA-TMD model system (see section 2.7.2), differently charged C-termini 
have been introduced into the E3/K3-TMD peptides.[207] The exchange of the carboxy 
group with an amide yielded the most fusogenic system, whereas additional negative 
charges reduced overall fusion efficiency. Furthermore, antiparallel variants of E3-Syb and 
K3-Sx have already been synthesized and their fusion behavior studied in lipid mixing 
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assays. This orientation significantly hampered with the systems ability to perform fusion 
and is in line with the expectations considering the natural machineries setup. 
Considering all the above, the E3/K3-TMD model system offers many possibilities of 
modification, easy synthesis and high potential regarding its comparability to the natural 




 Detection of Liposome Fusion Events 
Over the years many different methods of monitoring liposome fusion in vitro have been 
developed.[208] Techniques ranging from bulk assays with many liposomes fusing 
simultaneously to the observation of single vesicle fusion events are used for this 
purpose.[209,210] Most of these methods use a fluorescence-based approach, where a 
fluorophore is incorporated either into the membranes or the peptides itself. Fusion can 
then be observed by monitoring changes in the fluorescence intensity using a microscope 
or spectrometer. During the fusion process, different stages are passed (e.g. docking or 
hemifusion, see section 2.3) which can be distinguished using some of these methods.  
Many of the techniques use two fluorophores which form a Förster resonance energy 
transfer (FRET) pair.[211] FRET is a physical phenomenon where energy is transferred non-
radiatively between a donor and acceptor fluorophore.[212] The donors emission spectrum 
overlaps with the acceptors excitation spectrum. The energy transfer is very sensitive to the 









The FRET efficiency 𝜂𝐹𝑅𝐸𝑇 is a result of the distance r between the fluorophores and the 
Förster radius R0, a value describing the distance where 50 % efficiency is reached between 
the specific fluorophores. FRET is most efficient between the ranges of 1-10 nm.[213] In the 
following chapters, fusion monitoring methods are described which were used in this work. 
3.1 FRET Dequenching Assay 
FRET dequenching assays are bulk fusion detection methods where total lipid mixing 
(TLM) is observed using a FRET pair. The donor fluorophore N-(7-nitro-2-1,3-
benzoxadiazol-4-yl) (NBD) and the acceptor dye Lissamine rhodamine B (Rh) are both 
introduced into the same liposome species (see Figure 3.1). Both are connected to a lipid 
head group e.g. DOPE and embedded in an appropriate concentration inside the membrane. 
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Due to the fluorophores being in close proximity within the FRET range (see equation 3.1), 
excitation of the donor leads to the energy transfer and light emission of the acceptor. FRET 
can be reduced by increasing the distance between the dyes in the vesicle. This can be 
achieved by the merger with a liposome lacking fluorophores. As the average distance 
between the FRET pair increases, the acceptor emission decreases. This results in an 
increase of the donor emission during its excitation.  
 
Figure 3.1: Illustration of FRET dequenching assay. Two liposome species are 
decorated with different peptides. The labeled liposome contains both 
fluorophores and the E3-Syb peptide. Due to the small distance between the 
fluorophores, FRET occurs, which leads to the emission of light by the acceptor. 
The unlabeled liposome only contains the K3-Sx peptide. After fusion, the 
concentration of the fluorophores decreases and the distance between the 
molecules increases. FRET can no longer occur and the donor emits light. 
However, this method cannot differentiate between full and hemifusion, as the fluorophores 
are located in the inner and outer leaflet. To distinguish between the two, NBD of the outer 
leaflet can be destroyed e.g. through oxidation. Consequently, an increasing NBD emission 
can only be due to inner leaflet mixing (ILM).  
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3.2 Dynamic Light Scattering 
An alternative method of detecting fusion between liposomes is dynamic light scattering 
(DLS). With DLS the sizes of the liposomes can be monitored. Comparing sizes of the 
initially used liposomes with the population post fusion is a direct way of observing fusion 
or aggregation. Using DLS to determine the size increase has been established in the past 
decades.[214–217]  
The technique uses monochromatic light which is directed at the sample. The light is then 
scattered depending on the size and shape of the macromolecules.[218] Additionally, the 
intensity fluctuates due to Brownian motion is measured. The particle size is one of the 
defining properties responsible for the fluctuation frequency. The smaller the particle, the 
faster it moves. The fluctuations of the scattered light are recorded and analyzed according 








The hydrodynamic diameter dh is calculated using the Boltzmann constant kB, the absolute 
temperature T, the viscosity of the solvent 𝜂 and the diffusion coefficient D. The coefficient 
is calculated out of the decay rate, which is gathered during the autocorrelation analysis of 
the fluctuations. The equation applies only to spherical particles, which makes the 
interpretation of other shaped pieces challenging. Furthermore, the hydrodynamic diameter 
includes the core particles as well as anything bound to the surface e.g. ions and the 
hydration sphere. The measured size is therefore always larger than its actual size. The 
hydrodynamic radius is often presented as a Z-average value, which is the intensity 
weighted mean of the measurement.  
An additional value obtained with this method is the polydispersity index (PdI), which 
describes the heterogeneity of the measured sample based on size. The larger the number, 
the more heterogenic the sample.  
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 Optimization of Fusion Assays 
In this chapter, the experimental setup and parameters are investigated thoroughly to 
improve upon previous difficulties in the analysis of the fusion behavior of the E3/K3-TMD 
model system. In section 4.1, the applied experiments are described and introduced 
refinements are discussed. Section 4.2 focusses on the synthesis of the peptides used in this 
work. Here, different methods were tested and evaluated to improve the overall purity of 
these peptides. Finally, part 4.3 is about multiple optimization approaches in the different 
experimental steps of FRET dequenching assays. The resulting effects and outcomes are 
presented and discussed regarding their benefits. 
4.1 Fusion Assays 
The main measurement technique employed in this work were FRET dequenching assays. 
As described in chapter 3.1, two different liposome species were used. The one including 
the FRET pair (labeled liposome) was either not containing any peptide or exclusively a 
E3-TMD peptide variant. The unlabeled vesicles were always decorated with a K3-TMD 
if a peptide was used. 
4.1.1 Liposome Preparation 
The liposomes were prepared by combining all components in small glass tubes (detailed 
description in chapter 9.4). The lipids and peptides were stored as stock solutions in 
chloroform or TFE at -20 °C. Lipids were additionally stored under an argon atmosphere 
to reduce the amount of oxidation. In order to minimize evaporation of the solvents, the 
solutions were kept at 0 °C during usage and only briefly exposed to ambient air for 
withdrawal. After combining of all components in the glass tube, the samples were vortexed 
for 5 s and heated to ambient temperature. As TFE and chloroform are immiscible at 0 °C, 
the samples were vortexed a second time for 5 s to ensure even mixing. Next, the solvent 
was evaporated at 50 °C using a nitrogen stream. A lipid film formed in the bottom part of 
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the glass tube which was dried overnight in vacuo. Lipid films were generally used one day 
after preparation. Rehydration was achieved by using HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) buffer and small glass beads at a temperature of 40 °C while 
stirring for at least 2.5 h. During this time, the formation of multilamellar vesicles (MLVs) 
occurred by the detachment of the lipid films from the glass wall. Prior to extrusion, the 
solution was vortexed for 5 s, exposed to sonication for a maximum of 10 s and vortexed 
again for 5 s to yield a fine cloudy solution. The solution was extruded through a 
polycarbonate membrane to yield large unilamellar vesicles (LUVs) with diameters ranging 
from 120-150 nm. Lipid loss was determined for E3-Syb peptide containing vesicles to be 
~32 % and K3-Sx containing vesicles at ~45 %. These values were highly dependent on 
the used peptide and also varied in between same peptide species. K3-Sx containing 
vesicles were always extruded last, as the stability is lower compared to the other used 
vesicle species. The time between extrusion and start of the measurements for each 
measurement was below 5 min, eliminating effects which could occur in case of 
aggregation of the vesicles over a period of time. 
4.1.2 Lipid Mixing Assays 
The measurements were performed at 25 °C in HEPES buffer to ensure comparability to 
previous experiments. [22,188,207,219] To the buffer ethylenediaminetetraacetic acid (EDTA) 
was added to catch present Ca2+-ions, which are known to be involved in the natural 
SNARE mediated vesicle fusion (see section 2.6.3). Effects due to the ion are inhibited in 
presence of EDTA. Additionally, dithiothreitol (DTT) was added to prevent disulfide 
bridge formation of cystein residues by oxidation.  
Primarily, FRET dequenching assays were performed using the FRET donor 7-nitro-2-1,3-
benzoxadiazole (NBD) and acceptor Lissamine Rhodamine B (Rh). These labels were also 
used in previous experiments which increases comparability between these 
results.[188,206,207] The use of Oregon Green 488 (OG) and Texas Red (TR) was also tested, 
but did not show significant benefits compared to NBD and Rh. In fact, handling these 
labels was more challenging, as they are more sensitive to ambient light and are therefore 
more prone to photo bleaching. In addition to the dequenching assays, FRET quenching 
assays were also performed for a few samples. However, the obtained results were not 
consistent and reproducible and consequently not included in this work.  
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Vesicles containing E3-Syb peptides were prepared containing the lipidic fluorophores 
whereas K3-Sx vesicles were always unlabeled. As described in section 4.3.3, it cannot be 
ruled out, that the fluorophores interact with the peptides. The interaction is small but is 
nevertheless being taken into account by the use of the right control measurements (see 
section 4.3.4). Stability of the vesicles was the main complication in previous 
experiments.[207] Indeed, K3-Sx vesicles are much more prone to aggregation and lipid loss 
during extrusion. But the optimizations employed to the FRET dequenching assays 
improved vesicle stability significantly (see section 4.3). 
4.1.3 Dynamic Light Scattering Experiments 
Dynamic light scattering (DLS) experiments were performed for each single vesicle 
population as well as with the mixed populations after the FRET dequenching assays (for 
a more detailed description see chapter 9.4). Measurements for different vesicle species 
were done within 5 min after extrusion. The exception being the mixed population, which 
was measured directly after the 20 min fusion assay finished. With this approach, the 
vesicle sizes at the start of the dequenching assays could be determined consistently. For 
the measurements, part of the vesicle sample was diluted with buffer. The reason for this 
was twofold. A too high concentration of particles in the DLS sample can lead to multiple 
light scattering.[218] This phenomenon occurs when a photon is scattered by more than one 
particle. The result is a reduction in the particle size measured. Second, the DLS and fusion 
assay measurements could be performed simultaneously. The times between extrusion, 
DLS and dequenching assay measurements were reduced to a minimum. This way, the 
sizes of the vesicles conform to both experiments, ruling out time dependent alterations of 
the sample. The measured sizes differed for the different peptide species as illustrated in 
Figure 4.1. 
Generally, E3-Syb containing vesicles were smaller compared to K3-Sx vesicles. 
Liposomes without peptides were about the same size as E3-Syb vesicles with a diameter 
intensity mean (Z-average) of ~125 nm. K3-Sx vesicles were usually measured with 
~135 nm and mixed vesicles with ~145 nm. The value for the mixed vesicles is a 
composition of the two used vesicle species and fused vesicles. The increased size of the 
particles after mixing indicates that the vesicles either fused or aggregated. In conjunction 
with the fusion assays as well as with previous results using this model system,[22] the size 
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increase is believed to be due to vesicle fusion rather than aggregation. Size increase was 
only observed in case of a positive FRET dequenching assay result. 
 
Figure 4.1: Exemplary DLS data of the three different vesicle populations. (blue) 
Vesicle population containing E3-Syb peptides and the FRET fluorophores. 
(red) Vesicles with K3-Sx peptides. (green) Mixed population consisting of E3-
Syb, K3-Sx and fused vesicles. 
The relatively small size increase can be explained with the stoichiometry of the fusion. In 
the case of E3-Syb vesicles having a size of 125 nm and K3-Sx vesicles 135 nm, the 
theoretical size can be calculated using the volume of a sphere with the following equation: 
 𝑉 = 1 6⁄ 𝜋𝑑3. After summation of both volumes, the diameter of the fused vesicle can be 
calculated yielding 164 nm. This implies a fusion ratio of K3-Sx/E3-Syb = 1:1. However, 
the volume ratio at which the two vesicle species are mixed is K3-Sx/E3-Syb = 4:1. 
Therefore, after the hypothetical complete fusion, two kinds of vesicles are left in the 
sample. Three parts of K3-Sx vesicles and one part of the fused species. Calculating the 
mean diameter of these four vesicles yields ~142 nm. This diameter lies in the size range 
of the measured mixed species. Of course, this explanation attempt has to be treated very 
cautiously, as it leaves out many other plausible liposome species and other factors. For 
example, fused liposomes resulting of more than one fusion event, or docked liposomes are 
not factored in. Moreover, as the FRET dequenching assays show, not all vesicles are 
involved in fusion events. The majority of particles in the sample remain sized like the 
initial two species. With these caveats in mind, the size increase is expected to be small, 
rather than to show a significant difference. Additionally, smaller sizes indicate that no 
4.2 Peptide Synthesis 
________________________________________________________________________ 
41 
aggregates are formed, which in return can help to draw conclusions about the used model 
system. Consequently, the DLS data acquired has to be accompanied by other 
measurements for interpretation. Nevertheless, the technique can give more information 
about the fusion experiment and especially the quality of the vesicles used (see also section 
4.3.2). 
4.2 Peptide Synthesis 
The E3/K3-TMD model system is a combination of an artificial motif connected to the 
native linker and transmembrane domain (TMD) of synaptobrevin II and syntaxin 1A. The 
motif consists of the well-studied E3/K3 coiled coil pair.[21,220–222] The model system has 
been developed earlier and was already tested for its fusion capabilities.[22,184,206] Synthesis 
of all peptides was performed via automated microwave assisted solid phase peptide 
synthesis (SPPS). Briefly, SPPS uses a solid support onto which the peptide is bound 
covalently and is elongated with consecutive couplings.[223] Excess reagents and other 
solvable side products can be removed easily via filtration. The synthesis utilizes an 
orthogonal protecting group strategy and optimized reagents for high yields and purity.  
 
The syntheses were performed on a total of three different synthesizers. Two of which were 
of the same model but used different methods for coupling. Generally, the same reagents 
were used for all synthesizers, but different coupling times, concentrations and 
temperatures were applied. As solvent dimethylformamide (DMF) was used for all 
synthesizers. The specific reaction conditions for every machine are listed in section 9.3. 
For the solid support a low loaded Wang resin, preloaded with the first amino acid, either 
glycine or threonine, was used. The low load density (0.28-0.36 mmol/g) makes the 
individual peptides spatially more available and reduces aggregation of the peptides. The 
resins were equipped with sufficient swelling properties, enhancing the handling and 
reducing swelling times prior to synthesis. After cleavage, the peptides were left with a 
carboxylic acid at the C-terminus. The effect of different C-terminal groups and amino 
acids was previously studied with the E3/K3-TMD and PNA-TMD model system.[184,207] 
To stay close to the natural system, no additional modifications have been made in the 
TMDs of both peptide species.  
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Deprotection of the N-terminal fluorenylmethyloxycarbonyl (Fmoc) group was achieved 
with 20 % or 25 % piperidine in DMF. The reaction was heated to 90 °C for 90 s to 
maximize the deprotection rate. After deprotection, the next amino acid was coupled onto 
the peptide. The coupling method was chosen following three criteria. First, which 
synthesizer was the peptide coupled on. Second, which kind of amino acid was coupled. 
For arginine, cysteine and modified amino acids, specialized methods were used to reduce 
side reactions and improve coupling efficiency. Third, the position of the amino acid in the 
peptide sequence was considered. The first 30 amino acids were coupled once, whereas all 
subsequent amino acids were coupled twice. This was done to maximize coupling 
efficiency and reduce the amount of undesired peptides with errors in the sequence due to 
omission. Coupling was facilitated with commercially available amino acids (5 eq.), the 
activator N, N′-diisopropylcarbodiimide (DIC) (5/10 eq.), Oxyma Pure (5 eq.) as an 
additive to prevent racemization and DIPEA (0.5 eq.) to reduce formation of precipitates 
of the reagents. Coupling times and temperatures differed between the individual 
synthesizers. Most peptides were coupled at 90 °C for 4 min. However, the best results 
were obtained using the CarboMAX method which was developed by CEM.[224] Here, an 
increased amount of DIC (10 eq.) and an elevated temperature of 105 °C were used. This 
method decreased the overall needed time and yielded better HPLC separation results and 
less impurities in mass spectra of the raw peptide. 
Cleavage from resin and deprotection of all protecting groups of the amino acid side chains 
was achieved simultaneously with a mixture of TFA/TIS/EDT/H2O (95:2:2:1, v/v/v/v). TIS 
and H2O were used to capture reactive products and EDT to prevent disulfide formation 
between cysteine residues. Prior to HPLC purification, the raw peptide was precipitated 
multiple times in ice cold diethyl ether and resolubilized in HFIP and water to get a uniform 
powder after lyophilization. 
All in all, the synthesis of the peptides was improved due to the use of optimized synthesis 
methods. The peptide quality before purification was increased, which is beneficial for all 
consecutive steps e.g. FRET dequenching assays. 
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4.3 Enhancement of FRET Dequenching Assays 
In previous experiments FRET dequenching assays conducted with K3-Sx and E3-Syb 
revealed many obstacles. Especially, the stability of K3-Sx vesicles posed a challenge in 
the preparation and use during measurements.[207] The main problem has been identified as 
an aggregation process of the vesicle solution pre and post extrusion. The aggregation was 
monitored with a variety of techniques and was also visible for the naked eye as the 
formation of precipitant would occur within only a few minutes. Vesicles containing no 
peptides, either labeled or unlabeled, did not show any kind of aggregation. This lead to the 
conclusion, that the used peptides are the main factor of this event. To improve upon the 
above-mentioned challenges, several tests have been performed in this thesis. 
The following experiments were done using the peptides shown in Table 4.1. The 
combination of E3-Syb(RKY) and K3-Sx(QSK) is referred to as the reference system in 
this work. The peptide sequences match the ones originally introduced by 
MEYENBERG.[22,206] 
Table 4.1: Peptides used for the optimization process. The sequences of the 
transmembrane domains and linker (bold) resemble the ones of the natural 
proteins synaptobrevin 2 and syntaxin 1A. 
Peptide Sequence No. 
E3-Syb(RKY) G-(EIAALEK)3-RKYWWKNLK-MMIILGVICAIILIIIIVYFST-OH (1) 
K3-Sx(QSK) WWG-(KIAALKE)3-QSKARRKK-IMIIICCVILGIIIASTIGGIFG-OH (2) 
4.3.1 Peptide Purity as a Factor for Fusion 
In previous works, the decrease of vesicle concentration from 5 nM to 1.3 nM yielded more 
stable vesicles, as well as an increase of fusogenicity.[188] These advancements were 
achieved using a similar model system consisting of an aegPNA motif attached to the 
natural TMD. These improvements were implemented in this thesis using the E3/K3-TMD 
system. However, this complex behaves quite differently and therefore additional 
adjustments had to be made. 
To gather more consistent and reliable data in experiments where peptides are used in 
vesicles, the production of these vesicles had to be optimized. The first approach was to 
use peptides of a higher purity. In previous experiments, the purification of the E3-Syb and 
K3-Sx was not successful.[206] After more research and optimization, these peptides could 
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be purified successfully (for more details, see chapter 9.2.7). Solvation of the raw peptides 
in HFIP and water before elution upon a HPLC column yielded a significant increase in 
peptide purity (See Figure 4.2). Each peptide used for this thesis was successfully purified 
and its quality verified via UHPLC and high-resolution mass spectrometry.  
 
Figure 4.2: UPLC chromatograms of a raw/unpurified peptide and the same 
peptide after HPLC purification. Parameters: ACE Excel 2, 100 A 2 m C18, 
gradient 70-99 % B in 8 min, 50 °C, 215 nm. A: water + 0.1 % TFA; B: 
MeOH + 0.85 % TFA. 
Intuitively, purified peptides should be capable of fusing LUVs more efficiently and 
effectively, as no impurities should interfere with the pure peptides. In addition, 
determination of peptide concentration should be more accurate as a consequence of the 
reduced number of break-off peptide sequences. This entails a higher number of peptides 
capable of performing the fusion process. According to these assumptions, unpurified 
peptides should yield a lower signal and a slower increase in dequenching FRET assays. 
Surprisingly, the exact opposite effect was observed in multiple experiments as seen in 
Figure 4.3. After 20 min the disparity in the absolute signal is about 6 % which translates 
to a relative difference of 40 % between the curves. Furthermore, in the first 200 s a 
noticeable contrast in kinetics, regarding the slope is present. From these observations, it 
can be concluded that the vesicle species with unpurified peptides fuse more rapidly as well 
as more effectively, leading to a higher total signal. These findings contradict the initial 
predictions regarding the fusion behavior.  
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Figure 4.3: FRET dequenching assay of the reference system with a peptide/lipid 
ratio of 1:200. The effect of using HPLC-purified peptides (red) in comparison to 
unpurified peptides (blue) is shown. The curves represent the average of at least 
three measurements and the error bars show the standard deviation. 
Apparently, break-off peptide sequences and other impurities have a different effect on the 
fusion process as previously thought. A reason for this observation could be that the 
impurities destabilize the vesicle membranes, reducing the energy needed for fusion. 
Another approach to explain this discovery, is that the lack of impurities leads to more 
homomeric interactions with the completed peptides. For example, K3 is capable of 
forming homodimeric structures, albeit the percentage of peptides following this behavior 
is quiet low.[225] In combination with observations of syntaxin 1A clustering in 
membranes,[226–229] it is possible that the interaction between the peptides is more prominent 
without impurities. A stronger homomeric binding behavior entails less peptides which are 
engaged in the fusion process. Furthermore, kinetics can change as a result of the new 
formed complex of K3-Sx, reducing the speed of fusion. One more reason for the higher 
signal of the unpurified species can be related to the peptide concentration. Especially in 
case of K3-Sx, a big discrepancy in the number of peptides in the vesicles is possible. The 
tryptophan residues used for the determination of the concentration are located at the 
N-terminus and are therefore coupled last. The coupling efficiency decreases with the 
length of the peptide, making it more likely to produce peptides with just one or even 
without tryptophan residues.[230] In the end, the tryptophans are not important for the 
interaction of the E3/K3 motif (see chapter 2.7.3), making them capable of performing the 
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fusion. However, the tryptophan residues are vital for determining the concentration of the 
stock solution.  
To summarize, these results show that the impurities increase the FRET intensity measured, 
rendering peptide purification as an essential step to obtain more accurate results. Without 
purification, more peptides capable of performing the necessary interactions are used in the 
experiment than intended, leading to a higher total signal. Additionally, the stability of the 
vesicles was improved as no precipitant formed within a few hours after extrusion. 
However, a polymodal particle solution could be measured via DLS after a few minutes, 
indicating aggregation. Further improvements had to be implemented to produce even more 
consistent and reliable data. 
4.3.2 Peptide to Lipid Ratio 
The use of purified peptides in the dequenching FRET experiments lead to a decrease in 
total fusion efficiency. However, the loss of intensity was accompanied with more reliable 
data and a deeper understanding of the role of impurities in this process. After all, the main 
complication in preceding experiments was the stability of the K3-Sx vesicles. Although 
using purified peptides did not solve this problem, a significant improvement in data quality 
was achieved. The next approach focused on the number of peptides included in the 
vesicles. 
Determining the quality of the vesicles was achieved by DLS measurements (see also 
section 4.1.3). A monomodal sample with a small Polydispersity index (PdI) is a good 
indication whether the used vesicles are stable and can therefore be used for the FRET 
dequenching assays. As illustrated in Figure 4.4, E3-Syb and labeled vesicles without 
peptides show a narrow distribution with an average diameter of 125 nm and 124 nm 
respectively. Both vesicle species maintained their size for several days and can therefore 
be considered as stable. K3-Sx vesicles on the other hand, showed a much bigger PdI of 
0.406, in comparison to 0.069/0.078, a mean diameter of 172 nm and multiple peaks 
ranging up to 6000 nm. In this polymodal solution the mean diameter is not a reliable value 
anymore. The measurement for the K3-Sx vesicle species was observed just 2 min after 













E3-Syb(RKY) 125 0.069 
K3-Sx(QSK) 172 0.406 






E3-Syb(RKY) 123 0.047 
K3-Sx(QSK) 134 0.083 
 
Figure 4.4: DLS data of the different used vesicle species. (red) E3-Syb vesicles. 
(blue) K3-Sx vesicles. (green) Labeled vesicle without peptide. (a) DLS data of 
vesicles used in the experiments with P/L = 1:200. (b) Vesicles used in 
experiments with P/L = 1:500. The labeled vesicle species is omitted, as there is 
no difference in the experiments due to the lack of peptides in this vesicle. 
To improve on the inconsistent K3-Sx vesicles, a variety of changes in the preparation 
method have been tested. For example, the vesicles were exposed to several freeze-thaw 
cycles, purification of the vesicles using gel-columns and the lipid composition was 
changed. Despite several tests, the quality of the K3-Sx vesicles could not be improved 
significantly until changes in the peptide to lipid ratio were implemented. Previously, 
changes to the peptide to lipid ratio from 1:200 to 1:1000 yielded promising results in the 
PNA-TMD system.[188] However, this ratio was not suitable for the use with the E3/K3-
TMD system, as the FRET dequenching assay signal were too low. The difference between 
the control and a measurement with the reference system in total intensity was below 1 %, 
making it impossible to detect any changes in the fusion behavior. In the end, using a 
P/L = 1:500 ratio resulted in positive results regarding the dequenching assay intensities as 
well as vesicle quality as illustrated in Figure 4.5. 
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Figure 4.5: FRET dequenching assay comparison between different P/L ratios 
and their corresponding control. (red) 1:200 measurements with a difference in 
intensity after 20 min of 5.5 %. (blue) Measurements with P/L = 1:500 showing a 
difference of 8.2 % after 20 min. The nearly identical curve of the 1:200 control 
and 1:500 reference is coincidental. Error bars for control measurements were 
omitted due to the comparably small error. All measurements were performed 
thrice. 
First, the reference measurements of P/L = 1:200 show the biggest total increase after 
20 min in signal intensity. Surprisingly, one of the measurements reached a total intensity 
of over 23 %, making it the highest recorded measurement in this work. However, this is 
also accompanied by the biggest mean variation as indicated by the error bars. These 
measurements were much more inconsistent in terms of their total signal intensity. In the 
first 200 s of the measurements, the P/L = 1:200 reference and control experiments showed 
very similar kinetics. This observation is quiet surprising, as the control has only one of the 
two needed peptides (K3-Sx(QSK)) and should therefore show completely different 
kinetics in the beginning. In fact, this observation leads to the conclusion that the vesicles 
of the control interact with each other in some way, that the fluorophores are being 
separated from each other. The liposomes are capable of either fusing with only one peptide 
present, or K3-Sx destabilizes the other vesicle species. Both scenarios are not desirable 
during the investigation. The total intensity difference between control and reference was 
5.5 % after 20 min. This translates to only a 30 % lower end state of the control compared 
to the reference. Also, as indicated by the error bars, an overlap between control and the 
other experiment is quite possible, making it difficult to draw conclusions. 
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The P/L = 1:500 measurements show an overall lower total intensity increase. Nonetheless, 
the difference between control and the reference measurement in the total signal intensity 
is 8.2 %, making the control measurement 65 % less efficient than the reference. 
Furthermore, all P/L = 1:500 measurements showed less deviation in the individual 
experiments, hence more consistent data was produced.  
Another improvement was observed in the vesicle stability. For this experiment, vesicles 
with the purified peptides incorporated were prepared and immediately analyzed via DLS. 
Afterwards, the stock solution of the vesicles was left at room temperature for 15 days and 
subsequently analyzed again. The experiments were performed with both P/L ratios as 








E3-Syb Fresh 125 0.069 
E3-Syb Old 129 0.103 
K3-Sx Fresh 154 0.254 






E3-Syb Fresh 122 0.047 
E3-Syb Old 126 0.071 
K3-Sx Fresh 140 0.094 
K3-Sx Old 145 0.111 
 
Figure 4.6: DLS data comparison of vesicle species with different P/L ratios and 
different age. (red) E3-Syb vesicles. (blue) K3-Sx vesicles. Dark colors depict 
vesicles which were measured within 5 min after extrusion (fresh). Pale curves 
show measurements after 15 days (old). (a) Measurements with P/L = 1:200. The 
correlation data of the old K3-Sx and fresh E3-Syb measurement is shown for 
comparison. (b) Measurements with P/L = 1:500 vesicles. 
E3-Syb vesicles did not show a significant change regarding the DLS signals after 15 days 
regardless of which peptide to lipid ratio was used. Surprisingly, the same effect was 
observed with K3-Sx vesicles with P/L = 1:500. Both, the change of the mean diameter and 
the PdI was minimal and no visible precipitate could be seen. On the other hand, K3-Sx 
4 Optimization of Fusion Assays 
________________________________________________________________________ 
50 
species with P/L = 1:200 showed significant formation of precipitate as well as a noticeable 
shift to bigger vesicle sizes. Unfortunately, the size representation of the old K3-Sx sample 
is not accurate due to the macroscopic particles in the sample. The correlation data shown 
in Figure 4.6, illustrates, that the 15 days old K3-Sx vesicles cannot be described 
sufficiently with the mean diameter and PdI. This is also true for the fresh K3-Sx sample 
due to the polymodal character of the sample. 
In conclusion, changing the P/L to 1:500 improved the stability and size distribution of the 
K3-Sx vesicles significantly. In addition, the deviations of the individual FRET 
dequenching assays were significantly lowered, improving the overall data quality in 
respect to reliability, reproducibility and handling of the sample. 
4.3.3 Effect of Fluorophores  
The FRET pair used for the fusion assays are Lissamine rhodamine B (Rh) and N-(7-nitro-
2-1,3-benzoxadiazol-4-yl) (NBD) which are attached to the lipid anchor DOPE. The 
fluorophores are located at the polar head group region and can therefore interact with 
peptides or proteins.[231,232] Depending on the pH, the fluorophores are likely charged and 
can therefore interact with other charged molecules. To investigate whether this is also the 
case for the E3/K3-TMD model system, experiments involving the fluorophores 
monitoring the effect on fusion assays and vesicle sizes have been performed. The impact 
of the interaction between fluorophore and E3/K3-TMD peptides can be seen in Figure 4.7. 
In these experiments there are two main differences between the curves apparent. First, 
they differ in the matter of which vesicle population the FRET fluorophores are 
incorporated. Second, the ratio at which the vesicle species are mixed stays the same 
regarding the labeled and unlabeled species. This means, that the experiments from the red 
curve have a ratio of E3-Syb vesicle/K3-Sx vesicle = 1:4 and the blue curve the inverted 
ratio. From a statistical standpoint it does not matter which population is more abundant. 
However, this might still affect the fusion assays in an unexpected manner.  
Primarily, FRET dequenching assays were performed with the fluorophores present in the 
E3-Syb vesicles (red curve). In this case an increase in signal intensity and an expected 
curve form can be observed in the fusion assay. On the other hand, incorporation of the 
fluorophores in the K3-Sx vesicles lead to a very small intensity increase, comparable with 
control measurements.  
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Figure 4.7: FRET dequenching assays of different labeled vesicle species. (red) 
Standard assay with E3-Syb peptides in the labeled vesicle. (blue) K3-Sx peptide 
in the labeled vesicle. The labeled vesicles contained NBD-DOPE and Rh-DOPE 
lipids, each at 1.5 mol%. The measurements were performed with P/L = 1:200. 
Apparently, the location of the fluorophores matters in this assay with the E3/K3-TMD 
models system. There are three possible explanations for this behavior. First, K3-Sx 
interacts with the fluorophores rather than or in addition with E3-Syb to perform fusion. 
This hypothesis would explain the high signal increase in the standard fusion assay with 
the labels incorporated in the opposing vesicles of K3-Sx. This can be disproven by doing 
the same experiment but without the incorporation of the E3-Syb peptide. The experiment 
is discussed in more detail in section 4.3.4. Second, K3-Sx sticks to the own membrane 
more strongly due to the fluorophores interacting electrostatically with it. In this case fusion 
efficiency would suffer as the peptide to peptide interaction would decrease. This would 
explain the blue curve in Figure 4.7. Third, the ratio of E3-Syb vesicles and K3-Sx vesicles 
in the sample has a direct impact on the fusion efficiency.  
To elaborate on the possible explanations, DLS experiments were performed concomitant 
to the fusion assays (see Table 4.2). Comparison of the E3-Syb vesicle sizes shows a small 
difference (~5 nm) depending on the presence of fluorophores in the same vesicle. The size 
difference of the K3-Sx vesicles is noticeably bigger with ~20 nm indicating an effect of 
the fluorophores. Furthermore, the comparison between the different vesicle species is also 
showing differences regarding the fluorophore placement. Generally, K3-Sx vesicles are 
10-15 nm bigger in diameter compared to E3-Syb vesicles. Especially using the reference 
peptides K3-Sx(QSK) and E3-Syb(RKY), the sizes were fairly consistent and were 
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therefore used as a vesicle quality indicator. In the case of the experiments with labeled 
K3-Sx vesicles, both vesicle species show a nearly identical mean size average of 144 nm. 
This result is unexpected and differs from other experiments. A possible explanation for 
this behavior is that the fluorophores interact with K3-Sx in such a way that it is not capable 
of interacting with other vesicles. As mentioned in chapter 2.7.3, the K3-motif of the similar 
E3/K3-PEG-lipid model system was proposed to attach to the membrane, disturbe it and 
consequently facilitate fusion.[197,199,202,205] Though, this effect was most efficient using 
PEG12 which has a length of 4.4 nm and is therefore significantly longer than the linker 
region of syntaxin.[197] Another hint for the K3-membrane interaction comes from the 
vesicle sizes of the mixed population. 
Table 4.2: Sizes of differently labeled vesicle species obtained via DLS. The sizes 
differ depending on the presence of fluorophores in the same membrane. Vesicles 
were prepared with P/L = 1:200. 








E3-Syb 139.8 0.099 144.4 0.106 
K3-Sx 163.1 0.192 143.3 0.098 
Mix 200.6 0.219 156.7 0.131 
 
In the standard fusion arrangement (E3-Syb vesicles labeled) a compelling size increase 
was observed after mixing. In combination with the results of the dequenching assay, fusion 
of the two vesicle species is most probable. In contrast, the inverse fusion arrangement 
(K3-Sx vesicles labeled) does only show a moderate size increase, which supports the 
corresponding fusion assay results.  
It has to be noted, that these experiments were performed with P/L = 1:200. Therefore, the 
sizes and the polydispersity index for the K3-Sx vesicles are larger than usual. A straight 
up comparison to P/L = 1:500 measurements has to be made cautiously. However, the 
before mentioned effects are more pronounced here than with a lower peptide to lipid ratio 
and accordingly emphasize the obtained observations.  
In summary, placement of the fluorophores for FRET dequenching assays appears to matter 
in the case of the E3/K3-TMD model system. Especially the vastly different sizes of the 
K3-Sx vesicles indicate an involvement of the fluorophores in the vesicle behavior. Still, 
the possibility of an effect due to the ratio of the vesicles in the mixed sample has not been 
ruled out and may thus be also a contributor to these observations. 
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4.3.4 Assessment of Control Experiments 
Control experiments play an important role for the interpretation of data. Effects which are 
not due to the intended event but rather to other phenomena, can be quantified and 
accounted for. Especially in the employed FRET dequenching assays with different vesicle 
and peptide species, many factors have to be considered during data interpretation. Thus, 
several different controls have been tested to identify the best experiment setup. Figure 4.8 
depicts three different controls which were tested.  
 
Figure 4.8: Comparison of FRET dequenching assay control measurements using 
different vesicle species. (red) K3-Sx vesicles interacting with labeled vesicles. 
(blue) Labeled vesicles interacting with simple vesicles. (green) Labeled E3-Syb 
vesicles interacting with simple vesicles. Simple vesicle refers to the standard lipid 
composition of DOPC/DOPE/Chol = 2:1:1 without peptides. All measurements 
including peptides were done with a P/L ratio of 1:500 with the reference peptides 
K3-Sx(QSK) and E3-Syb(RKY). 
The simplest control consists of two vesicles containing no peptide. The labeled vesicles 
contained the FRET fluorophores, whereas the simple vesicles consisted only of DOPC, 
DOPE and cholesterol. Upon mixing the two vesicle species (at 30 s), a minimal increase 
of fluorescence intensity is observed. The maximum is reached 150 s after mixing. This 
small artefact is detected for every labeled vesicle type and is most likely an effect due to 
the polarity change around the embedded NBD.[233] The addition of the second vesicle 
species decreases the polarity and increases the fluorescence intensity. The same curve 
shape was observed in the experiment with labeled E3-Syb and simple vesicles (green 
4 Optimization of Fusion Assays 
________________________________________________________________________ 
54 
curve). The fusion assay results of these two experiments suggest that no lipid mixing of 
the opposing membranes in any way occurred. Conversely, the results of the unlabeled 
K3-Sx vesicles interacting with the labeled vesicles show a clear increase in signal intensity 
after the mixing point at 30 s. The shape of the curve resembles a typical fusion curve of 
this model system. Additionally, the fluorescence intensity is much higher compared to the 
other two control experiments. This general trend was observed for every type of K3-Sx 
except K3-Sx(QSXARRXK). Apparently, the presence of the K3-Sx peptide triggers a 
positive signal in the experiment. To investigate whether K3-Sx by itself is sufficient to 
initiate the fusion process, DLS measurements were performed (Table 4.3). 
Table 4.3: Vesicle sizes of liposomes from varying control experiments obtained 
via DLS. Mixed populations consist of a ratio of labeled/unlabeled = 1:4 vesicles 





K3-Sx + labeled 
K3-Sx 141.2 0.095 
Labeled 117.8 0.066 
Mix 142.1 0.138 
Labeled + simple 
Simple 124.1 0.044 
Labeled 120.6 0.068 
Mix 125.0 0.074 
E3-Syb labeled + 
simple 
Simple 122.4 0.059 
E3-Syb labeled 124.5 0.054 
Mix 125.1 0.061 
 
For the fusion experiment of K3-Sx and a labeled vesicle the DLS data is not conclusive. 
The size of the mixed population is nearly identical with the size of the K3-Sx vesicle. 
Though, the polydispersity index is considerably higher which is to be expected as a 
mixture of at least two different vesicle types with a big size difference (~20 nm) are present 
in the measured sample. This observation was also discovered for the other two controls. 
Due to the ratio of labeled/unlabeled vesicle of 1:4 in the mixed sample, it is difficult to 
draw conclusions of the DLS results in these control measurements. A small increase in the 
fusion assay suggests only a small number of vesicles fusing. In the case of DLS 
measurements, the intensity increase is not sufficient to see a noticeable average size 
increase. Consequently, it cannot be ruled out that K3-Sx is capable of performing fusion 
on its own to a small extent. However, it is also possible that hemifusion, other unspecific 
interactions or the destruction of the labeled vesicles are the reason for the obtained FRET 
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data. Undeniably the peptide is interacting in some way with the labeled vesicle due to the 
completely different curve form in the fusion assay. A possible explanation for the obtained 
data is the interaction of the K3-motif with the labeled vesicle. Here, the “snorkeling” effect 
of lysins as well as the interaction of the hydrophobic face with the membrane can be part 
of this strong interaction.[197,199,202,205] As the motif contains six lysines, this effect is likely 
to happen. In fact, researchers using a similar model system with the E3/K3 motif showed 
this behavior to be critical for high fusion efficiency (see chapter 2.7.3).[197] In addition, 
due to the fluorophores the labeled vesicle contains negatively charged lipids.[231,232,234] It 
is plausible, that the positively charged K3 motif interacts more easily with the labeled 
vesicle, leading to the obtained results. 
To summarize, E3-Syb peptides by themselves do not show signs of being capable to 
perform fusion or destroy the membrane they are incorporated in. For K3-Sx vesicles a 
different behavior was observed. Although, it is not clear what the underlying reason of the 
intensity increase is, K3-Sx seems to be responsible for it. To draw a conclusion, the control 
including K3-Sx and a labeled vesicle is the most reasonable, if a K3-Sx peptide is involved 
in the experiment. The inherent trait of this peptide to give a positive signal in the FRET 
dequenching assay has to be taken into account when interpreting the fusion assays. 
Nevertheless, compared to experiments with both peptides present, a clear distinction 
between control and fusion experiment is possible. Furthermore, the change to a peptide to 
lipid ratio of 1:500 overall decreased the effect of the K3-Sx peptide on the fusion assay as 
illustrated in Figure 4.5. Therefore, the specific interaction between the different peptides 
can still be considered the main reason for positive fusion signals. 
4.3.5 Loss of Lipids during Extrusion 
The following experiments were performed mostly by Fehmke Reichardt during her 
bachelor thesis under the supervision of Mike C. Groth.[235]  
 
Aggregation of liposomes was a significant problem in previous experiments which lead to 
a loss of lipid and peptide material during and after liposome preparation.[207] Two main 
factors for the loss were already identified. First, during the extrusion process, where MLVs 
are pushed through a polycarbonate membrane, a lot of material adheres to it. This can be 
seen clearly in case of labeled liposomes, as the polycarbonate membrane changes its color 
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from white to pink. Second, self-aggregation of liposomes of the same species over time 
which concludes in the formation of precipitate.  
Determination of lipid loss before and after extrusion was performed for selected vesicle 
species via phosphate test. For experimental details see section 9.4.6. The results are 
presented in Table 4.4. 
Table 4.4: Results of phosphate tests for different vesicle species. Lipid loss is 
obtained by the calculated input of phospholipids. 
Peptide in vesicle No. Lipid loss / % 
E3-Syb(RKY) (1) 34 ± 7 
E3-Syb(RKYAW) (3) 32 ± 2 
E3-Syb(RKYWA) (4) 31 ± 9 
K3-Sx(QSK) (2)   42 ± 10 
K3-Sx(QSXARRXK) (5) 49 ± 7 
 
Overall, lipid loss lies in between 30-50 % with a high dependency on the incorporated 
peptide. Lipid films with K3-Sx peptides tend to be affected with 10-15 % more lipid loss 
than E3-Syb containing films. This result is in agreement with previous experiences and 
observations from other experiments.  
A drawback of this method is that the amount of peptide loss cannot be determined. Merely 
the number of phospholipids (eg. DOPC, DOPE, DOPS) can be obtained. As cholesterol 
does not feature a phosphate group, it also stays invisible for this method. With the peptide 
to lipid ratio a rough estimation of the number of peptides left in the sample could be 
calculated. But this approach does not take into account, that the peptides might interact 
with each other, cholesterol or the polycarbonate membrane, forming aggregates which 
stick to the membrane or are too big to pass it. Due to these many compromises and 




 Modifications of the E3/K3-TMD 
Model System 
The focus of this chapter lies on the E3/K3-TMD model systems response to modifications 
in the peptide sequences during fusion assays. In section 5.1 the effect of the linker length 
on fusion efficiency is discussed. Here, the specific connection between artificial and the 
natural part of the system and the resulting structural conformation is investigated. Sections 
5.2 and 5.3 portray the importance of the aromatic amino acids, which are present in both 
linkers. Some of these residues have been found to be important during the fusion 
mechanism of natural SNARE complexes. The effects on this model system are examined. 
5.1 Effect of the Linker Length on Fusion 
Efficiency 
The length of the linkers in Synaptobrevin and Syntaxin have been of interest for a long 
time. As the stiffness or flexibility is postulated to be a key feature of the linker, several 
experiments have been performed regarding its length in past years.[25,170,236,237] In fact, one 
experiment focusing on linker length with the E3/K3-TMD model system has already been 
performed.[206] K3-Sx was elongated with its native sequence by six amino acids. In content 
mixing assays the elongated peptide performed slightly less efficient compared to the 
reference model system. To further understand the linkers function in the model system, 
multiple experiments are presented in the following section regarding the linker length. 
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5.1.1 Sequence Shift 
The reference system which consists of the two peptides E3-Syb(RKY) and K3-Sx(QSK) 
was designed in such a way, that the sequence length of the natural TMD and linker is 
equally long. For both species 30 amino acids starting from the C-terminus were counted 
and cut off from the rest of the natural protein. Amino acid 31 is part of the artificial E3/K3 
coiled coil (see Figure 5.1). 
 
Figure 5.1: Visualization of the shift in the sequence between natural protein and 
model system. The arrows indicate possible interactions between the two 
proteins/peptides and visualize the shift due to the attachment of the artificial 
motif after 30 amino acids. (a) Native sequence, (b) E3/K3-TMD standard 
sequence, (c) sequence with adjusted length. 
In the assembled natural SNARE complex, the amino acids 90 of synaptobrevin and 260 
of syntaxin are aligned with each other. Specific interactions between different residues in 
the linker and TMD have been proposed previously and are illustrated with double sided 
arrows in Figure 5.1.[23] Interaction between the two model system peptides starts at the 
N-termini with the formation of the coiled coil. The alignment starts here and propagates 
toward the C-termini. Assuming the conformation of the linker and TMD of the artificial 
system stays the same as in the natural complex, a shift of two amino acids is expected 
starting with the first amino acid of the linker in the model system. This is due to the fact 
that in the natural complex, syntaxin has an overhang of two amino acids at the 
C-terminus.[23] To elucidate the significance of the right sequence position in the 
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E3/K3-TMD model system, the peptides have been adjusted in length to depict the situation 
in the natural one (Table 5.1). 
Table 5.1: Comparison of the peptide sequences for the experiments targeting 
sequence shift. The E3/K3 motif is omitted. Amino acids of the linker domain are 
denoted in bold. 
Peptide Sequence No. 
Sx(QSK) Q S K A R R K K I M I I I C C V I L G I I I A S T I G G I F G   (2) 
Sx(KYQSK) K Y Q S K A R R K K I M I I I C C V I L G I I I A S T I G G I F G (6) 
Syb(RKY) R K Y W W K N L K M M I I L G V I C A I I L I I I I V Y F S T   (1) 
 
The peptides K3-Sx(QSK) and E3-Syb(RKY) are referred to as the standard system in this 
thesis. Both feature 30 amino acids from the natural SNARE proteins. The sequence shift 
adjusted peptide K3-Sx(KYQSK) has 32 amino acids from the natural sequence. On paper, 
if the assembly of the heterodimeric complex starts from the N-terminus and continues 
throughout the TMD, then the positions of the involved amino acids should resemble the 
natural complex as depicted in the X-ray data of the cis-complex.[23] The results of the 
FRET dequenching assay are illustrated in Figure 5.2. 
 
Figure 5.2: FRET dequenching assay of E3-Syb(RKY) and K3-Sx(KYQSK). The 
measurements (red), standard system as reference (blue) and a control 
measurement (green) consisting of labeled vesicles without peptide and 
K3-Sx(KYQSK) vesicles are shown. 
The size adjusted system shows an unambiguous positive signal. Compared to the 
reference, the fusion efficiency after 20 min is slightly lower. Also, the slope is less steep 
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at every time point during the experiments. The error of the measurement is quite small, 
but this is due to the experiment being performed only two times. The control experiment 
shows a relatively high signal compared to other controls in this work. The acquired DLS 
data validates the results obtained from the fusion assays (Table 5.2). 
Table 5.2: Vesicle sizes of liposomes from experiments targeting the linker length 





E3-Syb + K3-Sx 
E3-Syb(RKY) 132.3 0.056 
K3-Sx(KYQSK) 144.5 0.112 
Mix 161.5 0.143 
Control 
Labeled 125.0 0.067 
K3-Sx(KYQSK) 144.2 0.124 
Mix 144.0 0.123 
 
The measurements with both peptides clearly show an increase in vesicle sizes after mixing, 
confirming the length adjusted systems fusion capabilities. The control measurement does 
not show a size change in the mixed population. Reasons for the mixed results of the 
dequenching assay and DLS data are discussed in section 4.3.4.  
To summarize, the sequence adjusted peptide performs slightly less efficient than the 
reference system. The misalignment on paper does not correlate to the experimental results, 
suggesting the reference sequence to be aligned ideally for the E3/K3-TMD model systems 
fusion abilities. 
5.2 Aromatic Residues in the Linker Domains 
The X-ray structure of the natural SNARE complex of syntaxin 1A and synaptobrevin 2 
shows multiple aromatic residues present in the linker. These are arranged in such a way, 
that they wrap around the synaptobrevin linker to form a collar of aromatic residues. It is 
assumed that these aromatic residues stiffen the linker region due to intermolecular 
interactions.[23] Furthermore, the tryptophan residues of synaptobrevin are proposed to be 
controlling the positions of adjacent lysine and arginine residues.[29] The following chapter 
is about the significance of the mentioned amino acids for the functionality of the 
E3/K3-TMD system. 
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5.2.1 E3-Syb Tryptophans 
Synaptobrevin has been of interest for researchers for many decades. Especially, the two 
tryptophans in the linker have been studied by several research groups.[237,238] In chromaffin 
cells, different experiments including substitutions of these amino acids have been 
performed. Interestingly, the substitution of just one of the tryptophans with serine or 
alanine did not affect the exocytotic burst of chromaffin cells.[29] Nonetheless, it was also 
suggested, that the tryptophans act as a fusion clamp making fusion stimulus-dependent.[30] 
Furthermore, MD simulations lead to the conclusion, that the tryptophan residues 
determine the insertion depth of the protein in the membrane.[29] Due to the adjacent basic 
residues, this has an effect on the electrostatic potential on the fusion site. The tryptophan 
motif was also linked to the rigidity of the linker itself.[129] A substitution with alanine lead 
to a more flexible linker, highlighting the importance of these residues. The position of the 
residues as well as the approximate insertion in the membrane are illustrated in Figure 5.3. 
 
Figure 5.3: Illustration of the aromatic amino acids in the linkers of synaptobrevin 
2 and syntaxin 1A. Tyrosins are colored in teal, tryptophans are colored in orange, 
syntaxin 1A is colored blue and synaptobrevin 2 is red. (a) Interface of both 
proteins from X-ray data. (b) Illustration of the SNARE complex inside a 
membrane. X-ray data from STEIN et al.[23] Molecular graphics and analyses were 
performed with the UCSF Chimera package.[121] 
Investigating these aromatic amino acids with the less complex E3/K3-TMD model system 
might yield further information regarding their tasks in membrane fusion. With this system, 
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interactions with associated proteins can be excluded and parts of their functions isolated. 
This approach is also working vice versa, as the results can be compared to the studies with 
the associated proteins and therefore make predictions about their importance in this 
process. However, as the E3/K3 motif behaves differently to the natural motif, conclusions 
must be drawn conservatively. 
To determine the effects of WW 89/90 of synaptobrevin 2 in the E3/K3-TMD model 
system, three peptides have been synthesized (Table 5.3). Peptide 3 and 4 have only one 
substitution, whereas peptide 7 has both tryptophans substituted with alanine. The 
substitution was performed using alanine for its low interaction with other residues, neutral 
net charge and helix favoring traits. Furthermore, the results can be compared more easily 
with other systems including the natural complex. 
Table 5.3: Peptide names and sequences synthesized for the determination of the 
role of the WW-domain in synaptobrevin 2. 
Peptide Sequence No. 
E3-Syb(RKYAW) G-(EIAALEK)3-RKYAWKNLK-TMD (3) 
E3-Syb(RKYWA) G-(EIAALEK)3-RKYWAKNLK-TMD (4) 
E3-Syb(RKYAA) WG-(EIAALEK)3-RKYAAKNLK-TMD (7) 
 
Synthesis and purification of these peptides did not show significant changes in behavior 
compared to the standard E3-Syb peptide (see sections 9.2.7 and 9.3). The peptide 
E3-Syb(RKYAA) had to be modified with an additional tryptophan residue at the 
N-terminus. This is due to the light absorption properties at 280 nm which were used for 
the determination of the peptides concentration (see chapter 9.2.6). Indeed, tyrosine is also 
absorbing at this wavelength, but at a much lower efficiency. Consequently, much more 
sample material would be needed for the determination of the peptide concentration. As the 
final amount of purified peptides is quite small, the addition of an N-terminal tryptophan 
was reasonable. Also, the N-terminal ends of the E3/K3 motif should not interact strongly 
with each other. 
The results of the FRET dequenching assays show a slight reduction in fusion efficiency 
for all three peptides compared to the reference (Figure 5.4). It is quite remarkable, that the 
substitution of one amino acid has such a big impact on the efficiency of the system. This 
highlights the importance of the specific sequence of amino acids in the linker of 
synaptobrevin 2.  
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E3-Syb(RKYWA) shows an unusually small error margin due to two of the four 
measurements being nearly identical in their shape and intensity. This observation is most 
likely by chance, as no other experiment yielded such a small error. The error of the 
E3-Syb(RKYAW) measurement is substantial, whereas the double substituted peptide has 
a medium error. In general, all three peptides behave fairly similar in regard to curve form 
and end intensity. Due to their proximity and the associated error, conclusions can only be 
drawn conservatively in regard to the position of each other. 
 
Figure 5.4: Comparison of different E3-Syb modified peptides. (blue) Reference 
measurement with the standard peptides. (teal) E3-Syb peptide with the second 
tryptophan substituted for alanine. (purple) E3-Syb peptide with the first 
tryptophan substituted for alanine. (red) E3-Syb peptide with both tryptophans 
substituted for alanine. (green) Control measurement. All measurements were 
performed at least thrice and with P/L = 1:500. 
Apparently, it does not matter which of the tryptohans is substituted, as the curves are alike. 
Interestingly, the substitution of both tryptophans did not lower the fusion efficiency 
noticeably lower compared to single substitution. The lack of one residue is sufficient to 
interfere with the fusion process. Here, the difference of the model system with the natural 
SNARE complex becomes apparent. As initially mentioned, a study using chromaffin cells 
to investigate the WW-domain published the opposite result.[29] Substitution of both 
tryptophans lead to a decrease in primed release-ready vesicles but did not change the 
kinetics of the process. One explanation for this difference might be, that the lack of just 
one tryptophan can be compensated by other proteins involved in the process. Another 
reason might be that the model system and the natural complex perform the fusion very 
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differently in regard to the mechanism. In fact, the observations done by BORISOVSKA et al. 
referred to the priming process in which other proteins such as synaptotagmin or 
munc13/munc18-1 are involved.[94,239] Due to other proteins interacting with the core 
complex, the process is more sophisticated compared to the E3/K3-TMD model system. 
Investigations about possible interactions between other proteins and the model system 
were not performed in this work. 
The sizes of the used vesicles determined by DLS show homogenic distribution for all 
vesicle species (Table 5.4). All K3-Sx-vesicles, which used the same peptide, show an 
average size of 140 nm. The PdI is well below 0.1 indicating a narrow monomodal 
distribution. Consequently, the vesicles were of proper quality.  
Table 5.4: DLS data of the vesicles used for experiments regarding the 
WW-domain of synaptobrevins linker.  
Peptide       E3-Syb K3-Sx(QSK)        Mix 
E3-Syb(RKYAW) 
dh /nm 124.9 ± 3.8 139.9 ± 4.2 152.1 ± 1.4 
PdI 0.062 ± 0.023 0.093 ± 0.02 0.124 ± 0.05 
E3-Syb(RKYWA) 
dh /nm 127.6 ± 3.5 140.1 ± 3.9 154.3 ± 1.3 
PdI 0.080 ± 0.019 0.105 ± 0.021 0.139 ± 0.020 
E3-Syb(RKYAA) 
dh /nm 128.3 ± 2.1 140.2 ± 3.0 147.0 ± 1.9 
PdI 0.084 ± 0.036 0.100 ± 0.016 0.126 ± 0.018 
 
The sizes of the E3-Syb vesicles did not differ in a significant amount. The reference 
vesicles size with the E3-Syb(RKY) peptide is around 125 nm. The other E3-Syb species 
did not show noticeable changes in their sizes. The PdI for all species is also well below 
0.1, certifying their proper quality. Thus, the small sequence changes have no effect on 
vesicle sizes. This observation is an indication, that the peptides do not interact with the 
membrane in a significantly different manner compared to the reference peptide. DLS data 
of the mixed population also show an increase in particle size after 20 min. In combination 
with the results of the FRET dequenching assay the three E3-Syb peptide variants seem to 
be able to perform vesicle fusion. Determination of lipid loss after extrusion also showed 
no significant difference compared to the reference, suggesting no major changes in vesicle 
precipitation due to the peptide (Table 4.4). Still, the changes in the amino acid sequence 
could influence the peptide’s insertion depth or angle into the membrane. Clustering 
properties of the peptide could also be changed but not observed with the measurement 
techniques applied. Summarizing the results of the FRET dequenching assay and DLS 
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measurements, an explanation for the reduced fusion efficiency could be linked to the 
insertion depth of the peptide inside the membrane. Recent MD simulations of the TMD 
with the linker showed, that the WW-domain is responsible for the insertion depth of the 
adjacent basic residues of the natural TMD of synaptobrevin.[29] Nonetheless, a substantial 
change was only observed for the double substituted mutants. Again, the results obtained 
with the E3/K3-TMD system show an effect starting with the substitution of just one of the 
tryptophans. The reduced fusogenicity could also be an effect of a changed insertion angle 
into the membrane. The shallower the angle, the smaller is the distance of the motif from 
the membrane. This in return means, that the E3 motif is less able to reach for the K3 motif 
of the opposing vesicle. Reduced fusion activity could be the consequence.  
To conclude, the WW-domain is important for the fusion behavior of the E3/K3-TMD 
model system. However, there are differences compared to the natural SNARE system. In 
contrast to nature, the model system shows a significant change upon the substitution of 
only one tryptophan. This suggests a different fusion mechanism. Due to the substantial 
changes in the structure as well as the absence of other proteins involved in the process, 
this result is not surprising. Besides, the model system is meant to reduce complexity and 
make small changes more noticeable. However, this makes it difficult to compare both the 
analog with the natural system. 
5.2.2 K3-Sx/E3-Syb Tyrosines 
The linkers of both peptides contain a total of four aromatic amino acids, two of which are 
tyrosines and the other tryptophan residues. One tyrosine is located in the linker of syntaxin, 
whereas the remaining three aromatic amino acids are located in synaptobrevin. Tyr 257 of 
syntaxin is buried inside a basic pocket of adjacent lysine residues (Figure 5.5). Previously, 
several substitution experiments have been performed with the focus of the linker, but only 
the substitution of Tyr 257 lead to a significantly reduced thermal stability.[23] Furthermore, 
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             (a) (b) 
  
Figure 5.5: Linker and TMD of synaptobrevin 2 and syntaxin 1A in the post 
fusion cis configuration. Tyrosine residues which were substituted with alanine 
are marked in orange, synaptobrevin is red and syntaxin is blue. Basic residues 
surrounding the tyrosines are also displayed. (a) Side view. (b) Front view from 
N- to C-termini. X-ray data from STEIN et al.[23] Molecular graphics and analyses 
were performed with the UCSF Chimera package.[121] 
Due to their close proximity, interactions between those residues are probable. To 
investigate whether these two tyrosines are important for fusion in the model system, two 
new peptide species have been synthesized (Table 5.5). The E3-Syb peptide was altered by 
the substitution of Y88A referring to the position in the natural protein. The K3-Sx peptide 
had to be modified even more compared to the E3-Syb peptide. The sequence of the 
standard model system does not include the targeted tyrosine. Therefore, the linker had to 
be extended by at least one amino acid. In the end, two more residues from the native linker 
(KY) have been introduced to the new peptide. The additional lysine was added to maintain 
the basic environment around the tyrosine residues. Furthermore, the addition of two amino 
acids should change the relative positions of the linker in the complex (see section 5.1.1). 
Further insight into the importance of the right sequence shift could be gained with this 
peptide. Synthesis and purification were performed as described in the standard procedures 
without noticeable differences. 
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Table 5.5: Peptide names and sequences with substituted tyrosine residues. 
Substituted amino acids are marked in orange. The K3-Sx peptide was elongated 
by two amino acids (underlined) as they are not present in the reference peptide. 
Peptide Sequence No. 
E3-Syb(RKA) G-(EIAALEK)3-RKAWWKNLK-TMD (8) 
K3-Sx(KAQSK) WWG-(KIAALKE)3-KAQSKARRKK-TMD (9) 
 
The performed FRET dequenching assays show a high degree of variation regarding 
kinetics and total intensity increase (Figure 5.6). The average curve suggests a slightly less 
efficient fusion behavior compared to the reference system and a higher efficiency 
compared to the elongated reference. The latter one resembles the sequence of the measured 
peptides with the exception of the two tyrosines still being included (discussed in more 
detail in section 5.1.1). However, due to the big error of the measurements, no definitive 
conclusion can be made. The substitution of both tyrosine residues does not completely 
shut down the ability of the system to perform fusion. One explanation for the significant 
difference between the measurements are errors linked to the experiment itself. Bulk fusion 
assays are very susceptible to having a wide distribution of results. Furthermore, other 
phenomena e.g. aggregation of the particles or interaction with the quartz glass wall are 
possible. Immobilized vesicles have a lower chance of performing fusion. 
Figure 5.6: FRET dequenching assay of tyrosine substituted peptides. (blue) 
Standard reference with E3-Syb(RKY) + K3-Sx(QSK). (red) Tyrosine substituted 
peptides. (teal) Reference of E3-Syb(RKY) + K3-Sx(KYQSK). (green) Control 
with tyrosine substituted K3-Sx(KAQSK).The average of five measurements with 
the standard deviation as error bars is illustrated. P/L = 1:500. 
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All vesicles used in the experiments were also analyzed via DLS (Table 5.6). K3-Sx 
vesicles are bigger than the E3-Syb ones for every measurement. This behavior was 
observed for every species tested in this work. The mixed population, which was measured 
20 min after mixing, showed a higher average size value indicating fusion of at least two 
vesicles. Indeed, the size increase is expected to be higher. For example, for the first 
measurement, fusion of a 135 nm and a 123 nm vesicle should yield ideally a ~162 nm 
vesicle. As the average size value is a cumulants mean including all fused and unfused 
vesicles, this discrepancy is to be expected.  
Table 5.6: DLS data of measurements performed for the investigation of the role 
of tyrosine in the linker. 











1 135.40 0.107 123.77 0.148 150.03 0.130 
2 133.17 0.083 130.77 0.148 155.10 0.142 
3 141.87 0.123 123.03 0.075 161.53 0.193 
4 143.47 0.177 127.77 0.063 153.00 0.129 
5 136.13 0.097 124.43 0.063 145.20 0.118 
 
The polydispersity indices behave differently for every measurement, but generally no 
major changes compared to the two parent vesicles were recorded. Interestingly, between 
vesicle species of the same kind, mentionable differences were observed. Especially 
K3-Sx(KAQSK) vesicles show a high variability in the vesicle quality although the peptide 
was used from the same stock solution. This is also true for the same vesicle population 
and can be seen in Figure 5.7. Every population is measured three times to form the average 
value (see section 9.4.5). Normally the standard deviation between the measurements is 
quite small. However, in these experiments the error was considerably higher, as depicted 
by the error bars. This behavior was not observed in this magnitude for other experiments, 
suggesting that the inconsistencies are due to the used peptides. The size distribution clearly 
shifts to bigger sizes in the mixed sample, signaling fusion or aggregation of the vesicles.  
 
Combining the results of the FRET dequenching assay with the DLS data, interpretation is 
rather difficult. The high inconsistencies between measurements show a different behavior 
of the modified peptides compared to other modifications. A comparison between the 
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measurement, standard reference and the elongated reference hints, that the high error 
margin might be due to the tyrosine substitution. Surprisingly, the elongated reference 
shows a significantly lower intensity increase as well as a different curve form than the 
tyrosine substituted species. The tyrosines appear to be inhibiting the fusion mechanism of 
the model system. Though, this observation might also be due to increased destructive 
aggregation or other phenomena which could also lead to these results. Ultimately, the 
employed techniques are not sufficient to exclusively explain the obtained results. 
Nevertheless, they show that the lack of the tyrosines is sufficient to interfere with the 
fusion mechanism of the model system. 
 
Figure 5.7: Exemplary DLS data of one measurement with E3-Syb(RKA) (blue) 
and K3-Sx(KAQSK) (red) containing vesicles. The mix curve (green) shows data 
gathered directly after the FRET dequenching assay. 
5.3 Polybasic Region in Syntaxin 1A 
The polybasic region KARRKK of the syntaxin domain is located in the linker connecting 
motif and TMD. It is positioned at the junction between polar head groups of the lipid 
bilayer and the aqueous phase. Due to this location there are multiple interaction partners 
possible. There are several reports about interaction with specific lipids e.g. 
PIP2.
[28,172,240,241] These interactions are presumed to be responsible for the energetics and 
stability of the membranes. Furthermore, calcium dependent release was impaired in PC12 
cells after substitution of this region with alanine.[242] To investigate the role of the lysine 
5 Modifications of the E3/K3-TMD Model System 
________________________________________________________________________ 
70 
and arginine residues in the E3/K3-TMD model system, peptides with modifications in the 
sequence were synthesized and their fusion behavior monitored. The specific substitution 
pattern was derived from the cis-complex of the native system. As illustrated in Figure 5.8, 
the lysine residues 260/264 are located near the interface of the two proteins. Interactions 
with residues of the opposing protein are likely, especially Lys 264 which is in close 
proximity to Asn 92 and Met 95 of synaptobrevin 2.  
 
Figure 5.8: Linkers and TMDs of synaptobrevin 2 and syntaxin 1A in the post 
fusion cis configuration. Lysine residues which were modified are marked in 
orange, synaptobrevin is red and syntaxin is blue. Arginine residues which were 
substituted for alanine are marked in teal. (a) View from the N-terminal end, 
(b) view from the side, (c) residues in close proximity to the polybasic area are 
shown. X-ray data from STEIN et al.[23] Molecular graphics and analyses were 
performed with the UCSF Chimera package.[121] 
In contrast to the lysine residues, the arginine moieties are facing the opposite direction in 
the cis-complex. Embedded into a membrane, these arginines can possibly interact with 
other proteins or the lipid headgroups surrounding the protein. To investigate if these 
residues affect the fusion behavior of the E3/K3-TMD model system, two new peptides 
were synthesized (see Table 5.7). 
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Table 5.7: Peptide sequences of reference and modified K3-Sx peptides used for 
the investigation of the polybasic area in syntaxin. The marked arginines (teal) 
and lysines (orange) are exchanged with alanine residues. 
Peptide Sequence No. 
K3-Sx(QSK) WWG-(KIAALKE)3-QSKARRK-TMD (2) 
K3-Sx(QSKAAAK) WWG-(KIAALKE)3-QSKAAAK-TMD (10) 
K3-Sx(QSAARRA) WWG-(KIAALKE)3-QSAARRA-TMD (11) 
5.3.1 Role of the Arginine Domain in the Linker of Syntaxin 1A 
To investigate the role of the arginine residues in the linker, both amino acids have been 
substituted with alanine residues. With this substitution the charge and polarity has been 
reduced in this area due to the lack of functional groups in the alanine residue. In the used 
model system, the substitution has a dramatic effect on the fusion efficiency as illustrated 
in Figure 5.9. The ability of the system to perform fusion is abolished completely. The 
control experiment consisting of the K3-Sx(QSKAAAK) vesicle and a labeled vesicle is 
similar in intensity from the start. In contrast, the measurements intensity increases over 
the course of the experiment more compared to the control. A small amount of interaction 
between the peptides is therefore possible. 
 
Figure 5.9: FRET dequenching assay of the modified K3-Sx(QSKAAAK) 
peptide. (blue) reference system. (green) Control measurement. (red) Average of 
five measurements containing the modified peptide. All measurements were 
performed with P/L = 1:500. 
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The error of the measurement is noticeably small in spite of being calculated out of five 
measurements. The used peptide is of an excellent quality as verified via ESI-MS and 
UPLC, eliminating effects from impurities during the fusion assay. Consequently, the 
results emphasize the importance of the arginine residues in the syntaxin 1A linker of the 
model system. To see whether the modified K3-Sx peptide has an effect on the vesicles, 
DLS data was collected for every measurement and vesicle species (Table 5.8). 
Table 5.8: DLS data of vesicle species used in the experiments regarding the 
arginine domain of syntaxin 1A. 











1 149.0 0.129 138.6 0.105 146.5 0.111 
2 161.1 0.099 150.0 0.127 160.5 0.081 
3 157.3 0.081 148.4 0.106 160.7 0.122 
4 158.2 0.083 147.5 0.091 160.7 0.104 
5 158.9 0.088 148.6 0.108 160.6 0.102 
 
The initial vesicles are relatively large with ~157 nm for the K3-Sx vesicles and ~147 nm 
for the E3-Syb vesicles. Also, a significant difference between the first and the rest of the 
measurements is apparent. This inconsistency was caused due to the use of a new batch of 
polycarbonate membranes which are used during the extrusion process. Unfortunately, 
there are considerable discrepancies in the quality of these membranes. Due to this, the 
manufacturer had to be changed, to maintain comparable sizes to previous measurements. 
Despite the relatively big size difference, the overall trend and observation is the same for 
all five measurements. The mixed population (post fusion) shows no significant increase in 
size after being mixed and incubated for 20 min. Usually an increase of ~10 nm in 
comparison to the K3-Sx vesicle is detected for fusion. Here, the increase is minimal with 
~2 nm.  
For the interpretation of these results, many factors have to be considered. The positioning 
of the arginine residues in the cis-complex facing the lipid environment is ideal for 
interaction with lipid head groups. As this is the final conformation, it should be low in 
energy and therefore the desired end state. Nevertheless, the complex has to be formed first 
to get to the low energy state. The obtained results suggest that the formation did not occur 
in the first place, otherwise the FRET signal and vesicle sizes would be different. The 
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arginines most likely have an effect on the fusion process of the model system prior to the 
assembly of the complex. The possible effects which explain the observation are manifold. 
First, the aggregation of the peptide inside the membrane might be altered. It is well known 
that syntaxin 1A forms clusters in the natural environment.[27,172,243,244] Exchanging the 
arginines might lead to a different clustering behavior and consequently change crucial 
properties which are needed for the mechanism. However, in the natural system the 
substitution of the arginines showed low effect on the binding behavior with PIP2.
[26,245,246] 
This trait correlates with the formation of clusters, hence attesting the contrary of this 
explanation. Yet, the model system has already shown that it behaves quite differently in 
many other regards. For example, the formation of K3 homodimers has to be considered, 
which could potentially increase clustering and therefore challenge the results obtained 
with the natural system. Second, the flexibility of the linker region itself could be improved, 
as alanine is slightly more flexible than arginine.[45,247] An improved flexibility could mean, 
that the K3-motif can interact more with the lipid membrane. As it was previously shown, 
K3 can attach to the membrane due to the lysines being able to “snorkel” into the 
membrane.[197,199,202,248] A stronger attachment to the membrane is harder to overcome, thus 
might lead to less fusion activity of the peptide. Third, due to the substitution the total 
charge in the linker has changed significantly. The two arginines contribute a net plus two 
charge toward the peptide. This might interfere with the incorporation of the peptide into 
the membrane during the extrusion process. The lower the amount of peptide inside the 
vesicle, the lower the fusion efficiency. Unfortunately, the peptide concentration in the 
membrane cannot be determined for these types of experiments. The peptides would have 
to be labeled with a different fluorophore or another group, which would most likely 
interfere with the ability of the peptide to perform fusion. Furthermore, the substitution of 
adjacent lysines did not stop fusion completely (see section 5.3.2). Consequently, the loss 
of the charge is not the conclusive reason for the obtained results. 
In summary, substitution of the two arginines drastically changed the peptides ability to 
perform fusion. This in turn means, that these residues are crucial parts of the model system. 
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5.3.2 Lysines in the Linker of Syntaxin 1A 
Lys 260/264 are part of the polybasic area in syntaxin’s linker and are positioned near the 
interface of the SNARE cis-complex (Figure 5.8). To see whether the lysines are important 
for the model systems performance regarding fusion, a peptide species with substituted 
alanines was synthesized (see Table 5.7).  
The results from the FRET dequenching assay show a reduction in fusion efficiency due to 
the substitution of the lysines 260/264 (see Figure 5.10). In comparison to the reference the 
measurements show a decrease in total intensity of 30 % after 20 min. The standard 
deviation, displayed by the error bars, is reasonably low. Toward the 10 min mark the error 
is smaller compared to the beginning and end of the experiment. This can be explained due 
to the various single measurements showing a different slope of the fusion curves. 
Coincidentally, some of the measurements intersect at the 10 min mark. A peptide specific 
reason for this observation is highly unlikely as this was not noticed for any other species 
before. Furthermore, the curve shapes of all measurements do not show a kink or other 
anomalies. The control measurement consisting of a labeled vesicle with an unlabeled 
K3-Sx(QSAARRA) vesicle shows a typical curve shape and intensity.  
 
Figure 5.10: FRET dequenching assay of the modified K3-Sx(QSAARRA) 
peptide. (blue) Reference. (red) Average of five measurements containing the 
modified peptide. (green) Control. All measurements were conducted with 
P/L = 1:500. 
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Comparing all three curves of Figure 5.10, several conclusions regarding the lysines 
260/264 can be drawn. First, substitution of both lysines with alanine did not abolish the 
peptides ability to perform fusion. This can be clearly seen by comparing the measurements 
with the control. The lysines do not appear to be essential for the model system but do 
increase the efficiency of this process. Neither the loss of the two positive charges in the 
membrane headgroup area nor the possible missing interactions of the two residues with 
synaptobrevin or lipids is sufficient to render K3-Sx(QSAARRA) incapable of fusion. In 
regard to the initial assumption that the lysines might interact with synaptobrevin, hence 
stabilizing the complex, it is likely that these interactions are not the driving force of this 
process. Indeed, it is assumed that the main function of the polybasic area is the interaction 
with lipids, especially PIP2 and the resulting formation of syntaxin clusters.
[24,27,28,249] 
Particularly lysines 264/265 have been found to be effective at binding PIP2.
[26] However, 
as no charged lipids (except the labeled lipids) were used during the experiment, this 
specific function of the lysines was of no need. Therefore, the reduced fusion efficiency 
might still be due to minimal interaction between the two peptides. Results of the 
accompanying DLS measurements are shown in Table 5.9. 
Table 5.9: DLS data of vesicle species used in the experiments regarding the 
lysines of the linker of syntaxin. 











1 152.4 0.132 128.3 0.115 152.9 0.127 
2 162.7 0.114 148.7 0.111 185.4 0.138 
3 159.4 0.107 134.6 0.105 170.3 0.124 
4 163.3 0.093 134.6 0.105 173.3 0.103 
5 157.4 0.083 141.2 0.116 169.3 0.114 
 
Measurements 3-5 show normal vesicle sizes and size development after fusion. The first 
measurement does not show a size increase and the second presents an unusually high 
increase in the mixed population. In combination with the individual FRET dequenching 
curves (not shown) there is no obvious correlation. All measurements except measurement 
5 show a fairly identical curve shape. All in all, the modified K3-Sx(QSAARRA) is 
handicapped in its ability to perform fusion compared to the reference. If the initial 
assumption of these lysines being involved in intermolecular peptide to peptide interactions 
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is true, the lysines contributions are important, but not as essential as the arginines (see 
section 5.3.1). Indeed, the reason for this behavior can not be determined with just the 
employed techniques. However, one of the main differences between the two lysines and 
the arginines is their positions in the peptide. The charge should be the same at pH = 7.40 
as both amino acids have pK values for the ionizable groups well over 9.[250] Consequently, 
if the ionic interactions are the reason for the change in fusion behavior, it is most likely 
because of the charges position in the peptide.  
In the end, the lysines seem to be suitable points of modification, as the peptides functional 
ability is not completely inhibited. These results are the basis for the mechanistic 
investigations as described in chapter 6.
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 Photocaging of K3-Sx 
The zippering hypothesis is the most accepted theory regarding the membrane fusion 
mechanism of SNARE complexes.[168] One of the initial reasons for the design of the 
E3/K3-TMD model system was to maintain the peptidic backbone to study the zippering 
mechanism.[22] To investigate this process, numerous experiments can be performed. One 
approach is to stop the process at a specific point and starting it again upon a specific 
trigger. This method was chosen for investigating the mechanism in the E3/K3-TMD model 
system.  
Briefly, the interactions between the peptides should start at the N-termini with the 
formation of the E3/K3 coiled coil, similar to the natural system. At some point the 
interaction either of the motif, linker or TMD is encumbered by means of steric hindrance, 
arresting the peptides in a state where the C-terminal parts are not engaging in contact with 
each other. A trigger, e.g. pH- or temperature change, light or specific chemicals releases 
the obstruction, continuing the formation of the complex and ideally leading to membrane 
fusion. In this chapter the specific experiment and the peptide requirements are elucidated 
(section 6.1). Further, the design specifications of the caging group and the synthesis are 
discussed in section 6.2. Ultimately, the results of the experiments are presented (sections 
6.3 and 6.4) 
6.1 Design of the Photocaged Peptide 
The aim of the introduction of the photo caging group is to get more insight into the 
mechanism of the fusion process of the E3/K3-TMD system. This can be achieved by the 
introduction of these groups at specific positions in the peptide sequence (see Figure 6.1). 
The cage is inserted in the linker region of one of the peptides, more specifically in K3-Sx. 
The initial interactions of the two motifs are not encumbered by this. The coiled coil at the 
N-terminal end can form, but stops in the middle of the peptide at the linker region. The 
cage sits in between both peptides, making it sterically impossible for more interactions. 
At this point, both vesicles are in close proximity but arrested in a primed like state. Similar 
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to the natural system, where the influx of Ca2+ starts the fusion step, a trigger is applied. In 
this case, light of ~400 nm starts the rearrangement of the photo active group, leading to 
the elimination of the steric group. The interaction of the peptides continues, and membrane 
fusion is facilitated. This process can be observed via FRET dequenching assays, as one of 
the vesicles is equipped with a FRET pair. 
 
Figure 6.1: Schematic depiction of the experiment employed for the investigation 
of the fusion process of the E3/K3-TMD model system. DEACM is the used 
photocage. (1) The two peptides E3-Syb(RKY) and K3-Sx(QSXARRX) are 
incorporated in opposing vesicles. (2) Interaction of the motifs starts at the 
N-terminal end, pulling the vesicles closer to each other. The zippering stops after 
the caging groups are reached. (3) The peptides stay in the ready state until light 
of suitable wavelength cleaves the photocages off. (4) The peptides proceed with 
the pore opening, leading to the fusion of both vesicles. A positive signal in the 
FRET dequenching assay can be observed as a result of the successful fusion. 
6.1 Design of the Photocaged Peptide 
________________________________________________________________________ 
79 
To perform an experiment where the fusion process is stopped in the middle, special 
peptides had to be synthesized. Here, the obstruction was introduced into the linker region 
of K3-Sx (Table 6.1). Two lysines in the polybasic area, namely Lys 260 and Lys 264 of 
the natural syntaxin 1A were chosen, as they showed to be important for the fusion of this 
system (see section 5.3.2).  
Table 6.1: Comparison between the reference K3-Sx peptide and the caged 
species sequence. The syntaxin 1A TMD sequence is omitted. 
Peptide Sequence No. 
K3-Sx(QSK) WWG-(KIAALKE)3-QSKARRKK-TMD (2) 
K3-Sx(QSXARRX) WWG-(KIAALKE)3-QSXARRXK-TMD (5) 
 
Arguably, the adjacent arginine domain seems to have an even bigger impact on the fusion 
behavior of the model system. However, there are two reasons why the substitution of the 
two lysines was preferred for the mechanistic study. First, in the natural SNARE 
cis-complex the arginines point away from the interface of the two proteins, whereas the 
lysins are near it (see Figure 6.2). Assuming that the configuration in the model system is 
similar to nature during the fusion process, the lysins are the preferred point of 
modification. Second, the target component which is used for steric hindrance was already 
synthesized and successfully incorporated into the model system.[219] The building block, 
which consists of a lysine with a coumarin based photocleavable group in the sidechain, 
was already established in several other experiments and proved to be reliable.[219] 
 
Figure 6.2: Illustration of a composition of the caged linker region of syntaxin 1A 
with DEACM. The DEACM cage is marked in orange. Lys 260/264 are marked 
in purple and Arg 262/263 are marked in teal. X-ray data from STEIN et al.[23] 
Molecular graphics and analyses were performed with the UCSF Chimera 
package.[121] 
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To increase the steric hindrance and therefore ensure the stop of the fusion process, both 
lysines were modified simultaneously. With two bulky groups in slightly different 
positions, the effectiveness is increased due to more spatial coverage. Also, the X-ray data 
of the cis-complex does not necessarily reflect the situation in the model system. As 
described in chapter 5.1, the model system might be in a slightly other configuration 
compared to the natural system. Therefore, the positions of the two lysine residues might 
be aligned in another way. 
In case of synaptobrevin 2, there are also two lysine residues namely Lys 85/91 in the linker 
which might be suitable candidates for modification (see Figure 6.3). However, Lys 85 is 
not included in the model system as the artificial motif is attached to Arg 86 of the 
synaptobrevin linker. Addition of the extra amino acid might interfere with the rest of the 
system as a sequence shift would be implied (see also section 5.1).  
 
      (a) (b) 
 
 
Figure 6.3: Marked lysines in the linkers and TMDs of synaptobrevin 2 and 
syntaxin 1A in the post fusion cis-configuration. Lysine residues in syntaxin (blue) 
which were modified with the photocage are marked in purple. Mint green marked 
lysines in synaptobrevin 2 (red) are possible candidates for caging groups. (a) 
View from the top. (b) View from the side. X-ray data from STEIN et al.[23] 
Molecular graphics and analyses were performed with the UCSF Chimera 
package.[121]  
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6.2 Synthesis of the Photocaged Peptide 
The group which is used to stop the annealing has to have specific properties. First, it has 
to be big enough to prevent the interaction of the peptides. A small group might interfere, 
but due to the length of the peptides would not be able to stop the process. Second, it should 
not interact with other amino acid residues, lipids or other parts of the system. A charged 
group, for example, could interact with the other peptide strongly, making it difficult to 
leave and therefore keep interfering with the process. Additionally, products formed during 
cleavage should also follow these criteria. These molecules have a high movability as they 
are not bound covalently to anything, making them prime candidates for unwanted 
interactions. Third, cleaving the group should be time efficient. The fusion process itself is 
fast and thus observation of this event would not be possible using a group which needs too 
much time during cleavage. Also, the more time is used, the less information can be 
gathered regarding fusion kinetics. Fourth, the outgoing group must be stable for use in 
SPPS. The incorporation of the group has to be done on the amino acid building block prior 
to peptide synthesis. The peptides of the model system are about 50 amino acids long. 
Introducing the group after peptide synthesis is far more challenging due to the many 
different amino acid residues present. Also, steric hindrance because of the peptide length 
could interfere with the yield of the reaction. 
 
For the caging group 7-Diethylamino-4-methylcoumarin (DEACM) has been selected. 
DEACM is one of the fastest cages currently known.[251] The quantum yields are high and 
the excitation wavelength is around 400 nm, making it a prime candidate for incorporation 
into a peptide.[252] Additionally, the group was already modified for the use on amines and 
successfully tested in bacterial and mammalian cells.[253] Furthermore, the photo group was 
already tested in the MEYENBERG model system.[219] A modified Lys-(DEACM) amino acid 
was used in the artificial motif to stop the zippering process. Due to their positioning in the 
g and e position of the coiled coil, the steric hindrance was too low resulting in no inhibition 
of the process.[219]  
Synthesis of the building block was successful following the procedure of ZHANG and 
SCHIRMACHER (Figure 6.4).[219,254] Briefly, 7-Diethylamino-4-methylcoumarin (12) was 
oxidized with SeO2 and subsequently reduced to the alcohol 13. The alcohol was then 
activated with 4-nitrophenyl chloroformate to anhydride 14. The anhydride was then 
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converted by nucleophilic substitution with Fmoc-L-Lys-OH to form the desired Fmoc-L-
Lys(DEACM)-OH building block 15. 
 
Figure 6.4: Synthesis route of the photo cage Fmoc-L-Lys-(DEACM)-OH. In the 
first step, 12 is oxidized and subsequently reduced to the alcohol 13. Next, 
activation of the alcohol is performed with 4-nitropheyl chloroformate to the 
anhydride 14. In the last step, a nucleophilic substitution with the amine of Fmoc-
L-Lys-OH leads to the target structure 15. 
The incorporation of the Fmoc-Lys-(DEACM)-OH building block into the peptide was 
done during automated peptide synthesis (see chapter 9.3). Owing to the fact that the 
building block had to be synthesized over several days, the coupling method was modified 
slightly compared to the other amino acids. The concentration was lowered but the reaction 
time was increased to ensure a good coupling yield. Because of the lower concentration of 
the building block, double coupling was performed for both positions, increasing the 
efficiency even further. Subsequent coupling steps of standard amino acids were performed 
as usual. After peptide synthesis was finished, every following step was done under the 
exclusion of light to minimize unwanted uncaging. Cleavage from resin and the workup 
procedure were not altered compared to the other peptides. The quality was checked using 
UPLC and mass analysis. 
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6.3 FRET Dequenching Assays of DEACM caged 
Peptide 
To test if the two cages are capable of stopping the fusion process, different FRET 
dequenching assays have been performed. One experiment consisted of the standard 
E3-Syb and K3-Sx(QSXARRXK) vesicles being mixed in the fluorescence cuvette, 
following the standard procedure (Figure 6.5). Due to the bulky cage, fusion is inhibited, 
as can be seen in the first 300 s. A small increase in signal intensity was observed, but this 
might be due to unspecific interaction of the K3-Sx peptide with the other vesicle as already 
discussed in section 4.3.4. After 300 s the sample was taken out of the fluorescence 
spectrometer and irradiated with a laser of 400-415 nm (75mW) for 60 s. During this time, 
no data points could be obtained. Subsequently, the cuvette was put back into the 
spectrometer and the measurement was continued. In the first few seconds, a small irregular 
increase followed by an intensity drop was observed. This is most likely due to the stirring 
of the sample starting again after inserting the cuvette into the spectrometer. After that, data 
points with a significant increase in intensity compared to the first 300 s were gathered. 
These results indicate the successful uncaging of the K3-Sx peptide and the subsequent 
fusion process between the two vesicle species. Arguably, the exact mechanism cannot be 
derived from this experiment as there are multiple feasible explanations for this behavior. 
First, the mechanism could follow the intended way of the motifs forming a coiled coil but 
not being able to perform the fusion process. This hypothesis is supported by the fact, that 
the increase after the first laser session is as pronounced as observed. The system would be 
in a primed state which formed in the first 300 s of the experiment, waiting for the trigger 
to continue the fusion. A second possible explanation is, that there is no interaction of the 
two peptides up until the uncaging. The fusion mechanism would start from the beginning 
directly after cleaving of the cage. The steepest intensity increase in dequenching assays 
can be observed in the first seconds after mixing the two vesicle species. Yet, in comparison 
to similar experiments the increase jump is much steeper. Most likely a combination of 
both hypothesis is the cause of these findings. The “primed” system is in equilibrium with 
the two free peptides. Consequently, a significant number of vesicles is ready to fuse with 
each other. 
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Figure 6.5: FRET dequenching assay with the caged K3-Sx peptide. (red) Curve 
corrected for photo bleaching and fluorescence increase by uncaging. (blue) Curve 
without corrections. At 300 s and 500 s the sample was taken out of the detector 
and irradiated with laser light of 400-415 nm for 60 s each. The numbers on top 
show the sections, where different amounts of laser irradiation were applied to the 
vesicle population. 
To ensure that most of the caging groups were cleaved, the sample was irradiated a second 
time for 1 min at 500 s. The increase in intensity is much lower compared to the first time. 
This indicates that the majority of the caging groups are cleaved off after the first 60 s. 
These results are coherent with previous findings using similar peptides.[219] Furthermore, 
DLS data was acquired for this experiment (Table 6.2). The E3-Syb vesicle shows typical 
average size and PdI values. The K3-Sx species shows an unusually small PdI but otherwise 
the size is comparable to other vesicles with different K3-Sx peptides. The mixed species 
is 8.6 nm bigger than the K3-Sx vesicle, supporting the observations of the dequenching 
assay of successful fusion. It was measured at the end of the experiment after both laser 
irradiation periods. However, determining the sizes between the different stages of 
irradiation without interfering in the lipid mixing assay is impossible. The DLS 
measurements take between 5-7 min at which time no fluorescence data can be obtained. 
On basis of these results, all following experiments with the caged peptides were conducted 
using a photo cleaving time of 60 s. 
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Table 6.2: DLS data of vesicle species used in the uncaging experiment. 
Peptide 
Z-Average 
dh /nm  
PdI 
E3-Syb(RKY) 133.3 0.072 
K3-Sx(QSXARRX) 148.0 0.058 
Mix 156.6 0.906 
 
This type of measurement turned out to be quite important for understanding the behavior 
and handling of the caged peptide. First, in this measurement the whole sample was 
irradiated with the laser. This included the fluorophores present in the E3-Syb vesicles. For 
this reason, it had to be tested what effect the laser has on the fluorophores as 
photobleaching is a common phenomenon among this group of chemicals. To investigate 
this, measurements have been done using the same amount of E3-Syb vesicles and applying 
different durations of laser light to it (Figure 6.6).  
 
Figure 6.6: Fluorescence emission spectrum with excitation at 460 nm of E3-Syb 
vesicles. (green) Emission without laser. (red) Emission after 60 s laser 
irradiation. (blue) Emission after 120 s irradiation. The laser has a range of 
400-415 nm with 75 mW. 
The emission maximum of Rhodamine at 587 nm decreases significantly after 60 s laser 
irradiation by 18 %. After subsequent 60 s the decrease is much smaller but still noticeable. 
The laser radiation is, as expected, contributing to photobleaching. As the time course 
measurements were recorded at 530 nm, the change in intensity at this wavelength was 
quantified. Here, the decrease was even stronger with 23 % after 60 s. As a result of this, 
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for each section a data correction value, which was derived from Figure 4.6 was added to 
take this effect into account (red curve in Figure 4.5). Furthermore, different maximum 
values, which are recorded after the addition of TritonX-100, had to be set due to different 
amounts of photo bleaching in the three sections of the experiment (see chapter 9.4.4 for 
more detail).  
In addition to the photo bleaching, a second phenomenon was observed. After cleavage of 
the photo group, the fluorescence intensity at 530 nm increased depending on the amount 
of cage present (Figure 6.7). This jump in intensity is visible for all dequenching assays 
where the uncaging occurred. The reason for this anomaly is most likely the fluorescence 
of the free DEACM-OH which is a result of the cleaving process. Although the excitation 
maximum for this group is at around 385 nm depending on the solvent, a small fraction is 
also absorbed at 460 nm.[255,256] Emission at 530 nm is possible and could therefore be 
detected in this assay. Consequently, all the measurements were corrected to accommodate 
to this effect. For the ones depicted in Figure 6.5 two separate corrections for section two 
and three were performed, as the intensity increase is proportional to the amount of the 
cleaved group. In regard to the impact of this effect on the overall measurement, it is 
roughly a 3-4 % increase in fusion efficiency which in the scale of these experiments is a 
significant amount. In comparison, photo bleaching reduces the intensity by 5-7 %. 
Combining both effects, the values were effectively increased by ~2.5 % fusion efficiency, 
making the jump in intensity from section one to two bigger compared to the uncorrected 
data.  
Because of the many different phenomena in this experiment, the results have to be treated 
with caution. The gathered information is merely showing the proof of concept as it is also 
noticeable in the uncorrected curve of Figure 4.5. In the end, the adjustment of the data is 
necessary to emphasize the jump in fusion efficiency because of the removal of the steric 
obstruction. Furthermore, the adjusted values are more in line with the results from the 
experiments obtained in section 6.4. 
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Figure 6.7: Fluorescence emission spectrum with excitation at 460 nm of 
K3-Sx(QSXARRX) vesicles with different amounts of laser exposure. (red) 
Spectrum after 60 s of laser irradiation. (blue) Spectrum with no laser exposure at 
the standard concentration in buffer. (green) Spectrum of HEPES buffer. 
To verify if the peptide is uncaged completely after 60 s, the efficiency was monitored via 
UPLC (Figure 6.8). Due to the high UV/Vis absorption of the caging group at 380 nm, the 
allocation of the peaks is fairly easy. Furthermore, the identities of the peaks were 
confirmed by LC-MS measurements. The initial chromatogram of the K3-Sx(QSXARRX) 
peptide without exposure to the laser shows the main peak at 15.1 min which corresponds 
to the double caged peptide. Traces of cleaved DEACM-OH at 5.8 min are visible, 
indicating that a small percentage of the peptide is not caged fully. This assumption is 
further supported by the small peak at 14.5 min which is most likely a single caged peptide. 
However, the LC-MS data was not conclusive for this peak. 
After 30 s of laser exposure, the main peaks intensity is significantly reduced. Several other 
peaks appear, which are side products of the photo cleaving step. These were not 
investigated further due to ambiguous MS data. The intensity ratio between all peaks 
changes only slightly after 60 s and 120 s exposure to the laser. 
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Figure 6.8: UPLC chromatograms of K3-Sx(QSXARRX) after different amounts 
of laser exposure. (yellow) After 120 s laser exposure; (red) 60 s laser exposure. 
(blue) 30 s laser exposure. (green) No laser exposure. Data was acquired with 
ACE Excel 2 C18, 65-95% B in 18 min at 380 nm.  
All in all, the irradiation of the peptide with the laser leads to successful uncaging of the 
peptide. The peak at 15.1 min decreases in intensity whereas the amount of DEACM 
increases. Really, more than 30 s of irradiation did not alter the uncaging process. Some 
unidentified artefacts are formed which may interfere in the fusion assay. Also, it cannot 
be ruled out, that both cages are cleaved off of every peptide or that the free cage interacts 
with the peptide. Due to these observations, the chosen 60 s of irradiation for the fusion 
experiments is adequate. 
6.4 Effect of the Photocage on Fusion Efficiency 
Parts of the following experiments were done during Fehmke Reinhardt`s bachelor thesis 
under the supervision of Mike C. Groth.[235] 
 
The previously discussed experiments were complicated to interpretate, as several factors 
had a significant impact on the results. To reduce the complexity concerning data 
adjustments, the following FRET dequenching assays were performed in another way. 
Instead of the uncaging of the K3-Sx peptide with the labeled E3-Syb vesicles present, the 
cleavage was carried out before both populations were mixed (for experimental detail see 
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section 9.4.4). The freshly extruded K3-Sx vesicle solution was treated with laser light 
directly before insertion to the cuvette at the 30 s mark. Ideally, a solution consisting of the 
standard K3-Sx(QSK) vesicles and the cleaved DEACM-OH group was added to the 
labeled E3-Syb vesicles. This implies full uncaging of the photo group. Therefore, all data 
acquired using this method, was corrected by the intensity value produced because of the 
emission of the free DEACM-OH (see Figure 4.7). For this, the fluorescence of the K3-Sx 
sample at 530 nm was recorded prior to laser treatment and compared to the value after the 
procedure. The difference between the values was subtracted from the measurements. On 
average, a difference of ~125 Au was measured and consequently subtracted from the data 
points. The results of these measurements are shown in Figure 6.9. 
 
Figure 6.9: Comparison of different K3-Sx vesicle species in FRET dequenching 
assays. (blue) Reference vesicles containing K3-Sx(QSK) and E3-Syb(RKY). 
(red) K3-Sx(QSXARRX) vesicles after 60 s of irradiation with the laser. 
(teal) K3-Sx(QSXARRX) vesicles without laser. (green) Control measurement 
containing both K3-Sx(QSXARRX) and labeled vesicles. 
Uncaging the K3-Sx species prior to the introduction to the other vesicle population was 
successful. The fusion efficiency obtained after 20 min reaches about 11 % and falls short 
slightly behind the reference. However, these results have to be treated carefully as the 
measurements were only performed twice. Nevertheless, within the limits of the data a 
general trend can be postulated. In the first few seconds after injection (between 30 s and 
60 s), the intensity increase is minimal and some irregularities are visible. Here, the before 
mentioned correction is implemented. Another contributor to the irregular shape in the 
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beginning is most likely the fluorescence of the free cage which is introduced as a side 
product at the 30 s mark. As the method is very sensitive, a sudden injection of a new photo 
active group disturbs the measurement. After that, the curve shape follows the expected 
criteria. As initially discussed, multiple explanations for the lower fusion efficiency are 
possible. First, uncaging was not completed in the 60 s of laser irradiation. The irradiation 
time was chosen according to previous uncaging experiments that showed full uncaging 
after 1 min in a E3/K3 coiled coil system.[219] Longer uncaging times are not desirable as 
unexpected side reactions might occur due to the high energy. Furthermore, other 
experiments in which photo sensitive molecules are present (e.g. FRET quenching assays) 
would suffer from high photobleaching, rendering the caging group not useful. Therefore, 
a balance between laser irradiation time and amount of uncaging was chosen. The teal curve 
shows the outcome of the same experiment except that the K3-Sx vesicles are not treated 
with light prior to injection. Ideally, the fully caged peptide is introduced into the cuvette 
and should not show fusion. In comparison to the curve of the lasered experiments, a clear 
differentiation is possible. The kinetics vary as the slope of the not lasered curve flattens 
much more quickly. Furthermore, after about 1000 s the difference between the two in the 
total intensity becomes more apparent. However, considering the error margins of both 
curves, the deviation is not as pronounced as expected. Alongside the fusion experiments 
DLS data was also acquired for each measurement (Table 6.3). 
Table 6.3: Sizes of vesicle species used in the uncaging experiments obtained via 
DLS. 











No Laser 122.3 0.082 130.3 0.070 139.9 0.117 
60 s Laser 123.4 0.076 138.5 0.120 156.9 0.136 
Before Laser - - 134.2 0.083 - - 
 
The sizes of the E3-Syb vesicles do not differ between the experiments and are of proper 
quality. For the laser experiment, the sizes of the K3-Sx vesicles were measured before and 
after irradiation to see whether this influences the size. Indeed, a small increase of ~4 nm 
was observed. Additionally, the size distribution broadened significantly as indicated by 
the PdI values. Apparently, the uncaging process initiated changes in the structure of the 
vesicles. One possible explanation is that the K3-Sx peptide is more flexible after the 
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cleavage of the two bulky caging groups. The enhanced flexibility could lead to an 
improved interaction of the motif with the own membrane and consequently destabilizing 
it. This argument can be supported by the result of the control measurement in Figure 6.9. 
Typically, an increase of ~2 % is recorded for the control measurements. Here, virtually no 
increase was observed. This phenomenon is explained in more detail in section 4.3.4. For 
both experiments the DLS data show a size increase after mixing of the liposomes. For the 
lasered experiment the size increase is twice as high compared to the not lasered mixed 
samples. This is also accompanied by a larger PdI, which is most likely due to the broader 
size distribution of the K3-Sx vesicle. 
In summary, the introduction of two photocages into the linker region of the K3-Sx peptide 
was successful. The positioning of the cage at Lys260/264 of syntaxin 1A hampers fusion 
of the E3/K3-TMD model system. However, it does not completely stop the process. 
Reasons for this result are manyfold, ranging from pre cleavage of the photocage to 
insufficient obstruction of the coiled coil formation. Furthermore, the uncaging did not 
restore full fusion efficiency of the reference system. Nevertheless, the caging of the 
E3/K3-TMD model system shows potential concerning the elucidation of the fusion 
mechanism. Further investigations could yield valuable information in this regard. 
 
93 
 Lipids and the E3/K3-TMD System 
Many proteins involved in neuronal exocytosis show interactions with lipids of different 
nature. For example, synaptotagmin and syntaxin 1A are known to interact with PIP2 due 
to its charge.[257,258] Furthermore, membrane lipid composition is an important factor in 
liposome fusion and some lipids have been identified to be critical for this activity.[32,259–
261] Thus, investigations concerning membrane composition accommodate a high potential 
for gathering information about the E3/K3-TMD model system. In this chapter the effect 
of different lipid compositions (section 7.1) on fusion behavior of the E3/K3-TMD model 
system is presented. The chapters 7.2 and 7.3 show the influence of additional charges in 
the membrane on the model system. 
7.1 Effect of the Lipid Composition on the E3/K3-
TMD System 
In the majority of the fusion experiments in this work, a standard membrane lipid 
composition of DOPC/DOPE/Cholesterol = 2:1:1 mol% was used. This composition was 
used to produce easily comparable results to previous works.[184,185] Furthermore, the net-
charge of the membrane is kept mostly neutral (with the exception of the FRET 
fluorophores) to minimize interactions with the introduced peptides. Still, PC, PE and 
especially cholesterol concentrations might have an effect on the model system peptides 
fusion performance. Membrane thickness plays an important part in the TMD’s insertion 
depth and angle. These elements can potentially influence the peptides fusion ability. To 
investigate whether this is the case, FRET fusion assays with varying membrane lipid 
compositions have been performed (Figure 7.1). 
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Figure 7.1: FRET dequenching assay with the reference peptides E3-Syb(RKY) and K3-
Sx(QSK) in varying membrane lipid compositions. (blue) DOPC/DOPE/Chol = 55:30:15. 
(green) Standard lipid composition DOPC/DOPE/Chol = 2:1:1. (red) 
DOPC/DOPE/Chol = 45:20:35. 
The standard composition of DOPC/DOPE/Chol = 2:1:1 (green curve) shows the typical 
curve form and a minor standard error. In case of the red curve which depicts a higher 
cholesterol fraction, a small increase in total fluorescence intensity after 20 min was 
observed. Though, this minimal increase is accompanied by a noticeably bigger standard 
deviation. The increase in cholesterol or the decrease of DOPC and DOPE seem to 
influence the fusion process in such a way, that the fusion behavior is less consistent. The 
green curve shows the opposite case with a lower cholesterol fraction in the membrane 
composition with only 15 mol%. This measurement was performed only once, therefore 
the validity is much lower. Nevertheless, it shows a tendency of the effect on fusion 
efficiency. Previous studies show, that the amount of cholesterol in the membrane has an 
impact on fusion performance of the native SNARE complex.[262,263] This seems not to be 
the case for the model system, as small changes in the lipid composition between DOPC, 
DOPE and cholesterol do not alter the fusion behavior significantly. These results are useful 
regarding lipid film preparation (see section 9.4.1). Minor inconsistencies, which are 
unavoidable during the transfer of the lipid solutions, are less significant in case of 
alterations in the lipid composition. However, changes in the total amount of lipids 
transferred still have an effect on the number of vesicles in the sample. All in all, small 
changes in the lipid composition of DOPC, DOPE and cholesterol appear to have no effect 
on the model systems fusion capabilities.  
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7.2 Incorporation of DOPS in the Vesicle 
Membrane 
To mimic the natural lipid composition of vesicles in the neuronal exocytosis, experiments 
with an additional lipid were performed. 1,2-dioleoyl-sn-glycero-3-phospho-L-serine 
(DOPS) was added in a ratio of DOPC/DOPE/DOPS/Chol = 5:2:2:1 to reflect the native 
composition of neuronal vesicles more closely.[264] The results of the lipid mixing assay are 
shown in Figure 7.2. 
 
Figure 7.2: FRET dequenching assay of vesicles containing DOPS. 
(blue) Reference measurement with the standard lipid composition of 
DOPC/DOPE/Chol = 2:1:1. (red) measurements containing DOPS with 
DOPC/DOPE/DOPS/Chol = 5:2:2:1.  
The results indicate that the E3/K3-TMD system is not able to perform fusion with 
liposomes containing the above mentioned lipid composition. The measurements show a 
total fusion efficiency below 2 % after 20 min. The curve form resembles typical control 
measurements. It has to be noted, that these experiments were performed with a peptide to 
lipid ratio of 1:200. However, as described in section 4.3.2, the obtained signal in these 
assays is higher than with a P/L = 1:500. Therefore, a bigger effect should be observed. 
Despite this signal enhancing effect, the peptides are apparently not able to perform fusion. 
DOPS is a negatively charged lipid, and thus changes the electrostatic potential of the 
vesicles. As DOPS was introduced in both vesicle species, electrostatic repulsion between 
the vesicles increases. The E3/K3-TMD model system seems to be incapable of 
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compensating this phenomenon, hence no fusion can be observed. These results are in 
agreement with previous findings, showing the inhibitory effect of DOPS in liposome 
fusion.[265,266] Furthermore, similar results were obtained with the alternative PNA-TMD 
and Alanyl-PNA-TMD model systems.[188] Another explanation for the dramatic drop in 
fusion efficiency could be attributed to the motifs used in this system. In contrast to the 
Alanyl-PNA-TMD and PNA-TMD model systems, the E3/K3-TMD system is highly 
positively charged. An additional charge inside the membrane, which is introduced by 
DOPS, can interact with the motifs, immobilizing the peptide on the vesicle membrane. 
Especially K3-Sx with its highly positive K3-motif might interact more with the lipid head 
group of DOPS. As mentioned in section 2.7.3, in the E3/K3-PEG-Lipid system, it was 
demonstrated that K3 rests on its own membrane until being picked up by E3 to facilitate 
fusion.[197,199,203] Introduction of a negatively charged lipid will most likely enhance this 
behavior. In addition, the linker of syntaxin 1A is positively charged and well known to 
sequester negatively charged lipids like DOPS or PIP2.[26,241] An additional effect of the 
recruitment of these lipids is the disassembly of the syntaxin clusters. If K3-Sx clusters 
form, which has yet to be determined, the addition of negatively charged lipids will 
probably influence this structure. These results are supported by the data obtained from the 
DLS measurements with the modified lipid composition as depicted in Table 7.1. 
Table 7.1: DLS data of vesicle species with a lipid composition of 
DOPC/DOPE/DOPS/Chol = 5:2:2:1.  










137.5 0.096 137.8 0.091 141.0 0.120 
145.1 0.089 136.1 0.090 140.2 0.117 
 
The size difference of the K3-Sx vesicle and E3-Syb vesicles is typically ~10 nm with the 
K3-Sx vesicles being bigger for the standard lipid composition of 
DOPC/DOPE/Chol = 2:1:1. Here, in both measurements the size is either the same or even 
smaller than the E3-Syb-vesicles. Evidently, a change in the vesicles is already visible 
before the fusion assays are performed, which leads to the conclusion, that interactions 
inside the vesicle membrane have changed. The mixed vesicle population post FRET 
dequenching assay shows no significant increase in size. Consequently, the initial vesicle 
species did not fuse, backing the results obtained from the fusion assay. 
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Ultimately, DOPS inhibts fusion activity of the E3/K3-TMD complex. This is probably due 
to the introduced charges in the liposomes. Electrostatic interactions between DOPS and 
the peptides, as well as repulsion between the negatively charged vesicles might be the 
crucial factor for this result. 
7.3 Effect of PIP2 on Membrane Fusion 
The interaction between phosphatidylinositol 4,5-bisphosphate (PIP2) and syntaxin 1A has 
been a research topic for many years. As discussed in section 7.2, negatively charged lipids 
interact with positively charged areas of SNARE proteins. The polybasic area (KARRKK) 
in syntaxin’s linker has previously shown to be a major partner for these 
interactions.[28,172,241,267] Given the fact, that the K3-Sx model peptide includes the 
polybasic area, experiments have been performed with different PIP2 concentrations to 
investigate the behavior of the model system (Figure 7.3). 
 
Figure 7.3: Fusion curves obtained in FRET dequenching assays with different 
amounts of PIP2. (blue) Reference measurement containing no PIP2. 
(red) Measurements with 1 % PIP2. (teal) Measurements containing 2 % PIP2. 
(green) Control measurement with K3-Sx(QSK) and 2 % PIP2.  
A range between 0.01-2 mol% PIP2 has been chosen for the fusion assays. The initial 
measurements were done with 2 % PIP2 and showed, that this amount is sufficient to stop 
the model system from being able to fuse vesicles. The control measurement also included 
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2 % PIP2 in the K3-Sx(QSK) vesicle as well as in the labeled vesicle. The difference 
between both is insignificantly small, also including the standard deviation of the 
measurements. The measurements with 1 % PIP2 are slightly higher in intensity but are also 
accompanied with a bigger error. Nevertheless, a trend is visible with these two PIP2 
concentrations. Lower amounts of PIP2 seem to restore the ability of the model system to 
perform fusion. To verify this trend measurements with 0.1 % and 0.01 % PIP2 were 
conducted as depicted in Figure 7.4. 
 
Figure 7.4: Fusion curves obtained in FRET dequenching assays with different 
amounts of PIP2. (blue) Reference measurement containing no PIP2. (teal) 
Average of measurements containing 0.1 % PIP2. (red) Measurements with 
0.01 % PIP2. (green) Control measurement with K3-Sx(QSK) and 2 % PIP2. 
For both PIP2 concentrations, 0.1 % and 0.01 %, a similar result was obtained. The curve 
shape is as expected for this kind of experiment. The reference measurement does not 
contain PIP2 in the vesicles and resembles therefore the final measurement of the 
concentration gradient. The standard deviation of the 0.1 % and 0.01 % PIP2 vesicle species 
is equally big, rendering both sets of measurements virtually indistinguishable from each 
other. 
Literature suggests, that a concentration of ~6 mol% of PIP2 inhibits SNARE-dependent 
liposome fusion.[28] Here, as low as 1 mol% was sufficient to inhibit the model systems 
ability to fuse vesicles. Possible explanations are similar to the ones in section 7.2. 
A similarity between DOPS and PIP2 are the negatively charged headgroups. In fact, 
depending on the pH, PIP2 can adopt charges ranging from (-3) to (-5).
[268] This makes it 
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an even better binding partner for the polybasic stretch of amino acids in K3-Sx peptides. 
This is also true for the lysines of the K3 motif. K3-Sx is probably firmly attached to the 
vesicle membrane, making it unavailable for E3-Syb in the opposing vesicle and 
consequently inhibiting fusion. Taking into account the total number of PIP2 and putting it 
into perspective of the number of peptides present, an explanation on the molecular level 
is possible. The peptide to lipid ratio in these experiments was P/L = 1/500. With a 
concentration of 1 mol%, about five of these lipids are PIP2 lipids. This means, that on 
average every peptide can be accompanied by five PIP2 lipids, which might interact with 
the basic linker or motif. If the amount of PIP2 is dropped to 0.1 mol%, only 0.5 lipids per 
peptide are available in the vesicle. This is not sufficient to stop the vesicle in its entirety 
to fuse. Furthermore, it is highly likely that the PIP2 lipids are being recruited by K3-Sx, as 
this is the case for the natural syntaxin 1A protein due to the polybasic stretch of amino 
acids in the linker.[28,269] The acquired DLS data of the different measurements is presented 
in Table 7.2. 
Table 7.2: Average of the recorded sizes of vesicle species used with varying PIP2 
concentrations.Data obtained via DLS. 











0.00 mol% 128.5 0.091 131.7 0.102 149.9 0.131 
0.01 mol% 120.2 0.084 133.3 0.106 151.9 0.123 
0.10 mol% 128.4 0.090 141.2 0.114 161.7 0.153 
1.00 mol% 117.3 0.076 127.9 0.085 134.9 0.110 
2.00 mol% 133.4 0.087 147.0 0.088 147.1 0.097 
 
The observations made from the FRET dequenching assays are also supported by the DLS 
data. PIP2 concentrations below 1 mol% show a significant increase in the average size of 
the mixed vesicle population post fusion. For the 1 mol% PIP2 concentration 
measurements, only a small size increase was recorded.  
In combination with the dequenching assay data, it can be concluded that the 1 mol% mark 
is on the edge of the inhibitory effect of the lipid. The 2 mol% measurements clearly show 
that no size increase occurred confirming the inhibition due to PIP2.
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 Conclusion and Outlook 
This thesis focused on the linkers of the SNARE mimicking E3/K3-TMD model system. 
The system consists of the artificial E3/K3 coiled coil and the native sequences of the linker 
and TMD of synaptobrevin 2 and syntaxin 1A to form the E3-Syb and K3-Sx peptides. 
Modifications on the linkers of both peptides were performed and the changes in the fusion 
behavior in FRET dequenching assays recorded. Additionally, changes in the vesicle sizes 
due to the incorporated modified peptides were monitored with DLS. Insight into the fusion 
mechanism was gained by the introduction of photocleavable groups into one of the 
peptides. Furthermore, the effect of different lipid compositions and the introduction of 
charged lipids on the fusion behavior of the system was examined. 
 
To gather reliable data and produce more consistent results, peptide quality and 
measurement parameters have been optimized. Reaction conditions for the microwave 
assisted automated peptide synthesis were specifically tailored for the used peptides. This 
approach lead to less truncated peptides and to an overall increase in peptide quality. 
Peptide purification via HPLC improved the purity even further with considerable changes 
to the model systems fusion behavior. The unexpected reduction in fusion efficiency with 
purified peptides, emphasized the importance of these two steps.  
An improvement in the quality of the collected data during FRET dequenching assays and 
DLS measurements was achieved by changing the peptide to lipid ratio in the vesicles to 
P/L = 1:500. The lower overall signal intensity during the fusion assays was compensated 
by substantial improvements in the mean variation between measurements of the same type. 
The smaller error bars and consequently more convincing data was gained due to the 
improved vesicle quality. Notably, the improvements in the K3-Sx vesicle stability lead to 
these results. In previous experiments with this system, the stability of the vesicles was the 
limiting factor during fusion assays.[207] The improvements introduced in this work are 
therefore expanding the potential of the E3/K3-TMD system. 
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During the optimizations of the different experiments, first clues regarding the model 
systems fusion behavior could be obtained. It is possible, that K3-Sx peptides interact with 
the FRET fluorophores on the opposing vesicle membrane. The same behavior was also 
found in the similar PNA-TMD model system.[188] Furthermore, this observation is in line 
with experiments regarding the lipid composition of the vesicles. The addition of charged 
lipids e.g. DOPS or PIP2 into the vesicle membranes lead to a reduced or even completely 
abolished fusion efficiency of the system. One possible explanation for these observations 
is that the K3-Sx peptide interacts strongly with the own membrane due to the negative 
charges. The motif would not be available for the coiled coil formation with E3-Syb. 
Consequently, no fusion can be detected. Interaction of the K3 motif with the membrane 
was already investigated with the E3/K3-PEG-lipid system.[200,203] Due to the similarities 
between the two SNARE analoga, it is plausible that this behavior is also exhibited in the 
E3/K3-TMD system used in this thesis. 
However, to verify this theory, more tests remain to be performed. For example, the use of 
two vesicle populations with different lipid compositions could yield more information 
regarding this question. If the K3 motif is attached to the own vesicle membrane due to 
charged lipids, no fusion should be detected with liposome species lacking these lipids. The 
other way round, fusion is expected if the opposing vesicle is the one containing the 
negatively charged lipids. The positively charged K3 motif should prefer interaction with 
the other membrane. This experiment would be similar to the ones performed in section 
4.3.3. Another approach is to measure the distance of the K3 motif to the membrane. This 
can be achieved via tryptophan fluorescence emission, which is sensitive to the polarity of 
the environment.[270,271]  
 
The incorporation of the photocleavable protecting group into the K3-Sx peptide impaired 
the ability of the system to perform fusion. The jump in fluorescence intensity which was 
detected after the caged peptide was exposed to light irradiation confirms the intended 
effect of the group. Yet, this experiment is afflicted with several difficulties. 
Photobleaching of the FRET fluorophores due to the laser had to be accounted for. Also, 
the side products of the cleaved group interfered with the fluorescence measurements. 
These findings lead to adaptions of the experiment, where photobleaching due to the laser 
was removed as a factor. During these new measurements, the vesicles containing the caged 
peptides were separately lasered and subsequently introduced to the labeled vesicles. In 




However, the inhibition was not absolute, as the measurements with the fully caged K3-Sx 
peptide still showed some positive fusion activity. Due to the difficult synthesis and 
handling of the peptide, a small percentage of the protecting groups was already missing 
before the fusion assays were started. Consequently, some peptides were not sterically 
hindered and could fuse without problems. Furthermore, the positioning of the two cages 
might not be hindering the interaction between the two peptides sufficiently to stop the 
fusion completely.  
To improve this experiment, the inhibiting effect of the group could be enhanced by 
changing the positions in the peptide sequence or even introduce one additional group. A 
promising candidate would be Lys 265 of syntaxin due to its orientation in the cis-SNARE 
complex.  
 
In this thesis, the connection between the artificial motif and natural linker sequence was 
investigated. Analysis of the three dimensional conformation of the natural SNARE cis-
complex and the fundamentals of coiled coil heptad repeat interactions suggested that the 
original peptide sequence of the E3/K3-TMD model system was not optimal regarding 
intermolecular interactions between the peptides. To investigate this, a peptide pair with 
modified length was synthesized and its fusion behavior monitored. These modifications 
lead to a slightly reduced fusion efficiency compared to the reference system. Apparently, 
the model systems conformation and fusion behavior differ compared to the natural 
SNARE machinery. Accordingly, the initial design seems to be the best performing variant 
of this SNARE analog. 
 
Investigations concerning the aromatic collar in the linkers of synaptobrevin and syntaxin 
showed that they are important to maintain a high fusion efficiency of the system. However, 
in comparison to the natural machinery, opposing results were obtained in respect to the 
number of substituted residues. Whereas merely the substitution of both Trp 89/90 in 
synaptobrevin showed a change in the exocytotic burst of chromaffin cells,[29] the exchange 
of already one of the tryptophan residues decreased the fusion behavior of the E3/K3-TMD 
complex. Substitution of Y257A in the K3-Sx peptide and Y88A in the E3-Syb species did 
not lead to conclusive results. The mean variation between the individual measurements 
was significantly higher compared to other fusion assays in this work. In addition to the 
substituted amino acids, K3-Sx had to be elongated by at least one amino acid to include 
the tyrosine residue, as it is not included in the original sequence. Ultimately, two amino 
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acids were added to the peptide. This approach entailed the need for an elongated reference 
peptide without the tyrosine substitution. The comparison between elongated reference and 
the tyrosine substituted assays suggested an inhibitory effect of the tyrosines. Considering 
the high error margin of the measurements, further tests have to be conducted before a more 
accurate conclusion can be made. 
 
The polybasic area in syntaxin is a center of research interest, as interactions with a variety 
of lipids and other proteins have been observed in the past.[26,28,172] To answer the question 
whether this is also true for the E3/K3-TMD system, specific amino acids have been 
exchanged. The substitution of Lys 260/264 in K3-Sx with alanine reduced the fusion 
efficiency by ~40 % compared to the reference system. Initially, these lysines have been 
chosen due to their position sitting in between synaptobrevin 2 and syntaxin 1A.[23] Thus, 
possible stabilizing interactions would be eliminated and more information about their 
magnitude during the fusion mechanism could be gathered. An even bigger effect was 
observed during experiments where the two Arg 262/263 of K3-Sx were substituted for 
alanine. Fusion could not be observed during the FRET dequenching assays. Due to the 
arginines being adjacent to the two Lys 260/264 and having the same charge, the orientation 
in the peptide is most likely the reason for this result. In the natural SNARE cis-complex, 
the arginines point toward the membrane, which enables them to interact with lipids or 
other proteins. However, as the exact conformation of the model system is not identified, 
additional experiments have to be executed to verify this hypothesis. 
 
Although, the E3/K3-TMD system was verified to perform full fusion via content mixing 
assays in the past,[22,206] due to the many improvements in peptide and vesicle quality, these 
experiments have to be repeated under the new conditions. Additionally, inner lipid mixing 
assays as described by HUBRICH need to be executed with this system as well to distinguish 
between hemi- and full fusion.[185] Further insight about the fusion behavior could also be 





 Material and Methods 
9.1 Solvents and Reagents 
All used solvents were of laboratory grade (≥99.8 %) or higher. Ultrapure water was 
obtained by filtering demineralized water with an arium® mini ultrapure water system from 
Sartorius (Göttingen, Germany). Solvents for HPLC and UPLC were of HPLC grade 
quality (99.9 %). Solvents used for LC-MS were of LC-MS grade quality. Commercially 
available reagents were purchased from Merck KGaA (Darmstadt, Germany), Sigma-
Aldrich GmbH (München, Germany) and Fisher Scientific GmbH (Schwerte, Germany). 
Amino acids were purchased from GL Biochem (Shanghai) Ltd. (Shanghai, China) and 
Sigma-Aldrich GmbH (München, Germany). Lipids and fluorophores were purchased from 
Avanti Polar Lipids, Inc. (Alabaster, USA). Fluorinated solvents were obtained from 
chemPUR (Karlruhe, Germany). Phospholipids were purchased from Avanti Polar Lipids, 
Inc. (Alabaster, USA). 
9.2 General Methods 
9.2.1 Lyophilization 
Aqueous samples were thoroughly frozen in liquid nitrogen and dried in vacuo (< 1 mbar) 
using a Alpha 2-4 LD freeze dryer form Christ (Osterode am Harz, Germany) which was 
connected to a high vacuum pump. Raw peptides were solved in small amounts of HFIP 
and treated in a ultrasonic bath. The solution was diluted with a tenfold amount of ultrapure 
water and prior to freezing stirred thoroughly. Fractions collected from HPLC purification 
were reduced via nitrogen stream to a volume ~2 mL and diluted with 6 mL ultrapure water 
before freezing. 




Freeze dried peptides and peptides solved in TFE were stored at -18 °C in plastic tubes. 
Peptides attached to resins were stored under vacuum at room temperature. Chemicals were 
stored according to suppliers recommendation. Lipids were diluted in chloroform and 
stored under argon atmosphere in glass bottles at -18 °C. HEPES buffer stock solution (10x) 
was stored at 8 °C. Light sensitive compounds were additionally protected from light. 
9.2.3 Mass Spectrometry 
ESI (Electrospray ionization) mass spectra were recorded using a maXis spectrometer by 
Bruker Daltonik GmbH (Bremen, Germany) with a TOF analyser. The peptides were 
dissolved in HFIP and mixed with MeOH in a 1:10 ratio. The mass-to-charge ratio (m/z) 
with the corresponding relative intensity is reported. 
9.2.4 LC-MS 
LC-MS measurements were done on the UltiMate 3000 from Thermo Fischer Scientific 
(Waltham, USA) consisting of pumps, autosampler, column oven and diode array detector 
of the 3000 series. The UPLC was connected to the ion trap mass spectrometer LTQ XL 
from Thermo Fischer Scientific (Waltham, USA). The mobile phase used water (LC-MS 
grade) + 0.1 % FA and MeCN (LC-MS grade) + 0.1 % FA. The column used for separation 
was an ACE Excel (100A-2-C18 100 mm x 2.1 mm, 2 μm) which operated under a flow rate 
of 0.35 mL/min at 40 °C. Detection was done at 215 nm, 254 nm, 280 nm and 380 nm. 
9.2.5 Nuclear Magnetic Resonance Spectroscopy 
Measurements of 1H- and 13C-NMR were recorded on a Mercury-VX 300 or VNMRS-300 
from Varian (Palo Alto, USA). The deuterated solvents and measurement frequencies are 
disclosed at the respective compounds. As the internal standard, the residual proton signal 
of the solvent was used. The chemical shift  is given in ppm and coupling constants J in 
Hz. Coupling between nuclei is denoted with the following abbreviations: s (singlet), 
d (doublet), t (triplet), q (quartet) or m (multiplet). 
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9.2.6 UV/Vis Spectroscopy 
UV/Vis spectroscopy was used to determine the phosphorus content (see section 9.4.6) and 
the peptide concentrations of samples. For both, either NanoDrop 2000c or NanoDrop 
OneC from Thermo Fischer Scientific (Waltham, Massachusetts, USA) was used. As 
cuvettes a quartz SUPRASIL QS or disposable cuvettes from Brand GmbH (Wertheim, 
Germany) with a path length of 10 mm were used. Prior to the measurements a blank was 
measured with 195 μL of MeCN (HPLC grade) and 5 μL of TFE. The corresponding value 
was automatically subtracted by the software from the following measurements. The 
peptide concentration was determined at 280 nm or 385 nm for photocaged peptides with 








The absorption A is measured and corrected by the blank measurement, the molar extinction 
coefficient  is specific for every peptide and the path distance d is determined by the 
cuvette which is usually 10 mm. The extinction coefficient was calculated for every peptide 
individually by summation of every amino acids or building blocks contribution at the 
measured wavelength. The coefficients used in this thesis are listed in Table 9.1. 
 




Extinction coefficient  
M-1 · cm-1 
Reference 
Cysteine 280 120 [274] 
Tryptophan 280 5690 [274] 
Tyrosine 280 1280 [274] 
DEACM 385 16000 [256] 
9.2.7 Purification via RP-HPLC 
Analysis and bulk purification of all peptides was done via reversed phase high 
performance liquid chromatography (RP-HPLC) using the HPLC systems listed in Table 
9.2.  
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Table 9.2: HPLC-Systems used for analysis and bulk purification of peptides. 
System Modification 
UPLC 
Thermo Fisher (Waltham, Massachusetts, USA). 
Ultimate 3000: Detector DAD-3000; pumps LPG-3400SD; column oven 
TCC-3000SD; autosampler WPS-3000SL; software Chromeleon 7.2 SR4. 
HPLC Prep 
JASCO (Tokyo, Japan) 
Detector UV-4075, pumps PU-4086, column oven CO-4060, interface 
LC-NetII/ADC, collector interface Fraction collector interface, collector 
CHF122SC (Advantec), software ChromNav 2.01.06. 
HPLC 
Semi-Prep 
JASCO (Tokyo, Japan) 
Detector 2x UV-2075 Plus; UV-975, pumps PU-2080 Plus, column oven 
CO-4060, interface LC-NetII/ADC, degasser DG-2080-53, collector 
interface Fraction collector controller, software ChromNav 2.01.06. 
HPLC Prep-
DAD 
JASCO (Tokyo, Japan) 
Detector MD-2010 Plus, pumps PU-2080 Plus 20 ml version, interface 
LC-NetII/ADC, degasser DG-2080-53, collector interface FC-2088-30, 
collector CHF122SC (Advantec), software ChromNav 2.01.06. 
 
For the stationary phase, columns from Advanced Chromatography Technologies Ltd. 
(Aberdeen, Scotland) listed in Table 9.3 were used.  
Table 9.3: Columns used for peptide analysis and purification and the flow rates 
at which they were used. 
Column Name Specification Flow rate 
1 ACE Excel 2 C18 C18, 100 x 2.1 mm, 100 Å, 2 µm 0.3 mL/min 
2 ACE Excel 5 C18 C18, 150 x 10 mm, 100 Å, 5 μm 5.0 mL/min 
3 ACE Excel 5 C18 C18, 150 x 21.2 mm, 100 Å, 5 μm 10 mL/min 
 
As eluents, different gradients of ultrapure water, acetonitrile and methanol as depicted in 
Table 9.4 were used. Generally, the sample was first solved in HFIP. For every 10 mg of 
peptide sample 100 μL HFIP were used. To accelerate solvation, the sample was treated in 
a sonication bath until no solid residues were visible to the naked eye. The sample was then 
diluted with ultrapure water to a maximum volume of 700 μL. Subsequent, filtration using 
a Phenex-RC syringe filter (0.45 μm pore size) from Phenomenex (Aschaffenburg, Germany) 
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Table 9.4: List of solvent systems used during LC peptide analysis and 
purification. 
Solvent System Solvent A Solvent B 
I H2O + 0.1 % TFA MeOH + 0.1 % TFA 
II H2O + 0.1 % TFA MeCN + 0.1 % TFA 
III H2O + 0.1 % TFA MeCN + 0.85 % TFA 
 
Absorbance was detected at 215 nm, 280 nm and optionally at 254 nm. Peptides with 
fluorophores were detected at 380 nm. 
9.2.8 Flash chromatography 
Silica gel for flash chromatography was obtained by Merck KGaA (Darmstadt, Germany) 
with a grain size of 40-63 µm. The crude sample was eluted in a suitable solvent, mixed 
with a small amount of silica gel and afterwards separated by the solvent using a rotary 
evaporator. The column was run at low overpressure. 
9.2.9 Thin layer Chromatography 
Reaction monitoring was performed via thin layer chromatography with aluminum assisted 
silica gel 60 F254 from Merck KGaA (Darmstadt, Germany). Detection of the sample was 
achieved by fluorescence deletion at 254 nm.  
9.2.10 Graphs and Illustrations 
Graphs depicting experimental data were plotted with OriginPro 8.5 from OriginLab 
(Massachusetts, USA), images of structures obtained by X-ray data were edited with the 
UCSF Chimera package (California, USA), chemical structures were drawn with 
ChemDraw Professional from PerkinElmer (Massachusetts, USA) and all other 
illustrations were created using Affinity Designer, Affinity Photo and Affinity Publisher by 
Serif Inc. (Nottingham, Great Britain). 
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9.3 Peptide Synthesis 
9.3.1 Solid Phase Peptide Synthesis (SPPS) 
All peptides were synthesized using automated microwave assisted peptide synthesizers. 
For the synthesis either a Liberty Blue or Liberty Prime peptide synthesizer from CEM 
(Matthews, North Carolina, USA) was used, both were connected to a Discover microwave 
unit by CEM. The exact configurations are listed in Table 9.6. 
Table 9.5: List of synthesizers used for automated microwave assisted peptide 
synthesis. 
Synthesizer Name Configuration 
Liberty Blue 1 
Liberty Blue, Discover microwave, software Liberty Blue 
Application Software vers. 1.50. 
Liberty Blue 2 
Liberty Blue, Discover microwave, software Liberty Blue 
Application Software vers. 2.2. 
 
Depending on the synthesizer, different concentrations of reagents were used (see Table 
9.6). As solvent N,N-Dimethylformamide (DMF), as activator N,N'-
Diisopropylcarbodiimide (DIC), as activator base Oxyma Pure (Ethyl cyano-
(hydroxyimino)acetate) and as deprotection piperidine with N,N-Diisopropylethylamine 
(DIPEA) was used.  
Table 9.6: Used amino acids and concentrations of reagents for automated peptide 
synthesis on the Liberty Blue synthesizers. 
Reagent Concentration 
Amino acids 0.2 M 
DIC 0.5 M 
Oxyma 0.5 M 
Piperidine 20 % 
DIPEA 0.1 M 
Fmoc-Ala-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Asn(Trt)-OH, Fmoc-Cys(Trt)-OH, 
Fmoc-Gln(Trt)-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Gly-OH, Fmoc-Ile-OH, 
Fmoc-Leu-OH, Fmoc-Lys(Boc)-OH, Fmoc-Met-OH, Fmoc-Phe-OH, Fmoc-
Ser(tBu)-OH, Fmoc-Trp(Boc)-OH, Fmoc-Tyr(tBu)-OH, Fmoc-Val-OH 
 
For all K3-Sx peptides a preloaded Fmoc-Gly-Wang LL resin with a loading density 
between 0.33-0.36 mmol/g, for all E3-Syb peptides a preloaded Fmoc-Thr(tBu)-Wang LL 
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resin with a loading density of 0.28-0.34 mmol/g was used. Prior to synthesis, the resin was 
swollen with DMF for a minimum of 10 min.  
Synthesis conditions varied between specific amino acids as well as position in the peptide. 
All used coupling methods are listed in Table 9.7. Generally, amino acids coupled to the 
peptide from the position 30 onwards, were coupled twice to ensure higher yields. 
Table 9.7: List of the different coupling methods used for peptide synthesis. 
Name Method 
Optimized 
1. 75 °C, 170 W, 17 s; 2. 90 °C, 30 W, 225 s. 
5 eq. aa, 5 eq. DIC, 5 eq. OxymaPure, 0.5 eq. DIPEA. 
Carbomax 
1. 85 °C, 280 W, 20 s; 2. 105 °C, 90 W, 75 s. 
5 eq. aa, 10 eq. DIC, 5 eq. OxymaPure, 0.5 eq. DIPEA. 
Arginine 
First coupling: 1. 25 °C, 0 W, 1500 s; 2. 75 °C, 30 W, 120 s. 
Second coupling: 75 °C, 30 W, 300 s. 
Cysteine 1. 25 °C, 0 W, 120 s; 2. 50 °C, 30 W, 480 s. 
 
Generally, the different coupling methods follow the same procedure. First, the N-terminal 
amino acid on the resin is deprotected using piperidine at elevated temperatures (1. 75 °C, 
210 W, 15 s; 2. 90 °C, 30 W, 50 s). Second, the next amino acid, activator and activator base 
are added to the resin. Depending on the peptide and specific amino acid a method from 
Table 9.7 was used. Finally, the resin is washed several times with DMF and the next 
coupling step is started. After the coupling of the last amino acid, a final Fmoc deprotection 
was performed and the resin was washed with DMF. The resin was then transferred to a 
BD syringe equipped with a polyethylene frit and washed three times with DCM. Lastly, 
the resin was dried for at least 30 min in vacuo. 
9.3.2 Resin cleavage 
Cleaving the peptide from the resin was performed in a BD syringe equipped with a frit. 
The cleavage cocktail consisting of TFA/TIS/EDT/H2O (95:2:2:1, v/v/v/v) was added to the 
resin and shaken at room temperature for at least 2.5 h. Thereafter, the liquid was separated 
from the solid support using the frit in the BD syringe and the solid residue was rinsed with 
TFA to maximize peptide yield. The combined liquid phases were then concentrated in a 
nitrogen stream and afterwards precipitated with icecold diethyl ether. Using a 
Megafuge 8R centrifuge from Thermo Fisher (Waltham, Massachusetts, USA), the peptide 
pellet was separated from the liquid phase. The precipitation process was performed three 
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times. Finally, the crude peptide was dried for 30 min at ambient conditions and dissolved 
in minimal amounts of HFIP. The solution was diluted with ultrapure water (7-10 times the 
volume of HFIP), frozen in liquid nitrogen and freeze dried. 
9.4 Fusion Assays 
9.4.1 Lipid Film Preparation 
For the lipid stock solutions either premade solutions were used or they were prepared by 
the solvation of solid lipids in chloroform. The stock solutions were stored at -20 °C. The 
concentration of 1,2-dioleoyl-sn-glycero-3-phosphocholine (18:1, 9-cis, DOPC), 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine (18:1, 9-cis, DOPE) and cholesterol stock 
solution was 20 mg/mL. The labeled lipids stock solutions of 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD-
DOPE), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) 
(ammonium salt) (Rh-DOPE), 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine 
(Oregon green 488 DHPE) and 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine 
(triethylammonium salt) (Texas red DHPE) had a concentration of 1 mg/mL. Peptides were 
dissolved in TFE and their concentration was determined prior to lipid film preparation via 
UV/Vis absorption at 280 nm for uncaged peptides and 385 nm for caged peptides. 
 
The lipid films were prepared in small glass tubes which were prefilled with chloroform. 
Test tubes containing labeled lipids were covered by aluminum foil to reduce the exposure 
to light. During the preparation the tubes and stock solutions were cooled in an ice bath. 
The stock solutions of lipids were added to the test tube with the appropriate volume to a 
total lipid amount of 625 nmol. The lipid composition varied depending on the experiment 
and are shown in Table 9.8. Subsequently, the peptide stock solutions were added according 
to the peptide to lipid ratio and TFE was added accordingly to reach 250 L. Usually, 
P/L = 1:500 was used, leading to a total peptide amount of 1.25 nmol per film. Lipid films 
without peptides were topped with pure TFE. After all components were added, the 
mixtures were mixed for 5 s and heated to 50 °C. The solutions were vortexed again for 5 s 
and exposed to a slight nitrogen stream at 50 °C. After the volatile solvent was evaporated, 
the lipid films were stored overnight in vacuo at 50 °C and used the next day. 
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Table 9.8: List of the used lipid compositions in this thesis for the preparation of 
liposomes. 
Liposome Lipid composition (molar ratio) 
Unlabeled DOPC/DOPE/Chol = 50:25:25 
Unlabeled DOPC/DOPE/DOPS/Chol = 50:20:20:10 
Unlabeled DOPC/DOPE/PIP2/Chol = 50:25:0.1-2:25 
Labeled NBD+Rh DOPC/DOPE/NBD-DOPE/Rh-DOPE/Chol = 50:22:1.5:1.5:25 
Labeled OG+TR DOPC/DOPE/OG-DHPE/TR-DHPE/Chol = 50:22:1.5:1.5:25 
Labeled OG DOPC/DOPE/OG-DHPE/Chol = 50:23.5:1.5:25 
Labeled TR DOPC/DOPE/TR-DHPE/Chol = 50:23.5:1.5:25 
9.4.2 Liposome Preparation via Extrusion 
Liposomes were prepared by the extrusion of the prepared films in HEPES buffer following 
standard procedure.[275] The HEPES buffer (20 mM HEPES, 100 mM KCl, 1 mM EDTA, 
1 mM DTT, pH = 7.4) was prepared on the day of the experiment out of a stock solution 
consisting of a 10-fold stock of HEPES, KCl and EDTA in ultrapure water. After the 
addition of DTT, the pH was adjusted by the addition of 1 M KOH. The HEPES buffer was 
filtered using a Chromafil RC-45/15 MS syringe filter (0.45 μm pore size) from Macherey 
Nagel (Düren, Germany) and a fluorescence spectrum was measured to verify the quality. 
To the lipid films in the test tubes, ~10 glass beads (2 mm diameter) were added for better 
detachment of the glass wall. After the addition of 500 L buffer, the tubes were sealed 
with Parafilm and incubated at 40 °C while shaking at 190 rpm for a minimum of 2.5 h on 
an Unimax 1010 platform shaker by Heidolph (Schwabach, Germany) equipped with the 
heating unit Incubator 1000. 
For extrusion of the liposomes a LipoFast-Basic extruder from Avestin (Ottawa, Canada) 
was used with a 100 nm polycarbonate membrane either from Avestin or from GE 
Healthcare (Little Chalfont, UK). Additionally, Whatman polyester drain discs by GE 
Healthcare were used which were positioned before both membrane sides. The extruder 
was washed thoroughly before use with ethanol, ultrapure water and buffer. Next, the 
extruder was dried with paper tissues, assembled and filled with the buffer. All air bubbles 
were carefully removed during this process. After incubation, the lipid films were vortexed 
for 5 s, treated in an ultrasonic bath for a maximum of 10 s and subsequently vortexed again 
for 5 s. The homogeneous solution was filled inside one of the syringes of the extruder and 
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extruded for 31 times. The liposome solution was added directly to a plastic tube or glass 
vial.  
9.4.3 FRET Dequenching Assay 
Detection of lipid mixing was performed on the FP-8200 fluorospectrometer by JASCO (Tokio, 
Japan) which was equipped with a magnetic stirrer and an injection port for direct injection of 
the sample. Temperature control was achieved by a ETC-272T peltier thermostat by JASCO 
connected to a Thermo Haake WKL26 water recirculator. Data was acquired using the provided 
software Spectra Manager (version 2.13.00). The sample was measured in a quartz glass 
cuvette with a path length of 10 mm for the excitation and 4 mm for the emission from Hellma 
Analytics (Müllheim, Germany). 
The fusion experiments were performed at 25 °C with a stirring speed of 600 rpm. Two types 
of measurements were performed with the fluorophores NBD and Rh. First, fluorescence 
spectrum measurements were set to 460 nm excitation and emission was measured from 
500-610 nm. Second, time course measurements were performed with excitation at 460 nm and 
emission at 530 nm over 20 min. In case of the use of Oregon green and Texas red as 
fluorophores, excitation was set to 495 nm and emission to 615 nm or 550-650 nm for spectrum 
measurements. Additional parameters were set according to Table 9.9. 
Table 9.9: Parameters applied in fluorescence measurements. Values in 
parenthesis refer to measurements with Oregon green and Texas red. 
Parameters Spectrum Time course 
Excitation 460 nm (495 nm) 460 nm (495 nm) 
Ex bandwidth 5 nm 5 nm 
Emission 500-610 nm (550-650 nm) 530 nm (615 nm) 
Em bandwidth 5 nm 5 nm 
Response 0.5 s 0.5 s 
Sensitivity high high 
Data interval 1 nm 1 nm 
Scan speed/Measurement duration 200 nm/min 1200 s 
 
The measurements were performed according to the following standard operating 
procedure. First, a fluorescence spectrum of the buffer was recorded to obtain the value 
needed for background subtraction. For this, 1300 L were pipetted into the quartz cuvette. 
In case of deviations from the standard spectrum, the cuvette was washed again thoroughly 
with a solution of 3 % Hellmanex III from Hellma (Mühlheim, Germany), ultrapure water 
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and ethanol. Next, 10 L of the liposome sample with the fluorophores was added to the 
cuvette through the injection port with a Hamilton syringe and a spectrum was recorded to 
check whether the signal strength is enough for the measurement. After that, the time course 
measurement was started and 40 L of the unlabeled liposomes was added after exactly 
30 s to the cuvette. In total, approximately 62.5 nmol lipids were added the cuvette of which 
12.5 nmol are from the labeled sample and 50 nmol of the unlabeled one. However, the 
actual values are lower, as lipid loss during extrusion is not accounted for. After 20 min, 
1000 L of the sample is transferred to another cuvette for DLS measurements of the mixed 
population (see section 9.4.5) and retransferred to the quartz cuvette afterwards. A second 
time course measurement is started and around ~15 s in, 30 L of a TritonX-100 solution 
(2.5 % in buffer v/v) is added. After the signal stabilized, the measurement is aborted and a 
fluorescence spectrum from the mixed population is recorded. Here, the complete 
destruction of the vesicles is checked. The obtained data was subsequently analyzed 








The fusion efficiency F is calculated out of the recorded fluorescence Ft at the time t, the 
fluorescence before addition of the second liposome species F0 and the total fluorescence 
after TritonX-100 addition Ftotal. F0 is obtained by calculating the average of the last 10 
data points before the addition. Ftotal is the average of 50 data points after the signal 
stabilized. For visualization of the data, F is plotted as the function of the time t.  
9.4.4 Uncaging experiments 
FRET dequenching assays with photocaged peptides were performed with the same 
instruments and generally with the same procedure as in section 9.4.3. Two types of 
uncaging experiments were performed during this thesis. In the following the differences 
to the standard FRET dequenching assay is described. 
The first uncaging experiment starts with both liposome species being mixed in the 
fluorescence spectrometer. The photocaged peptide is not treated with a laser until this 
point. 5 min into the measurement, the fluorescence cuvette is taken out of the spectrometer 
and a handheld laser with a wavelength of 405 nm and 100 mW distributed by 
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starklasers.com (London, UK) is pointed inside the top of the cuvette to illuminate the 
whole sample for 60 s. Afterwards, the sample is put back into the spectrometer and the 
measurement is continued. The procedure is repeated after 500 s to verify if uncaging was 
complete.  
In the second uncaging experiment, the sample with the liposome species containing the 
photocaged peptide was split into two parts. One part was set aside for DLS measurements 
of the sample without being exposed to the laser. The second part was exposed for 60 s to 
the handheld laser, right before injection into the fluorescence cuvette. Injection was done 
exactly 30 s into the time course measurement. 
9.4.5 Dynamic Light scattering 
DLS measurements were performed using a Zetasizer Nano S by Malvern Panalytical 
(Kassel, Germany) with a 633 nm Laser at a probing angle of 173°. All data was acquired 
using the provided software. Each sample was measured at 25 °C using either disposable 
semi-micro or macro cuvettes from Brand GmbH (Wertheim, Germany). In case of semi-
micro cuvettes, single vesicle populations were measured using 100 μL of the sample with 
400 μL of buffer. For mixed populations, 500 μL of the sample was used. Using macro 
cuvettes, 900 μL buffer was added for single vesicle populations. Mixed populations were 
measured using 1000 μL of the sample. All measurements were performed as triplicates, 
while individual measurements were obtained with multiple runs between 12-18 times as 
determined by the software for optimal data quality. The collected data was processed by 
calculating the weighted arithmetic mean value of each measurement. The hydrodynamic 
radius (𝑑h) and PdI (Polydispersity index) were obtained using the instruments software. 
9.4.6 Phosphate Test 
The amount of lipids left in the sample after extrusion can be estimated with the phosphate 
test. Here, the total amount of phosphorus is determined of a small volume of the liposome 
sample and extrapolated for the whole sample. For this, a set of calibration samples with 
different specified quantity of dihydrogenphosphate, ranging from a total phosphorus 
amount of 0 μg to 2 μg were prepared from a stock solution (c = 0.089 g/L). Out of these 
samples a calibration curve can be generated, which is used for the determination of the 
phosphorus content in the liposome samples. The samples were topped with ultrapure water 
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to a total of 100 μL. For the liposome samples, 20 μL and 200 μL perchloric acid (70 % in 
water) were mixed in a glass vial. Every sample was made as duplicates and incubated at 
220 °C for 60 min without cap. The vials were cooled to room temperature and 700 μL of 
reagent A (0.45 % ammonium orthomolybdate and 12.6 % perchloric acid in water) and 
700 μL of reagent B (1.7 % ascorbic acid in water) were added. The vials were closed 
tightly with the caps and mixed thoroughly before incubating them in an 80 °C water bath 
for 7.5 min. After the samples cooled to room temperature, they were transferred to single 
use cuvettes from Brand GmbH (Wertheim, Germany) and their absorbance at 820 nm was 
measured using a NanoDrop One C or NanoDrop 2000c. Using the calibration samples, a 
linear fit was applied and the calibration curve could be obtained. 
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9.5 Synthesized Compounds 




7-Diethylamino-4-methylcoumarin (5.00 g, 21.6 mmol, 1.00 eq.) and selenium dioxide 
(2.72 g, 24.5 mmol, 1.13 eq.) were dissolved in xylene (500 mL) and stirred under reflux 
for 48 h. The mixture was cooled to room temperature, filtered and the filtrate was reduced 
in vacuo. The residue was redissolved in methanol (500 mL) and NaBH4 (0.80 g, 
21.1 mmol, 0.97 eq.) was added to the mixture. After stirring at room temperature 
overnight, the unreacted NaBH4 was quenched by neutralizing with HCl (1 M). Methanol 
was removed at reduced pressure and the aqueous phase was extracted with DCM (5 x 
100 mL). The combined organic layers were washed with brine (3 x 80 mL), dried over 
NaSO4 and the solvent was removed under reduced pressure. The crude product was 
purified by column chromatography (gradient of DCM/acetone = 19:1 → 5:1). The product 
(2.23 g, 9.00 mmol, 42 %) was obtained as a brown solid. 
 
1H-NMR (300 MHz, CD2Cl2); δ (ppm) = 1.19 (t, J = 7.1 Hz, 6 H, CH3), 2.60 (t, 
J = 6.0 Hz, 1 H, OH), 3.40 (q, J = 7.1 Hz, 4 H, CH2), 4.81 (dd, J = 5.9, 1.4 Hz, 2 H, CH2-
OH), 6.18 (d, J = 1.4 Hz, 1 H, CHarom), 6.47 (d, J = 2.6 Hz, 1 H, CHarom), 6.58 (dd, J = 9.0, 
2.6 Hz, 1 H, CHarom), 7.32 (d, J = 9.0 Hz, 1 H, CHarom).  
MS (ESI) m/z: 248.1 [M+H]+, 270.1 [M+Na]+.  
HR-MS (ESI) m/z: calc. for C14H18NO3 [M+H]
+: 248.1281, found: 248.1282; calc. for 
C14H17NO3Na [M+Na]
+: 270.1101, found: 270.1104. 
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(7-Diethylaminocoumarin-4-yl)methyl (4-nitrophenyl) carbonate 
 
 
Under a nitrogen atmosphere, 13 (1.80 g, 7.28 mmol, 1.00 eq.) and DIPEA (2.7 mL, 
15.5 mmol, 2.10 eq.) were mixed in chloroform (45 mL). To the mixture 4-nitrophenyl 
chloroformate (3.08 g, 15.2 mmol, 2.10 eq.) and 4-dimethylaminopyridine (0.89 g, 7.28 mmol, 
1.00 eq.) in THF (80 mL) were added. After the reaction mixture was stirred at room 
temperature for 24 h, the solvent was removed in vacuo. The precipitate was dissolved in 
EtOAc (300 mL) and washed with H3PO4 (1 M, 2 X 80 mL), water (2 x 80 mL), saturated 
NaHCO3 solution (2 x 80 mL) and brine (2 x 80 mL) before being dried over Na2SO4. The 
organic phase was adsorbed on silica and the crude product was purified by column 
chromatography (gradient DCM → DCM/acetone = 10:1). The product (1.2 g, 2.91 mmol, 
40 %) was obtained as a yellow solid. 
 
1H-NMR (300 MHz, DMSO-d6); δ (ppm) = 1.13 (t, J = 7.0 Hz, 6 H, CH3), 3.45 (q, 
J = 7.0 Hz, 4 H, CH2), 5.51 (d, J = 1.2 Hz, 2 H, O-CH2), 6.12 (s, 1 H, CHarom), 6.57 (d, 
J = 2.5 Hz, 1 H, CHarom), 6.73 (dd, J = 9.10 Hz, J = 2.60 Hz, 1 H, CHarom), 7.54 (d, J = 9.10 
Hz, 1 H, CHarom), 7.60-7.72 (m, 2 H, CHarom), 8.32-8.39 (m, 2 H, CHarom). 
MS (ESI) m/z: 413.2 [M+H]+, 435.1 [M+Na]+.  
HR-MS (ESI) m/z: calc. for C21H21N2O7 [M+H]
+: 413.1346, found: 413.1345; calc. for 
C21H20N2O7Na [M+Na]













The reaction was performed under exclusion of light. To a suspension of 14 (1.2 g, 
2.91 mmol, 1.0 eq.) in DMF (30 mL) and DCM (30 mL), Fmoc-L-Lys-OH (1.07 g, 
2.91 mmol, 1.0 eq.) in toluene (80 mL) was added. The mixture was cooled to 0 °C, DIPEA 
(510 L, 2.93 mmol, 1.0 eq.) was added and it was stirred for 12 h while allowing it to 
slowly come to room temperature. Further Fmoc-L-Lys-OH (0.54 g, 1.46 mmol, 0.5 eq.) 
and DIPEA (250 L, 1.44 mmol, 0.5 eq.) were added and stirred at room temperature 
overnight. After evaporation of the solvents in vacuo, the crude product was purified by 
column chromatography (DCM/MeOH/AcOH = 97:3:0.1) to yield a light yellow solid (0.50 g, 
0.78 mmol, 27 %). 
 
1H-NMR (300 MHz, DMSO-d6); δ (ppm) = 1.11 (t, J = 6.9 Hz, 6 H, CH3), 1.22- 1.81 (m, 
6 H, CH2), 3.04 (q, J = 6.4 Hz, 2 H, CH2), 3.43 (t, J = 7.0 Hz, 4 H,CH2-CH3), 3.86-4.00 (m, 
1 H, CH), 4.18-4.33 (m, 3 H, Fmoc-CH, Fmoc-CH2), 5.20 (s, 2 H, CH2), 5.97 (s, 1 H, 
CHArom), 6.53 (d, J = 2.5 Hz, 1 H, CHArom), 6.67 (dd, J = 9.1, 2.5 Hz, 1 H, CHArom), 7.33 
(td, J = 7.4, 1.2 Hz, 2 H, Fmoc-CHArom), 7.38- 7.46 (m, 3 H, Fmoc-CHArom, CHArom), 7.52 
(t, J = 5.7 Hz, 1 H, NH-CH2), 7.62 (d, J = 8.0 Hz, 1 H, NH-CH), 7.73 (d, J = 7.4 Hz, 2 H, 
Fmoc-CHArom), 7.89 (d, J = 7.4 Hz, 2 H, Fmoc-CHArom). 
MS (ESI) m/z: 664.3 [M+Na]+, 1305.5 [2M+Na]+.  
HR-MS (ESI) m/z: calc. for C36H40N3O8 [M+H]
+: 642.2810, found: 642.2791; calc. for 
C36H39N3O8Na [M+Na]




9.5.2 Synthesized Peptides 
E3-Syb(RKY) 
 
The peptide was synthesized according to section 9.3.1 at a scale of 50 mol. After 
cleavage and lyophilization the peptide was purified with HPLC Semi-Prep using column 
2 and a twostep gradient of solvent system I (75-85 % B in 3 min, 85-99 % B in 15 min). 
 
UPLC: (Column 1, solvent system II; 70-99 % B in 8 min) Rt = 9.6 min. 
MS (ESI) m/z: 1014.0 [M+6H]6+, 1216.5 [M+5H]5+, 1520.3 [M+4H]4+. 
HR-MS (ESI) m/z: calc. for C288H479N65O71S3 ([M+6H]
6+): 1014.0851, found: 1014.0848; 
calc. for C288H478N65O71S3 ([M+5H]
5+): 1216.7006, found: 1216.7011; calc. for 
C288H477N65O71S3 ([M+4H]




The peptide was synthesized according to section 9.3.1 at a scale of 50 mol. After 
cleavage and lyophilization the peptide was purified with HPLC Prep using column 3 and 
a twostep gradient of solvent system I (75-85 % B in 3 min, 85-99 % B in 15 min). 
 
UPLC: (Column 1, solvent system II; 70-99 % B in 8 min) Rt = 8.8 min. 
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MS (ESI) m/z: 994.7 [M+6H]6+, 1193.5 [M+5H]5+. 
HR-MS (ESI) m/z: calc. for C280H474N64O71S3 ([M+6H]
6+): 994.7443, found: 994.7480; 
calc. for C280H474N64O71S3 ([M+5H]




The peptide was synthesized according to section 9.3.1 at a scale of 50 mol. After 
cleavage and lyophilization the peptide was purified with HPLC Prep using column 3 and 
a twostep gradient of solvent system I (75-85 % B in 3 min, 85-99 % B in 15 min). 
 
UPLC: (Column 1, solvent system II; 70-99 % B in 8 min) Rt = 8.6 min. 
MS (ESI) m/z: 1193.6 [M+5H]5+, 1491.8 [M+4H]4+. 
HR-MS (ESI) m/z: calc. for C280H473N64O71S3 ([M+5H]
5+): 1193.6922, found: 1193.6931; 
calc. for C280H472N64O71S3 ([M+4H]




The peptide was synthesized according to section 9.3.1 at a scale of 50 mol. After 
cleavage and lyophilization the peptide was purified with HPLC Prep using column 3 and 





UPLC: (Column 1, solvent system II; 70-99 % B in 8 min) Rt = 8.5 min. 
MS (ESI) m/z: 862.9 [M+7H]7+, 1006.7 [M+6H]6+, 1207.7 [M+5H]5+, 1509.3 [M+4H]4+. 
HR-MS (ESI) m/z: calc. for C283H480N65O72S3 ([M+7H]
7+): 862.9300, found: 862.9289; 
calc. for C283H479N65O72S3 ([M+6H]
6+): 1006.7509, found: 1006.7500; calc. for 
C283H478N65O72S3 ([M+5H]
5+): 1207.6991, found: 1207.6981; calc. for C283H477N65O72S3 




The peptide was synthesized according to section 9.3.1 at a scale of 50 mol. After 
cleavage and lyophilization the peptide was purified with HPLC Semi-Prep using column 
2 and a gradient of solvent system I (75-85 % B in 3 min, 85-99 % B in 15 min). 
 
UPLC: (Column 1, solvent system II; 70-99 % B in 8 min) Rt = 9.1 min. 
MS (ESI) m/z: 998.6 [M+6H]6+, 1198.3[M+5H]5+, 1497.6 [M+4H]4+. 
HR-MS (ESI) m/z: calc. for C282H475N65O70S3 ([M+6H]
6+): 998.5803, found: 998.5802; 
calc. for C282H474N65O70S3 ([M+5H]
5+): 1198.4958, found: 1198.4924; calc. for 
C282H473N65O70S3 ([M+4H]
4+): 1497.6174, found: 1497.6186. 
  





The peptide was synthesized according to section 9.3.1 at a scale of 50 mol. After 
cleavage and lyophilization the peptide was purified with HPLC Semi-Prep using column 
2 and a twostep gradient of solvent system I (75-85 % B in 3 min, 85-99 % B in 15 min). 
 
UPLC: (Column 1, solvent system II; 70-99 % B in 8 min) Rt = 6.4 min. 
MS (ESI) m/z: 668.5 [M+9H]9+, 752.1 [M+8H]8+, 859.2 [M+7H]7+, 1002.3 [M+6H]6+. 
HR-MS (ESI) m/z: calc. for C279H488N73O66S3 ([M+9H]
9+): 668.5141, found: 668.5128; 
calc. for C279H487N73O66S3 ([M+8H]
8+): 7 52.0777, found: 752.0765; calc. for 
C279H486N73O66S3 ([M+7H]
7+): 859.2303, found: 859.2290; calc. for C279H485N73O66S3 




The peptide was synthesized according to section 9.3.1 at a scale of 10 mol. To the 
activator base additionally DIPEA (0.02 M) was added. Coupling of each caged amino acid 




light. After cleavage and lyophilization the peptide was purified with HPLC Semi-Prep 
using column 2 and a twostep gradient of solvent system I (75-85 % B in 3 min, 85-99 % 
B in 15 min). 
 
UPLC: (Column 1, solvent system II; 25-65 % B in 3 min, 65-95 % B in 12 min) 
Rt = 15.0 min. 
MS (ESI) m/z: 1093.3 [M+6H]6+, 1097.1 [M+5H+Na]6+, 1311.9 [M+5H]5+. 
HR-MS (ESI) m/z: calc. for C309H515N75O74S3 ([M+6H]
6+): 1093.3009, found: 1093.2952; 
calc. for C309H514N75O74S3Na ([M+5H+Na]
6+): 1097.1316, found: 1097.1288; calc. for 
C309H514N75O74S3 ([M+5H]




The peptide was synthesized according to section 9.3.1 at a scale of 50 mol. After 
cleavage and lyophilization the peptide was purified with HPLC Semi-Prep using column 
2 and a twostep gradient of solvent system I (75-85 % B in 3 min, 85-99 % B in 15 min). 
 
UPLC: (Column 1, solvent system II; 70-99 % B in 8 min) Rt = 6.1 min. 
MS (ESI) m/z: 788.41 [M+8H]8+, 901.0 [M+7H]7+, 1051.0 [M+6H]6+ 1260.8 [M+5H]5+. 
HR-MS (ESI) m/z: calc. for C294H508N76O69S3 ([M+8H]
8+): 788.4725, found: 788.4731; 
calc. for C294H507N76O69S3 ([M+7H]
7+): 900.9675, found: 900.9685; calc. for 
C294H506N76O69S3 ([M+6H]
6+): 1050.7939, found: 1050.7954; calc. for C294H505N76O69S3 
([M+5H]5+): 1260.9516, found: 1260.9520. 
 




The peptide was synthesized according to section 9.3.1 at a scale of 50 mol. After 
cleavage and lyophilization the peptide was purified with HPLC Semi-Prep using column 
2 and a twostep gradient of solvent system I (75-85 % B in 3 min, 85-99 % B in 15 min). 
 
UPLC: (Column 1, solvent system II; 70-99 % B in 8 min) Rt = 6.6 min. 
MS (ESI) m/z: 776.8 [M+8H]8+, 887.7 [M+7H]7+, 1051.0 [M+6H]6+. 
HR-MS (ESI) m/z: calc. for C288H504N76O68S3 ([M+8H]
8+): 776.8439, found: 776.8422; 
calc. for C288H503N76O68S3 ([M+7H]
7+): 887.6777, found: 887.6794; calc. for 
C288H502N76O68S3 ([M+6H]




The peptide was synthesized according to section 9.3.1 at a scale of 50 mol. After 
cleavage and lyophilization the peptide was purified with HPLC Prep using column 3 and 
a twostep gradient of solvent system I (75-85 % B in 3 min, 85-99 % B in 15 min). 
 
UPLC: (Column 1, solvent system II; 70-99 % B in 8 min) Rt = 7.5 min. 
MS (ESI) m/z: 834.9 [M+7H]7+, 973.9 [M+6H]6+, 1168.5 [M+5H]5+, 1460.6 [M+4H]4+. 
HR-MS (ESI) m/z: calc. for C273H472N67O66S3 ([M+7H]
7+): 834.9263, found: 834.9268; 
calc. for C273H471N67O66S3 ([M+6H]





5+): 1168.4939, found: 1168.4952; calc. for C273H469N67O66S3 




The peptide was synthesized according to section 9.3.1 at a scale of 50 mol. After 
cleavage and lyophilization the peptide was purified with HPLC Prep using column 3 and 
a twostep gradient of solvent system I (75-85 % B in 3 min, 85-99 % B in 15 min). 
 
UPLC: (Column 1, solvent system II; 70-99 % B in 8 min) Rt = 7.5 min. 
MS (ESI) m/z: 842.9 [M+7H]7+, 983.2 [M+6H]6+, 1474.3 [M+4H]4+. 
HR-MS (ESI) m/z: calc. for C273H472N71O66S3 ([M+7H]
7+): 842.9280, found: 842.9296; 
calc. for C273H471N71O66S3 ([M+6H]
6+): 983.2482, found: 983.2496; calc. for 
C273H469N71O66S3 ([M+4H]




10.1 FRET Dequenching Assay Data 
Additional data for Figure 4.3. 
 
Additional data for Figure 4.5. 
 
Additional data for Figure 4.7. 
 
Additional data for Figure 4.8. 
 
Figure A1: Individual fusion curves from FRET dequenching assays. The 










Additional data for Figure 5.2. 
 
Additional data for Figure 5.4. 
 
Additional data for Figure 5.4. 
 
Additional data for Figure 5.6. 
 
Additional data for Figure 5.9. 
 
Additional data for Figure 5.10. 
 
Figure A2: Individual fusion curves from FRET dequenching assays. The 










Additional data for Figure 6.9. 
 
Additional data for Figure 7.1. 
 
Additional data for Figure 7.2. Additional data for Figure 7.3. 
Additional data for Figure 7.4. 
 
 
Figure A3: Individual fusion curves from FRET dequenching assays. The 




  List of Abbreviations 
Amino acids are abbreviated using their standard three-letter or one-letter code. 
 
aa amino acid 
aeg-PNA N-(2-aminoethyl)glycine-PNA 
AFF-1 anchor-cell fusion failure 1 
ATP adenosine triphosphate 
AU absorption unit 
BD syringe syringe by Becton Dickinson 
Boc butyloxycarbonyl protection group 
calc. calculated 
Chol cholesterol 
COVID-19 coronavirus disease 2019 
Cpx complexins 





dh hydrodynamic diameter 
DLS dynamic light scattering 
DMF dimethylformamide 
DMSO dimethylsulfoxide 





 extinction coefficient 
EDT 1,2-ethanedithiole 
EDTA ethylenediaminetetraacetic acid 
EFF-1 epithelial fusion failure 1 
eq. equivalents 
EtOAC ethyl acetate 
EtOH ethanol 
ESI-MS electrospray ionisation mass spectrometry 
F530 normalized fluorescence intensity at 530 nm 
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FCCS fluorescence cross-correlation spectroscopy 
Fmoc 9-fluorenylmethoxycarbonyl protection group 
FRET Förster resonance energy transfer 
GTP guanosine tripshosphate 
HA hemagglutinin 
HIV human immunodeficiency viruses 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HFIP 1,1,1,3,3,3-hexafluoro-2-propanol 
HPLC high performance liquid chromatography 
HR-MS high resolution mass spectrometry 
J coupling constant 
LPC lysophosphatidylcholine 
LUV large unilamellar vesicle 




MLV multilamellar vesicles 
Munc18 mammalian uncoordinated-18 
NBD 7-nitro-2-1,3-benzoxadiazole 
NMR nuclear magnetic resonance 
NSF N-ethylmaleimide sensitive factor 
OG Oregon Green 488 
OPa1 optic atrophy protein 1 




PEG polyethylene glycol 
PIP2 phosphatidylinositol 4,5-bisphosphate 
P/L ratio peptide-to-lipid ratio 
PNA PNA peptide nucleic acid 
POPC 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
ppm ppm parts per million 
Rh Lissamine Rhodamine B 
RP reversed phase 
rpm rotations per minute 
RT room temperature 
Rt retention time 
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 
SM Sec1/Munc18-like 
SNAP soluble NSF attachment protein 




SNARE soluble N-ethylmaleimide-sensitive factor attachment protein receptor 
SPPS SPPS solid phase peptide synthesis 
SUV small unilamellar vesicle 
Sx Syntaxin 1A 
Syb synaptobrevin 2 
Syt1 synaptotagmin 1 
tBu tert-butyl protection group 




TLC thin layer chromatography 
TMD transmembrane domain 
TR Texas Red 
Trt trityl protection group 
UPLC ultra-performance liquid chromatography 
UV ultraviolet 





[1] T. C. Südhof, Neurotransmitter release: the last millisecond in the life of a synaptic 
vesicle, Neuron 2013, 80, 675. 
[2] T. C. Südhof, The synaptic vesicle cycle, Annu Rev Neurosci 2004, 27, 509. 
[3] W. Antonin, D. Fasshauer, S. Becker, R. Jahn, T. R. Schneider, Crystal structure of 
the endosomal SNARE complex reveals common structural principles of all 
SNAREs, Nat Struct Biol 2002, 9, 107. 
[4] R. W. Baker, F. M. Hughson, Chaperoning SNARE assembly and disassembly, Nat 
Rev Mol Cell Biol 2016, 17, 465. 
[5] Y. A. Chen, R. H. Scheller, SNARE-mediated membrane fusion, Nat Rev Mol Cell 
Biol 2001, 2, 98. 
[6] R. Jahn, R. H. Scheller, SNAREs--engines for membrane fusion, Nat Rev Mol Cell 
Biol 2006, 7, 631. 
[7] A. V. Pobbati, A. Stein, D. Fasshauer, N- to C-terminal SNARE complex assembly 
promotes rapid membrane fusion, Science 2006, 313, 673. 
[8] X. Lou, Y.-K. Shin, SNARE zippering, Biosci Rep 2016, 36. 
[9] Y. Gao, S. Zorman, G. Gundersen, Z. Xi, L. Ma, G. Sirinakis, J. E. Rothman, Y. 
Zhang, Single reconstituted neuronal SNARE complexes zipper in three distinct 
stages, Science 2012, 337, 1340. 
[10] R. B. Sutton, D. Fasshauer, R. Jahn, A. T. Brunger, Crystal structure of a SNARE 
complex involved in synaptic exocytosis at 2.4 A resolution, Nature 1998, 395, 347. 
[11] M. A. Poirier, W. Xiao, J. C. Macosko, C. Chan, Y. K. Shin, M. K. Bennett, The 
synaptic SNARE complex is a parallel four-stranded helical bundle, Nat Struct Biol 
1998, 5, 765. 
[12] D. Fasshauer, Structural insights into the SNARE mechanism, Biochim Biophys 
Acta Mol Cell Res 2003, 1641, 87. 
[13] W. Hong, SNAREs and traffic, Biochim Biophys Acta 2005, 1744, 120. 
[14] W. S. Trimble, D. M. Cowan, R. H. Scheller, VAMP-1: a synaptic vesicle-




[15] M. Baumert, P. R. Maycox, F. Navone, P. de Camilli, R. Jahn, Synaptobrevin: an 
integral membrane protein of 18,000 daltons present in small synaptic vesicles of 
rat brain, EMBO J 1989, 8, 379. 
[16] M. K. Bennett, N. Calakos, R. H. Scheller, Syntaxin: a synaptic protein implicated 
in docking of synaptic vesicles at presynaptic active zones, Science 1992, 257, 255. 
[17] P. Kumar, S. Guha, U. Diederichsen, SNARE protein analog-mediated membrane 
fusion, J. Pept. Sci. 2015, 21, 621. 
[18] A. Kashiwada, M. Tsuboi, K. Matsuda, Target-selective vesicle fusion induced by 
molecular recognition on lipid bilayers, Chem. Commun. 2009, 695. 
[19] H. Robson Marsden, N. A. Elbers, P. H. H. Bomans, N. A. J. M. Sommerdijk, A. 
Kros, A reduced SNARE model for membrane fusion, Angew. Chem. Int. Ed. 2009, 
48, 2330. 
[20] G. Stengel, R. Zahn, F. Höök, DNA-induced programmable fusion of phospholipid 
vesicles, J Am Chem Soc 2007, 129, 9584. 
[21] J. R. Litowski, R. S. Hodges, Designing Heterodimeric Two-stranded α-Helical 
Coiled-coils, J Biol Chem 2002, 277, 37272. 
[22] K. Meyenberg, A. S. Lygina, G. van den Bogaart, R. Jahn, U. Diederichsen, SNARE 
derived peptide mimic inducing membrane fusion, Chem. Commun. 2011, 47, 9405. 
[23] A. Stein, G. Weber, M. C. Wahl, R. Jahn, Helical extension of the neuronal SNARE 
complex into the membrane, Nature 2009, 460, 525. 
[24] D. Singer-Lahat, N. Barak-Broner, A. Sheinin, D. Greitzer-Antes, I. Michaelevski, 
I. Lotan, The Dual Function of the Polybasic Juxtamembrane Region of Syntaxin 
1A in Clamping Spontaneous Release and Stimulating Ca2+-Triggered Release in 
Neuroendocrine Cells, J Neurosci 2018, 38, 220. 
[25] J. S. van Komen, X. Bai, T. L. Rodkey, J. Schaub, J. A. McNew, The polybasic 
juxtamembrane region of Sso1p is required for SNARE function in vivo, Eukaryotic 
Cell 2005, 4, 2017. 
[26] D. H. Murray, L. K. Tamm, Clustering of syntaxin-1A in model membranes is 
modulated by phosphatidylinositol 4,5-bisphosphate and cholesterol, Biochemistry 
2009, 48, 4617. 
[27] K. Aoyagi, T. Sugaya, M. Umeda, S. Yamamoto, S. Terakawa, M. Takahashi, The 
activation of exocytotic sites by the formation of phosphatidylinositol 4,5-
bisphosphate microdomains at syntaxin clusters, J Biol Chem 2005, 280, 17346. 
[28] D. J. James, C. Khodthong, J. A. Kowalchyk, T. F. J. Martin, Phosphatidylinositol 





[29] M. Borisovska, Y. N. Schwarz, M. Dhara, A. Yarzagaray, S. Hugo, D. Narzi, S. W. 
I. Siu, J. Kesavan, R. Mohrmann, R. A. Böckmann et al., Membrane-proximal 
tryptophans of synaptobrevin II stabilize priming of secretory vesicles, J Neurosci 
2012, 32, 15983. 
[30] Q. Fang, Y. Zhao, M. Lindau, Juxtamembrane tryptophans of synaptobrevin 2 
control the process of membrane fusion, FEBS Lett 2013, 587, 67. 
[31] M. S. Bretscher, M. C. Raff, Mammalian plasma membranes, Nature 1975, 258, 43. 
[32] G. van Meer, D. R. Voelker, G. W. Feigenson, Membrane lipids: where they are and 
how they behave, Nat Rev Mol Cell Biol 2008, 9, 112. 
[33] M. Cai, J. Gao, H. Wang (Eds.) Composition and Function of Cell Membranes, 
Springer Nature, Singapore, 2018. 
[34] C. Tanford, The hydrophobic effect and the organization of living matter, Science 
1978, 200, 1012. 
[35] G. L. Nicolson, The Fluid-Mosaic Model of Membrane Structure: still relevant to 
understanding the structure, function and dynamics of biological membranes after 
more than 40 years, Biochim Biophys Acta 2014, 1838, 1451. 
[36] G. A. Jamieson, D. M. Robinson, Mammalian Cell Membranes. Volume 2: The 
Diversity of Membranes, Elsevier Science, Burlington, 1977. 
[37] D. J. Müller, N. Wu, K. Palczewski, Vertebrate membrane proteins: structure, 
function, and insights from biophysical approaches, Pharmacol Rev 2008, 60, 43. 
[38] Z. Cournia, T. W. Allen, I. Andricioaei, B. Antonny, D. Baum, G. Brannigan, N.-V. 
Buchete, J. T. Deckman, L. Delemotte, C. Del Val et al., Membrane Protein 
Structure, Function, and Dynamics: A Perspective from Experiments and Theory, J 
Membr Biol 2015, 248, 611. 
[39] L. E. Hedin, K. Illergård, A. Elofsson, An introduction to membrane proteins, J 
Proteome Res 2011, 10, 3324. 
[40] J. W. Fairman, N. Noinaj, S. K. Buchanan, The structural biology of β-barrel 
membrane proteins: a summary of recent reports, Curr Opin Struct Biol 2011, 21, 
523. 
[41] V. Monje-Galvan, J. B. Klauda, Peripheral membrane proteins: Tying the knot 
between experiment and computation, Biochim Biophys Acta 2016, 1858, 1584. 
[42] B. A. Seaton, M. F. Roberts in Biological membranes. A molecular perspective from 
computation and experiment (Eds.: K. M. Merz, B. Roux), Birkhäuser Boston, 
Boston, 1996, pp. 355–403. 
[43] J. M. Crane, V. Kiessling, L. K. Tamm, Measuring lipid asymmetry in planar 
supported bilayers by fluorescence interference contrast microscopy, Langmuir 




[44] M. S. Bretscher, Asymmetrical lipid bilayer structure for biological membranes, 
Nature New Biol 1972, 236, 11. 
[45] J. M. Boon, B. D. Smith, Chemical control of phospholipid distribution across 
bilayer membranes, Med Res Rev 2002, 22, 251. 
[46] S. J. Singer, G. L. Nicolson, The fluid mosaic model of the structure of cell 
membranes, Science 1972, 175, 720. 
[47] J. F. Danielli, H. Davson, A contribution to the theory of permeability of thin films, 
J. Cell. Comp. Physiol. 1935, 5, 495. 
[48] J. D. ROBERTSON, The ultrastructure of cell membranes and their derivatives, 
Biochem Soc Symp 1959, 16, 3. 
[49] J. D. ROBERTSON, The molecular structure and contact relationships of cell 
membranes, Prog Biophys Mol Biol 1960, 10, 343. 
[50] K. Simons, E. Ikonen, Functional rafts in cell membranes, Nature 1997, 387, 569. 
[51] R. Varma, S. Mayor, GPI-anchored proteins are organized in submicron domains at 
the cell surface, Nature 1998, 394, 798. 
[52] E. Sezgin, I. Levental, S. Mayor, C. Eggeling, The mystery of membrane 
organization: composition, regulation and roles of lipid rafts, Nat Rev Mol Cell Biol 
2017, 18, 361. 
[53] E. J. Shimshick, H. M. McConnell, Lateral phase separation in phospholipid 
membranes, Biochemistry 1973, 12, 2351. 
[54] L. J. Pike, Rafts defined: a report on the Keystone Symposium on Lipid Rafts and 
Cell Function, J Lipid Res 2006, 47, 1597. 
[55] F. M. Goñi, "Rafts": A nickname for putative transient nanodomains, Chem Phys 
Lipids 2019, 218, 34. 
[56] M. L. Kraft, Plasma membrane organization and function: moving past lipid rafts, 
Mol Biol Cell 2013, 24, 2765. 
[57] T. Yeung, G. E. Gilbert, J. Shi, J. Silvius, A. Kapus, S. Grinstein, Membrane 
phosphatidylserine regulates surface charge and protein localization, Science 2008, 
319, 210. 
[58] E. Sevcsik, G. J. Schütz, With or without rafts? Alternative views on cell 
membranes, Bioessays 2016, 38, 129. 
[59] R. G. W. Anderson, K. Jacobson, A role for lipid shells in targeting proteins to 
caveolae, rafts, and other lipid domains, Science 2002, 296, 1821. 
[60] L. Lim, M. R. Wenk in Handbook of Neurochemistry and Molecular Neurobiology. 
Neural Lipids (Eds.: A. Lajtha, G. Goracci, G. Tettamanti), Springer US, Boston, 




[61] T. Harayama, H. Riezman, Understanding the diversity of membrane lipid 
composition, Nat Rev Mol Cell Biol 2018, 19, 281. 
[62] O. G. Mouritsen, The liquid-ordered state comes of age, Biochim Biophys Acta 
2010, 1798, 1286. 
[63] M. Cebecauer, M. Amaro, P. Jurkiewicz, M. J. Sarmento, R. Šachl, L. Cwiklik, M. 
Hof, Membrane Lipid Nanodomains, Chem Rev 2018, 118, 11259. 
[64] O. S. Andersen, R. E. Koeppe, Bilayer thickness and membrane protein function: 
an energetic perspective, Annu Rev Biophys Biomol Struct 2007, 36, 107. 
[65] S.-T. Yang, A. J. B. Kreutzberger, J. Lee, V. Kiessling, L. K. Tamm, The role of 
cholesterol in membrane fusion, Chem Phys Lipids 2016, 199, 136. 
[66] L. Bagatolli, P. B. Sunil Kumar, Phase behavior of multicomponent membranes: 
Experimental and computational techniques, Soft Matter 2009, 5, 3234. 
[67] H. T. McMahon, E. Boucrot, Membrane curvature at a glance, J Cell Sci 2015, 128, 
1065. 
[68] A. M. Smondyrev, M. L. Berkowitz, Structure of Dipalmitoylphosphatidylcholine/ 
Cholesterol Bilayer at Low and High Cholesterol Concentrations: Molecular 
Dynamics Simulation, Biophys J 1999, 77, 2075. 
[69] P. Heftberger, B. Kollmitzer, A. A. Rieder, H. Amenitsch, G. Pabst, In situ 
determination of structure and fluctuations of coexisting fluid membrane domains, 
Biophys J 2015, 108, 854. 
[70] J. J. Hulce, A. B. Cognetta, M. J. Niphakis, S. E. Tully, B. F. Cravatt, Proteome-
wide mapping of cholesterol-interacting proteins in mammalian cells, Nat Methods 
2013, 10, 259. 
[71] J. Fantini, F. J. Barrantes, How cholesterol interacts with membrane proteins: an 
exploration of cholesterol-binding sites including CRAC, CARC, and tilted 
domains, Front Physiol 2013, 4, 31. 
[72] M. M. Kozlov, V. S. Markin, Vozmozhnyĭ mekhanizm sliiania membran, Biofizika 
1983, 28, 242. 
[73] L. V. Chernomordik, M. M. Kozlov, Membrane hemifusion: crossing a chasm in 
two leaps, Cell 2005, 123, 375. 
[74] P. M. Kasson, N. W. Kelley, N. Singhal, M. Vrljic, A. T. Brunger, V. S. Pande, 
Ensemble molecular dynamics yields submillisecond kinetics and intermediates of 
membrane fusion, Proc Natl Acad Sci U S A 2006, 103, 11916. 
[75] L. Yang, H. W. Huang, Observation of a membrane fusion intermediate structure, 




[76] S. Aeffner, T. Reusch, B. Weinhausen, T. Salditt, Energetics of stalk intermediates 
in membrane fusion are controlled by lipid composition, Proc Natl Acad Sci U S A 
2012, 109, E1609-18. 
[77] J. M. Hernandez, A. Stein, E. Behrmann, D. Riedel, A. Cypionka, Z. Farsi, P. J. 
Walla, S. Raunser, R. Jahn, Membrane fusion intermediates via directional and full 
assembly of the SNARE complex, Science 2012, 336, 1581. 
[78] J. Nikolaus, M. Stöckl, D. Langosch, R. Volkmer, A. Herrmann, Direct visualization 
of large and protein-free hemifusion diaphragms, Biophys J 2010, 98, 1192. 
[79] R. J. Ryham, T. S. Klotz, L. Yao, F. S. Cohen, Calculating Transition Energy 
Barriers and Characterizing Activation States for Steps of Fusion, Biophys J 2016, 
110, 1110. 
[80] Y. Kozlovsky, M. M. Kozlov, Stalk Model of Membrane Fusion: Solution of Energy 
Crisis, Biophys J 2002, 82, 882. 
[81] D. P. Siegel, Energetics of intermediates in membrane fusion: comparison of stalk 
and inverted micellar intermediate mechanisms, Biophys J 1993, 65, 2124. 
[82] P. I. Kuzmin, J. Zimmerberg, Y. A. Chizmadzhev, F. S. Cohen, A quantitative 
model for membrane fusion based on low-energy intermediates, Proc Natl Acad Sci 
U S A 2001, 98, 7235. 
[83] M. Fuhrmans, G. Marelli, Y. G. Smirnova, M. Müller, Mechanics of membrane 
fusion/pore formation, Chem Phys Lipids 2015, 185, 109. 
[84] M. Müller, K. Katsov, M. Schick, New mechanism of membrane fusion, J. Chem. 
Phys. 2002, 116, 2342. 
[85] H. J. Risselada, G. Marelli, M. Fuhrmans, Y. G. Smirnova, H. Grubmüller, S. J. 
Marrink, M. Müller, Line-tension controlled mechanism for influenza fusion, PLoS 
One 2012, 7, e38302. 
[86] A. F. Smeijers, A. J. Markvoort, K. Pieterse, P. A. J. Hilbers, A detailed look at 
vesicle fusion, J Phys Chem B 2006, 110, 13212. 
[87] K. Katsov, M. Müller, M. Schick, Field theoretic study of bilayer membrane fusion: 
II. Mechanism of a stalk-hole complex, Biophys J 2006, 90, 915. 
[88] M. Müller, K. Katsov, M. Schick, A New Mechanism of Model Membrane Fusion 
Determined from Monte Carlo Simulation, Biophys J 2003, 85, 1611. 
[89] S. A. Akimov, R. J. Molotkovsky, P. I. Kuzmin, T. R. Galimzyanov, O. V. 
Batishchev, Continuum Models of Membrane Fusion: Evolution of the Theory, Int 
J Mol Sci 2020, 21. 
[90] A. J. Markvoort, S. J. Marrink, Lipid acrobatics in the membrane fusion arena, Curr 




[91] L. V. Chernomordik, M. M. Kozlov, Mechanics of membrane fusion, Nat Struct 
Mol Biol 2008, 15, 675. 
[92] B. Katz, R. Miledi, The timing of calcium action during neuromuscular 
transmission, J Physiol (Lond ) 1967, 189, 535. 
[93] S. SANKARANARAYANAN, T. A. RYAN in Protein trafficking in neurons (Ed.: 
A. J. Bean), Elsevier/Academic Press, Amsterdam, Boston, 2007, pp. 97–124. 
[94] R. Jahn, D. Fasshauer, Molecular machines governing exocytosis of synaptic 
vesicles, Nature 2012, 490, 201. 
[95] P. S. Kaeser, W. G. Regehr, The readily releasable pool of synaptic vesicles, Curr 
Opin Neurobiol 2017, 43, 63. 
[96] S. C. Harrison, Viral membrane fusion, Virology 2015, 479-480, 498. 
[97] T. Tang, M. Bidon, J. A. Jaimes, G. R. Whittaker, S. Daniel, Coronavirus membrane 
fusion mechanism offers a potential target for antiviral development, Antiviral Res 
2020, 178, 104792. 
[98] S. Martens, H. T. McMahon, Mechanisms of membrane fusion: disparate players 
and common principles, Nat Rev Mol Cell Biol 2008, 9, 543. 
[99] J. M. White, S. E. Delos, M. Brecher, K. Schornberg, Structures and mechanisms of 
viral membrane fusion proteins: multiple variations on a common theme, Crit Rev 
Biochem Mol Biol 2008, 43, 189. 
[100] I. A. Wilson, J. J. Skehel, D. C. Wiley, Structure of the haemagglutinin membrane 
glycoprotein of influenza virus at 3 A resolution, Nature 1981, 289, 366. 
[101] J. J. Skehel, D. C. Wiley, Receptor binding and membrane fusion in virus entry: the 
influenza hemagglutinin, Annu Rev Biochem 2000, 69, 531. 
[102] M. Kielian, Mechanisms of Virus Membrane Fusion Proteins, Annu Rev Virol 2014, 
1, 171. 
[103] J. M. White, G. R. Whittaker, Fusion of Enveloped Viruses in Endosomes, Traffic 
2016, 17, 593. 
[104] L. Wang, Y. Wang, D. Ye, Q. Liu, Review of the 2019 novel coronavirus (SARS-
CoV-2) based on current evidence, Int J Antimicrob Agents 2020, 55, 105948. 
[105] S. Belouzard, J. K. Millet, B. N. Licitra, G. R. Whittaker, Mechanisms of 
coronavirus cell entry mediated by the viral spike protein, Viruses 2012, 4, 1011. 
[106] Y. Yuan, D. Cao, Y. Zhang, J. Ma, J. Qi, Q. Wang, G. Lu, Y. Wu, J. Yan, Y. Shi et 
al., Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal 




[107] B. J. Bosch, R. van der Zee, C. A. M. de Haan, P. J. M. Rottier, The coronavirus 
spike protein is a class I virus fusion protein: structural and functional 
characterization of the fusion core complex, J Virol 2003, 77, 8801. 
[108] G. Simmons, D. N. Gosalia, A. J. Rennekamp, J. D. Reeves, S. L. Diamond, P. 
Bates, Inhibitors of cathepsin L prevent severe acute respiratory syndrome 
coronavirus entry, Proc Natl Acad Sci U S A 2005, 102, 11876. 
[109] G. Simmons, J. D. Reeves, A. J. Rennekamp, S. M. Amberg, A. J. Piefer, P. Bates, 
Characterization of severe acute respiratory syndrome-associated coronavirus 
(SARS-CoV) spike glycoprotein-mediated viral entry, Proc Natl Acad Sci U S A 
2004, 101, 4240. 
[110] M. Giacomello, A. Pyakurel, C. Glytsou, L. Scorrano, The cell biology of 
mitochondrial membrane dynamics, Nat Rev Mol Cell Biol 2020, 21, 204. 
[111] L. Tilokani, S. Nagashima, V. Paupe, J. Prudent, Mitochondrial dynamics: overview 
of molecular mechanisms, Essays Biochem 2018, 62, 341. 
[112] A. M. van der Bliek, Q. Shen, S. Kawajiri, Mechanisms of mitochondrial fission 
and fusion, Cold Spring Harb Perspect Biol 2013, 5. 
[113] T. "Brandt, L. Cavellini, W. Kühlbrandt, M. M. Cohen, A mitofusin-dependent 
docking ring complex triggers mitochondrial fusion in vitro, Elife 2016, 5. 
[114] E. H. Chen, E. Grote, W. Mohler, A. Vignery, Cell-cell fusion, FEBS Lett 2007, 
581, 2181. 
[115] N. Takahashi, Y. Kobayashi, N. Udagawa in Principles of bone biology (Ed.: J. P. 
Bilezikian), Acad. Press, San Diego [u.a.], 2020, pp. 111–131. 
[116] V. Horsley, G. K. Pavlath, Forming a multinucleated cell: molecules that regulate 
myoblast fusion, Cells Tissues Organs (Print) 2004, 176, 67. 
[117] M. J. Petrany, D. P. Millay, Cell Fusion: Merging Membranes and Making Muscle, 
Trends Cell Biol 2019, 29, 964. 
[118] J. Pérez-Vargas, T. Krey, C. Valansi, O. Avinoam, A. Haouz, M. Jamin, H. Raveh-
Barak, B. Podbilewicz, F. A. Rey, Structural basis of eukaryotic cell-cell fusion, 
Cell 2014, 157, 407. 
[119] B. Podbilewicz, E. Leikina, A. Sapir, C. Valansi, M. Suissa, G. Shemer, L. V. 
Chernomordik, The C. elegans developmental fusogen EFF-1 mediates homotypic 
fusion in heterologous cells and in vivo, Dev Cell 2006, 11, 471. 
[120] A. Sapir, J. Choi, E. Leikina, O. Avinoam, C. Valansi, L. V. Chernomordik, A. P. 
Newman, B. Podbilewicz, AFF-1, a FOS-1-regulated fusogen, mediates fusion of 




[121] E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. 
Meng, T. E. Ferrin, UCSF Chimera--a visualization system for exploratory research 
and analysis, J Comput Chem 2004, 25, 1605. 
[122] D. Fasshauer, R. B. Sutton, A. T. Brunger, R. Jahn, Conserved structural features of 
the synaptic fusion complex: SNARE proteins reclassified as Q- and R-SNAREs, 
Proc Natl Acad Sci U S A 1998, 95, 15781. 
[123] D. Fasshauer, W. Antonin, V. Subramaniam, R. Jahn, SNARE assembly and 
disassembly exhibit a pronounced hysteresis, Nat Struct Biol 2002, 9, 144. 
[124] J.-K. Ryu, R. Jahn, T.-Y. Yoon, Review: Progresses in understanding N-
ethylmaleimide sensitive factor (NSF) mediated disassembly of SNARE complexes, 
Biopolymers 2016, 105, 518. 
[125] K. Wiederhold, D. Fasshauer, Is assembly of the SNARE complex enough to fuel 
membrane fusion?, J. Biol. Chem. 2009, 284, 13143. 
[126] X. Lu, Y. Zhang, Y.-K. Shin, Supramolecular SNARE assembly precedes 
hemifusion in SNARE-mediated membrane fusion, Nat Struct Mol Biol 2008, 15, 
700. 
[127] H. J. Risselada, C. Kutzner, H. Grubmüller, Caught in the act: visualization of 
SNARE-mediated fusion events in molecular detail, Chembiochem 2011, 12, 1049. 
[128] V. Knecht, H. Grubmüller, Mechanical Coupling via the Membrane Fusion SNARE 
Protein Syntaxin 1A: A Molecular Dynamics Study, Biophys J 2003, 84, 1527. 
[129] J. Han, K. Pluhackova, D. Bruns, R. A. Böckmann, Synaptobrevin transmembrane 
domain determines the structure and dynamics of the SNARE motif and the linker 
region, Biochim Biophys Acta 2016, 1858, 855. 
[130] A. E. Blanchard, M. J. Arcario, K. Schulten, E. Tajkhorshid, A highly tilted 
membrane configuration for the prefusion state of synaptobrevin, Biophys J 2014, 
107, 2112. 
[131] L. E. Dietrich, C. Boeddinghaus, T. J. LaGrassa, C. Ungermann, Control of 
eukaryotic membrane fusion by N-terminal domains of SNARE proteins, Biochim 
Biophys Acta Mol Cell Res 2003, 1641, 111. 
[132] M. Margittai, J. Widengren, E. Schweinberger, G. F. Schröder, S. Felekyan, E. 
Haustein, M. König, D. Fasshauer, H. Grubmüller, R. Jahn et al., Single-molecule 
fluorescence resonance energy transfer reveals a dynamic equilibrium between 
closed and open conformations of syntaxin 1, Proc Natl Acad Sci U S A 2003, 100, 
15516. 
[133] J. Rizo, T. C. Südhof, Snares and Munc18 in synaptic vesicle fusion, Nat Rev 




[134] J. S. van Komen, X. Bai, B. L. Scott, J. A. McNew, An intramolecular t-SNARE 
complex functions in vivo without the syntaxin NH2-terminal regulatory domain, J 
Cell Biol 2006, 172, 295. 
[135] Y. Wang, I. Dulubova, J. Rizo, T. C. Südhof, Functional analysis of conserved 
structural elements in yeast syntaxin Vam3p, J. Biol. Chem. 2001, 276, 28598. 
[136] R. F. Toonen, M. Verhage, Vesicle trafficking: pleasure and pain from SM genes, 
Trends Cell Biol 2003, 13, 177. 
[137] F. Li, F. Pincet, E. Perez, W. S. Eng, T. J. Melia, J. E. Rothman, D. Tareste, 
Energetics and dynamics of SNAREpin folding across lipid bilayers, Nat Struct Mol 
Biol 2007, 14, 890. 
[138] L. Ma, Y. Kang, J. Jiao, A. A. Rebane, H. K. Cha, Z. Xi, H. Qu, Y. Zhang, α-SNAP 
Enhances SNARE Zippering by Stabilizing the SNARE Four-Helix Bundle, Cell 
Rep 2016, 15, 531. 
[139] F. Li, N. Tiwari, J. E. Rothman, F. Pincet, Kinetic barriers to SNAREpin assembly 
in the regulation of membrane docking/priming and fusion, Proc Natl Acad Sci U S 
A 2016, 113, 10536. 
[140] J. Shin, X. Lou, D.-H. Kweon, Y.-K. Shin, Multiple conformations of a single 
SNAREpin between two nanodisc membranes reveal diverse pre-fusion states, 
Biochem J 2014, 459, 95. 
[141] D. Min, K. Kim, C. Hyeon, Y. H. Cho, Y.-K. Shin, T.-Y. Yoon, Mechanical 
unzipping and rezipping of a single SNARE complex reveals hysteresis as a force-
generating mechanism, Nat Commun 2013, 4, 1705. 
[142] J. Wang, O. Bello, S. M. Auclair, J. Coleman, F. Pincet, S. S. Krishnakumar, C. V. 
Sindelar, J. E. Rothman, Calcium sensitive ring-like oligomers formed by 
synaptotagmin, Proc Natl Acad Sci U S A 2014, 111, 13966. 
[143] D. Kümmel, S. S. Krishnakumar, D. T. Radoff, F. Li, C. G. Giraudo, F. Pincet, J. E. 
Rothman, K. M. Reinisch, Complexin cross-links prefusion SNAREs into a zigzag 
array, Nat Struct Mol Biol 2011, 18, 927. 
[144] Q. Fang, M. Lindau, How could SNARE proteins open a fusion pore?, Physiology 
(Bethesda) 2014, 29, 278. 
[145] A. N. Ngatchou, K. Kisler, Q. Fang, A. M. Walter, Y. Zhao, D. Bruns, J. B. 
Sørensen, M. Lindau, Role of the synaptobrevin C terminus in fusion pore 
formation, Proc Natl Acad Sci U S A 2010, 107, 18463. 
[146] F. Li, D. Kümmel, J. Coleman, K. M. Reinisch, J. E. Rothman, F. Pincet, A half-
zippered SNARE complex represents a functional intermediate in membrane fusion, 




[147] A. Witkowska, R. Jahn, Rapid SNARE-Mediated Fusion of Liposomes and 
Chromaffin Granules with Giant Unilamellar Vesicles, Biophys J 2017, 113, 1251. 
[148] T. C. Südhof, A molecular machine for neurotransmitter release: synaptotagmin and 
beyond, Nat Med 2013, 19, 1227. 
[149] S. Wang, Y. Li, J. Gong, S. Ye, X. Yang, R. Zhang, C. Ma, Munc18 and Munc13 
serve as a functional template to orchestrate neuronal SNARE complex assembly, 
Nat Commun 2019, 10, 69. 
[150] T. C. Südhof, J. E. Rothman, Membrane fusion: grappling with SNARE and SM 
proteins, Science 2009, 323, 474. 
[151] J. E. Gerst, SNARE regulators: matchmakers and matchbreakers, Biochim Biophys 
Acta Mol Cell Res 2003, 1641, 99. 
[152] J. Rizo, Mechanism of neurotransmitter release coming into focus, Protein Sci 2018, 
27, 1364. 
[153] K. M. Misura, R. H. Scheller, W. I. Weis, Three-dimensional structure of the 
neuronal-Sec1-syntaxin 1a complex, Nature 2000, 404, 355. 
[154] J. Rizo, J. Xu, The Synaptic Vesicle Release Machinery, Annu Rev Biophys 2015, 
44, 339. 
[155] E. He, K. Wierda, R. van Westen, J. H. Broeke, R. F. Toonen, L. N. Cornelisse, M. 
Verhage, Munc13-1 and Munc18-1 together prevent NSF-dependent de-priming of 
synaptic vesicles, Nat Commun 2017, 8, 15915. 
[156] M. Khvotchev, I. Dulubova, J. Sun, H. Dai, J. Rizo, T. C. Südhof, Dual modes of 
Munc18-1/SNARE interactions are coupled by functionally critical binding to 
syntaxin-1 N terminus, J Neurosci 2007, 27, 12147. 
[157] C. Ma, L. Su, A. B. Seven, Y. Xu, J. Rizo, Reconstitution of the vital functions of 
Munc18 and Munc13 in neurotransmitter release, Science 2013, 339, 421. 
[158] X. Yang, S. Wang, Y. Sheng, M. Zhang, W. Zou, L. Wu, L. Kang, J. Rizo, R. Zhang, 
T. Xu et al., Syntaxin opening by the MUN domain underlies the function of 
Munc13 in synaptic-vesicle priming, Nat Struct Mol Biol 2015, 22, 547. 
[159] Y. Lai, U. B. Choi, J. Leitz, H. J. Rhee, C. Lee, B. Altas, M. Zhao, R. A. Pfuetzner, 
A. L. Wang, N. Brose et al., Molecular Mechanisms of Synaptic Vesicle Priming by 
Munc13 and Munc18, Neuron 2017, 95, 591-607.e10. 
[160] E. R. Chapman, How does synaptotagmin trigger neurotransmitter release?, Annu 
Rev Biochem 2008, 77, 615. 
[161] K. L. Fuson, M. Montes, J. J. Robert, R. B. Sutton, Structure of human 
synaptotagmin 1 C2AB in the absence of Ca2+ reveals a novel domain association, 




[162] W. C. Tucker, T. Weber, E. R. Chapman, Reconstitution of Ca2+-regulated 
membrane fusion by synaptotagmin and SNAREs, Science 2004, 304, 435. 
[163] K. Reim, M. Mansour, F. Varoqueaux, H. T. McMahon, T. C. Südhof, N. Brose, C. 
Rosenmund, Complexins Regulate a Late Step in Ca2+-Dependent 
Neurotransmitter Release, Cell 2001, 104, 71. 
[164] J. Tang, A. Maximov, O.-H. Shin, H. Dai, J. Rizo, T. C. Südhof, A 
complexin/synaptotagmin 1 switch controls fast synaptic vesicle exocytosis, Cell 
2006, 126, 1175. 
[165] N. A. Courtney, H. Bao, J. S. Briguglio, E. R. Chapman, Synaptotagmin 1 clamps 
synaptic vesicle fusion in mammalian neurons independent of complexin, Nat 
Commun 2019, 10, 4076. 
[166] Q. Zhou, P. Zhou, A. L. Wang, D. Wu, M. Zhao, T. C. Südhof, A. T. Brunger, The 
primed SNARE-complexin-synaptotagmin complex for neuronal exocytosis, 
Nature 2017, 548, 420. 
[167] M. Zhao, S. Wu, Q. Zhou, S. Vivona, D. J. Cipriano, Y. Cheng, A. T. Brunger, 
Mechanistic insights into the recycling machine of the SNARE complex, Nature 
2015, 518, 61. 
[168] J. Han, K. Pluhackova, R. A. Böckmann, The Multifaceted Role of SNARE Proteins 
in Membrane Fusion, Front Physiol 2017, 8, 5. 
[169] M. S. Al-Abdul-Wahid, C. M. DeMill, M. B. Serwin, R. S. Prosser, B. A. Stewart, 
Effect of juxtamembrane tryptophans on the immersion depth of Synaptobrevin, an 
integral vesicle membrane protein, Biochim Biophys Acta 2012, 1818, 2994. 
[170] J. Kesavan, M. Borisovska, D. Bruns, v-SNARE actions during Ca(2+)-triggered 
exocytosis, Cell 2007, 131, 351. 
[171] F. Deák, O.-H. Shin, E. T. Kavalali, T. C. Südhof, Structural determinants of 
synaptobrevin 2 function in synaptic vesicle fusion, J Neurosci 2006, 26, 6668. 
[172] A. D. Lam, P. Tryoen-Toth, B. Tsai, N. Vitale, E. L. Stuenkel, SNARE-catalyzed 
fusion events are regulated by Syntaxin1A-lipid interactions, Mol Biol Cell 2008, 
19, 485. 
[173] T. Weber, B. V. Zemelman, J. A. McNew, B. Westermann, M. Gmachl, F. Parlati, 
T. H. Söllner, J. E. Rothman, SNAREpins: Minimal Machinery for Membrane 
Fusion, Cell 1998, 92, 759. 
[174] X. Chen, D. Araç, T.-M. Wang, C. J. Gilpin, J. Zimmerberg, J. Rizo, SNARE-
mediated lipid mixing depends on the physical state of the vesicles, Biophys J 2006, 
90, 2062. 
[175] B. L. Sabatini, W. G. Regehr, Timing of neurotransmission at fast synapses in the 




[176] M. Ma, A. Paredes, D. Bong, Intra- and intermembrane pairwise molecular 
recognition between synthetic hydrogen-bonding phospholipids, J Am Chem Soc 
2008, 130, 14456. 
[177] S. A. Whitehead, C. D. McNitt, S. I. Mattern-Schain, A. J. Carr, S. Alam, V. V. 
Popik, M. D. Best, Artificial Membrane Fusion Triggered by Strain-Promoted 
Alkyne-Azide Cycloaddition, Bioconjug Chem 2017, 28, 923. 
[178] Y.-H. M. Chan, B. van Lengerich, S. G. Boxer, Lipid-anchored DNA mediates 
vesicle fusion as observed by lipid and content mixing, Biointerphases 2008, 3, 
FA17. 
[179] G. Stengel, L. Simonsson, R. A. Campbell, F. Höök, Determinants for membrane 
fusion induced by cholesterol-modified DNA zippers, J Phys Chem B 2008, 112, 
8264. 
[180] C. Böhler, P. E. Nielsen, L. E. Orgel, Template switching between PNA and RNA 
oligonucleotides, Nature 1995, 376, 578. 
[181] P. Wittung, P. E. Nielsen, O. Buchardt, M. Egholm, B. Nordén, DNA-like double 
helix formed by peptide nucleic acid, Nature 1994, 368, 561. 
[182] A. Rabe, P. M. G. Löffler, O. Ries, S. Vogel, Programmable fusion of liposomes 
mediated by lipidated PNA, Chem. Commun. 2017, 53, 11921. 
[183] A. S. Lygina, K. Meyenberg, R. Jahn, U. Diederichsen, Transmembrane domain 
peptide/peptide nucleic acid hybrid as a model of a SNARE protein in vesicle fusion, 
Angew. Chem. Int. Ed. 2011, 50, 8597. 
[184] J.-D. Wehland, A. S. Lygina, P. Kumar, S. Guha, B. E. Hubrich, R. Jahn, U. 
Diederichsen, Role of the transmembrane domain in SNARE protein mediated 
membrane fusion: peptide nucleic acid/peptide model systems, Mol. Biosyst. 2016, 
12, 2770. 
[185] B. E. Hubrich, P. Kumar, H. Neitz, M. Grunwald, T. Grothe, P. J. Walla, R. Jahn, 
U. Diederichsen, PNA Hybrid Sequences as Recognition Units in SNARE-Protein-
Mimicking Peptides, Angew. Chem. Int. Ed. 2018, 57, 14932. 
[186] D. Weicherding, W. B. Davis, S. Hess, T. von Feilitzsch, M. E. Michel-Beyerle, U. 
Diederichsen, Femtosecond time-resolved guanine oxidation in acridine modified 
alanyl peptide nucleic acids, Bioorg Med Chem Lett 2004, 14, 1629. 
[187] O. Berger, L. Adler-Abramovich, M. Levy-Sakin, A. Grunwald, Y. Liebes-Peer, M. 
Bachar, L. Buzhansky, E. Mossou, V. T. Forsyth, T. Schwartz et al., Light-emitting 
self-assembled peptide nucleic acids exhibit both stacking interactions and Watson-




[188] Barbara Elisabeth Hubrich, Synthesis of model systems for SNARE mediated 
membrane fusion based on PNA/PNA base pair recognition, Cuvillier Verlag, 
Göttingen, 2018. 
[189] M. Sadek, D. Berndt, D. Milovanovic, R. Jahn, U. Diederichsen, Distance Regulated 
Vesicle Fusion and Docking Mediated by β-Peptide Nucleic Acid SNARE Protein 
Analogues, Chembiochem 2016, 17, 479. 
[190] H. R. Marsden, I. Tomatsu, A. Kros, Model systems for membrane fusion, Chem 
Soc Rev 2011, 40, 1572. 
[191] H. Robson Marsden, A. V. Korobko, T. Zheng, J. Voskuhl, A. Kros, Controlled 
liposome fusion mediated by SNARE protein mimics, Biomater Sci 2013, 1, 1046. 
[192] A. LUPAS, Coiled coils: new structures and new functions, Trends Biochem. Sci. 
1996, 21, 375. 
[193] K. M. Müller, K. M. Arndt, T. Alber in Methods in Enzymology, Elsevier, 2000, pp. 
261–282. 
[194] F. H. C. Crick, The packing of α-helices: simple coiled-coils, Acta Cryst 1953, 6, 
689. 
[195] D. N. Woolfson in Advances in Protein Chemistry : Fibrous Proteins: Coiled-Coils, 
Collagen and Elastomers, Academic Press, 2005, pp. 79–112. 
[196] D. A. Lindhout, J. R. Litowski, P. Mercier, R. S. Hodges, B. D. Sykes, NMR 
solution structure of a highly stable de novo heterodimeric coiled-coil, Biopolymers 
2004, 75, 367. 
[197] G. A. Daudey, H. R. Zope, J. Voskuhl, A. Kros, A. L. Boyle, Membrane-Fusogen 
Distance Is Critical for Efficient Coiled-Coil-Peptide-Mediated Liposome Fusion, 
Langmuir 2017, 33, 12443. 
[198] F. Versluis, J. Voskuhl, B. van Kolck, H. Zope, M. Bremmer, T. Albregtse, A. Kros, 
In situ modification of plain liposomes with lipidated coiled coil forming peptides 
induces membrane fusion, J Am Chem Soc 2013, 135, 8057. 
[199] M. Rabe, C. Schwieger, H. R. Zope, F. Versluis, A. Kros, Membrane interactions of 
fusogenic coiled-coil peptides: implications for lipopeptide mediated vesicle fusion, 
Langmuir 2014, 30, 7724. 
[200] G. A. Daudey, C. Schwieger, M. Rabe, A. Kros, Influence of Membrane-Fusogen 
Distance on the Secondary Structure of Fusogenic Coiled Coil Peptides, Langmuir 
2019, 35, 5501. 
[201] M. Rabe, H. R. Zope, A. Kros, Interplay between Lipid Interaction and Homo-
coiling of Membrane-Tethered Coiled-Coil Peptides, Langmuir 2015, 31, 9953. 
[202] E. Strandberg, J. Killian, Snorkeling of lysine side chains in transmembrane helices: 




[203] M. Rabe, C. Aisenbrey, K. Pluhackova, V. de Wert, A. L. Boyle, D. F. Bruggeman, 
S. A. Kirsch, R. A. Böckmann, A. Kros, J. Raap et al., A Coiled-Coil Peptide 
Shaping Lipid Bilayers upon Fusion, Biophys J 2016, 111, 2162. 
[204] K. Pluhackova, T. A. Wassenaar, S. Kirsch, R. A. Böckmann, Spontaneous 
adsorption of coiled-coil model peptides K and E to a mixed lipid bilayer, J Phys 
Chem B 2015, 119, 4396. 
[205] S. Y. Woo, H. Lee, All-atom simulations and free-energy calculations of coiled-coil 
peptides with lipid bilayers: binding strength, structural transition, and effect on 
lipid dynamics, Sci Rep 2016, 6, 22299. 
[206] Karsten Meyenberg, Synthese und Untersuchungen von peptidischen 
Modellsystemen für SNARE-induzierte Membranfusion, Books on Demand, 
Norderstedt, 2011. 
[207] J.-D. Wehland, Hybrids of SNARE Transmembrane Domains and Aritificial 
Recognition Motifs as Membrane Fusion Inducing Model Peptides, PhD thesis, 
Georg-August-Universität, Göttingen, 2017. 
[208] A. T. Brunger, D. J. Cipriano, J. Diao, Towards reconstitution of membrane fusion 
mediated by SNAREs and other synaptic proteins, Crit Rev Biochem Mol Biol 2015, 
50, 231. 
[209] J. W. Kuhlmann, M. Junius, U. Diederichsen, C. Steinem, SNARE-Mediated 
Single-Vesicle Fusion Events with Supported and Freestanding Lipid Membranes, 
Biophys J 2017, 112, 2348. 
[210] D. K. Struck, D. Hoekstra, R. E. Pagano, Use of resonance energy transfer to 
monitor membrane fusion, Biochemistry 1981, 20, 4093. 
[211] T. Forster, Energiewanderung und Fluoreszenz, Naturwissenschaften 1946, 33, 166. 
[212] B. T. Bajar, E. S. Wang, S. Zhang, M. Z. Lin, J. Chu, A Guide to Fluorescent Protein 
FRET Pairs, Sensors (Basel) 2016, 16. 
[213] L. M. S. Loura, M. Prieto, FRET in Membrane Biophysics: An Overview, Front 
Physiol 2011, 2, 82. 
[214] V. Trivedi, C. Yu, B. Veeramuthu, S. Francis, D. Chang, Fusion induced 
aggregation of model vesicles studied by dynamic and static light scattering, Chem 
Phys Lipids 2000, 107, 99. 
[215] S. Castorph, S. Schwarz Henriques, M. Holt, D. Riedel, R. Jahn, T. Salditt, Synaptic 
vesicles studied by dynamic light scattering, Eur Phys J E Soft Matter 2011, 34, 63. 
[216] A.-K. Awizio, F. Onofri, F. Benfenati, E. Bonaccurso, Influence of synapsin I on 
synaptic vesicles: an analysis by force-volume mode of the atomic force microscope 




[217] N. Moskowitz, S. Puszkin, W. Schook, Characterization of brain synaptic vesicle 
phospholipase A2 activity and its modulation by calmodulin, prostaglandin E2, 
prostaglandin F2 alpha, cyclic AMP, and ATP, J Neurochem 1983, 41, 1576. 
[218] J. Stetefeld, S. A. McKenna, T. R. Patel, Dynamic light scattering: a practical guide 
and applications in biomedical sciences, Biophys Rev 2016, 8, 409. 
[219] A. Schirmacher, Modification of transmembrane peptides to probe SNARE-induced 
membrane fusion and cross-presentation of membrane-buried epitopes, Georg-
August-Universität, Göttingen, 2020. 
[220] H. Chao, D. L. Bautista, J. Litowski, R. T. Irvin, R. S. Hodges, Use of a 
heterodimeric coiled-coil system for biosensor application and affinity purification, 
J. chromatogr., B, Biomed. sci. appl. 1998, 715, 307. 
[221] H. Chao, M. E. Houston, S. Grothe, C. M. Kay, M. O'Connor-McCourt, R. T. Irvin, 
R. S. Hodges, Kinetic Study on the Formation of a de Novo Designed Heterodimeric 
Coiled-Coil: Use of Surface Plasmon Resonance To Monitor the Association and 
Dissociation of Polypeptide Chains †, Biochemistry 1996, 35, 12175. 
[222] B. Tripet, L. Yu, D. L. Bautista, W. Y. Wong, R. T. Irvin, R. S. Hodges, Engineering 
a de novo -designed coiled-coil heterodimerization domain for the rapid detection, 
purification and characterization of recombinantly expressed peptides and proteins, 
Protein Eng Des Sel 1996, 9, 1029. 
[223] R. B. Merrifield, Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide, 
J Am Chem Soc 1963, 85, 2149. 
[224] J. M. Collins, S. K. Singh, "Use of Excess Carbodiimide for Peptide Synthesis at 
Elevated Temperatures", 2018, US20180066013A1. 
[225] B. Apostolovic, H.-A. Klok, pH-sensitivity of the E3/K3 heterodimeric coiled coil, 
Biomacromolecules 2008, 9, 3173. 
[226] P. Padmanabhan, A. T. Bademosi, R. Kasula, E. Lauwers, P. Verstreken, F. A. 
Meunier, Need for speed: Super-resolving the dynamic nanoclustering of syntaxin-
1 at exocytic fusion sites, Neuropharmacology 2020, 169, 107554. 
[227] C. Rickman, C. N. Medine, A. R. Dun, D. J. Moulton, O. Mandula, N. D. Halemani, 
S. O. Rizzoli, L. H. Chamberlain, R. R. Duncan, t-SNARE protein conformations 
patterned by the lipid microenvironment, J Biol Chem 2010, 285, 13535. 
[228] J. J. Sieber, K. I. Willig, R. Heintzmann, S. W. Hell, T. Lang, The SNARE motif is 
essential for the formation of syntaxin clusters in the plasma membrane, Biophys J 
2006, 90, 2843. 
[229] A. Ullrich, M. A. Böhme, J. Schöneberg, H. Depner, S. J. Sigrist, F. Noé, Dynamical 
Organization of Syntaxin-1A at the Presynaptic Active Zone, PLoS Comput Biol 




[230] B. L. Bray, Large-scale manufacture of peptide therapeutics by chemical synthesis, 
Nat Rev Drug Discov 2003, 2, 587. 
[231] K. Kachel, E. Asuncion-Punzalan, E. London, The location of fluorescence probes 
with charged groups in model membranes, Biochim Biophys Acta Biomembr 1998, 
1374, 63. 
[232] D. E. Wolf, A. P. Winiski, A. E. Ting, K. M. Bocian, R. E. Pagano, Determination 
of the transbilayer distribution of fluorescent lipid analogues by nonradiative 
fluorescence resonance energy transfer, Biochemistry 1992, 31, 2865. 
[233] S. Fery-Forgues, J.-P. Fayet, A. Lopez, Drastic changes in the fluorescence 
properties of NBD probes with the polarity of the medium: involvement of a TICT 
state?, J. Photochem. Photobiol. A 1993, 70, 229. 
[234] A. Chattopadhyay, E. London, Spectroscopic and ionization properties of N-(7-
nitrobenz-2-oxa-1,3-diazol-4-yl)-labeled lipids in model membranes, Biochim 
Biophys Acta Biomembr 1988, 938, 24. 
[235] Fehmke Reichardt, Untersuchung des Einflusses der Linker-Region von Coiled-
Coil SNARE-Analoga auf Vesikelfusion, Bachelor Thesis, Georg-August-
Universität, Göttingen, 2020. 
[236] J. A. McNew, T. Weber, D. M. Engelman, T. H. Söllner, J. E. Rothman, The Length 
of the Flexible SNAREpin Juxtamembrane Region Is a Critical Determinant of 
SNARE-Dependent Fusion, Mol. Cell 1999, 4, 415. 
[237] S. S. Rathore, Y. Liu, H. Yu, C. Wan, M. Lee, Q. Yin, M. H. B. Stowell, J. Shen, 
Intracellular Vesicle Fusion Requires a Membrane-Destabilizing Peptide Located at 
the Juxtamembrane Region of the v-SNARE, Cell Rep 2019, 29, 4583-4592.e3. 
[238] C. M. DeMill, X. Qiu, M. Kisiel, A. Bolotta, B. A. Stewart, Investigation of the 
juxtamembrane region of neuronal-Synaptobrevin in synaptic transmission at the 
Drosophila neuromuscular junction, J Neurophysiol 2014, 112, 1356. 
[239] Y. Lai, U. B. Choi, J. Leitz, H. J. Rhee, C. Lee, B. Altas, M. Zhao, R. A. Pfuetzner, 
A. L. Wang, N. Brose et al., Molecular Mechanisms of Synaptic Vesicle Priming by 
Munc13 and Munc18, Neuron 2017, 95, 591-607.e10. 
[240] D.-H. Kweon, C. S. Kim, Y.-K. Shin, The membrane-dipped neuronal SNARE 
complex: a site-directed spin labeling electron paramagnetic resonance study, 
Biochemistry 2002, 41, 9264. 
[241] G. van den Bogaart, K. Meyenberg, H. J. Risselada, H. Amin, K. I. Willig, B. E. 
Hubrich, M. Dier, S. W. Hell, H. Grubmüller, U. Diederichsen et al., Membrane 




[242] D. Greitzer-Antes, N. Barak-Broner, S. Berlin, Y. Oron, D. Chikvashvili, I. Lotan, 
Tracking Ca2+-dependent and Ca2+-independent conformational transitions in 
syntaxin 1A during exocytosis in neuroendocrine cells, J Cell Sci 2013, 126, 2914. 
[243] S. Barg, M. K. Knowles, X. Chen, M. Midorikawa, W. Almers, Syntaxin clusters 
assemble reversibly at sites of secretory granules in live cells, Proc Natl Acad Sci U 
S A 2010, 107, 20804. 
[244] A. T. Bademosi, E. Lauwers, P. Padmanabhan, L. Odierna, Y. J. Chai, A. 
Papadopulos, G. J. Goodhill, P. Verstreken, B. van Swinderen, F. A. Meunier, In 
vivo single-molecule imaging of syntaxin1A reveals polyphosphoinositide- and 
activity-dependent trapping in presynaptic nanoclusters, Nat Commun 2017, 8, 
13660. 
[245] D. H. Murray, L. K. Tamm, Molecular mechanism of cholesterol- and 
polyphosphoinositide-mediated syntaxin clustering, Biochemistry 2011, 50, 9014. 
[246] T. F. J. Martin, PI(4,5)P₂-binding effector proteins for vesicle exocytosis, Biochim 
Biophys Acta 2015, 1851, 785. 
[247] F. Huang, W. M. Nau, A conformational flexibility scale for amino acids in peptides, 
Angew. Chem. Int. Ed. 2003, 42, 2269. 
[248] E. E. Oude Blenke, J. van den Dikkenberg, B. van Kolck, A. Kros, E. Mastrobattista, 
Coiled coil interactions for the targeting of liposomes for nucleic acid delivery, 
Nanoscale 2016, 8, 8955. 
[249] G. van den Bogaart, T. Lang, R. Jahn, Microdomains of SNARE proteins in the 
plasma membrane, Curr Top Membr 2013, 72, 193. 
[250] R. L. Thurlkill, G. R. Grimsley, J. M. Scholtz, C. N. Pace, pK values of the ionizable 
groups of proteins, Protein Sci 2006, 15, 1214. 
[251] L. J. G. W. van Wilderen, C. Neumann, A. Rodrigues-Correia, D. Kern-Michler, N. 
Mielke, M. Reinfelds, A. Heckel, J. Bredenbeck, Picosecond activation of the 
DEACM photocage unravelled by VIS-pump-IR-probe spectroscopy, Phys Chem 
Chem Phys 2017, 19, 6487. 
[252] V. Hagen, S. Frings, B. Wiesner, S. Helm, U. B. Kaupp, J. Bendig, 7-
(Dialkylamino)coumarin-4-ylmethyl-Caged Compounds as Ultrafast and Effective 
Long-Wavelength Phototriggers of 8-Bromo-Substituted Cyclic Nucleotides, 
Chembiochem 2003, 4, 434. 
[253] J. Luo, R. Uprety, Y. Naro, C. Chou, D. P. Nguyen, J. W. Chin, A. Deiters, 
Genetically encoded optochemical probes for simultaneous fluorescence reporting 
and light activation of protein function with two-photon excitation, J Am Chem Soc 




[254] X. Zhang, W. Xi, C. Wang, M. Podgórski, C. N. Bowman, Visible-Light-Initiated 
Thiol-Michael Addition Polymerizations with Coumarin-Based Photobase 
Generators: Another Photoclick Reaction Strategy, ACS Macro Lett 2016, 5, 229. 
[255] L.-M. Herzig, I. Elamri, H. Schwalbe, J. Wachtveitl, Light-induced antibiotic 
release from a coumarin-caged compound on the ultrafast timescale, Phys Chem 
Chem Phys 2017, 19, 14835. 
[256] A. V. Pinheiro, P. Baptista, J. C. Lima, Light activation of transcription: 
photocaging of nucleotides for control over RNA polymerization, Nucleic Acids Res 
2008, 36, e90. 
[257] J. Bai, W. C. Tucker, E. R. Chapman, PIP2 increases the speed of response of 
synaptotagmin and steers its membrane-penetration activity toward the plasma 
membrane, Nat Struct Mol Biol 2004, 11, 36. 
[258] T. Liang, L. Xie, C. Chao, Y. Kang, X. Lin, T. Qin, H. Xie, Z.-P. Feng, H. Y. 
Gaisano, Phosphatidylinositol 4,5-biphosphate (PIP2) modulates interaction of 
syntaxin-1A with sulfonylurea receptor 1 to regulate pancreatic β-cell ATP-
sensitive potassium channels, J Biol Chem 2014, 289, 6028. 
[259] P. M. Kasson, V. S. Pande, Control of membrane fusion mechanism by lipid 
composition: predictions from ensemble molecular dynamics, PLoS Comput Biol 
2007, 3, e220. 
[260] G. van Meer, J. Davoust, K. Simons, Parameters affecting low-pH-mediated fusion 
of liposomes with the plasma membrane of cells infected with influenza virus, 
Biochemistry 1985, 24, 3593. 
[261] K. Emoto, M. Umeda, An essential role for a membrane lipid in cytokinesis. 
Regulation of contractile ring disassembly by redistribution of 
phosphatidylethanolamine, J Cell Biol 2000, 149, 1215. 
[262] L. H. Chamberlain, R. D. Burgoyne, G. W. Gould, SNARE proteins are highly 
enriched in lipid rafts in PC12 cells: implications for the spatial control of 
exocytosis, Proc Natl Acad Sci U S A 2001, 98, 5619. 
[263] J. Zhang, R. Xue, W.-Y. Ong, P. Chen, Roles of cholesterol in vesicle fusion and 
motion, Biophys J 2009, 97, 1371. 
[264] S. Takamori, M. Holt, K. Stenius, E. A. Lemke, M. Grønborg, D. Riedel, H. Urlaub, 
S. Schenck, B. Brügger, P. Ringler et al., Molecular anatomy of a trafficking 
organelle, Cell 2006, 127, 831. 
[265] M. K. Domanska, V. Kiessling, L. K. Tamm, Docking and fast fusion of 
synaptobrevin vesicles depends on the lipid compositions of the vesicle and the 




[266] M. E. Haque, T. J. McIntosh, B. R. Lentz, Influence of lipid composition on physical 
properties and peg-mediated fusion of curved and uncurved model membrane 
vesicles: "nature's own" fusogenic lipid bilayer, Biochemistry 2001, 40, 4340. 
[267] A. Honigmann, G. van den Bogaart, E. Iraheta, H. J. Risselada, D. Milovanovic, V. 
Mueller, S. Müllar, U. Diederichsen, D. Fasshauer, H. Grubmüller et al., 
Phosphatidylinositol 4,5-bisphosphate clusters act as molecular beacons for vesicle 
recruitment, Nat Struct Mol Biol 2013, 20, 679. 
[268] S. McLaughlin, J. Wang, A. Gambhir, D. Murray, PIP(2) and proteins: interactions, 
organization, and information flow, Annu Rev Biophys Biomol Struct 2002, 31, 151. 
[269] J. Wang, A. Gambhir, G. Hangyás-Mihályné, D. Murray, U. Golebiewska, S. 
McLaughlin, Lateral sequestration of phosphatidylinositol 4,5-bisphosphate by the 
basic effector domain of myristoylated alanine-rich C kinase substrate is due to 
nonspecific electrostatic interactions, J. Biol. Chem. 2002, 277, 34401. 
[270] J. R. Lakowicz, Principles of Fluorescence Spectroscopy, Springer US, Boston, MA, 
1999. 
[271] M. R. Eftink, Fluorescence techniques for studying protein structure, Methods 
Biochem Anal 1991, 35, 127. 
[272] P. Mühlenbrock, K. Herwig, L. Vuong, I. Mey, C. Steinem, Fusion Pore Formation 
Observed during SNARE-Mediated Vesicle Fusion with Pore-Spanning 
Membranes, Biophys J 2020, 119, 151. 
[273] R. Hubrich, Y. Park, I. Mey, R. Jahn, C. Steinem, SNARE-Mediated Fusion of 
Single Chromaffin Granules with Pore-Spanning Membranes, Biophys J 2019, 116, 
308. 
[274] S. C. Gill, P. H. von Hippel, Calculation of protein extinction coefficients from 
amino acid sequence data, Anal Biochem 1989, 182, 319. 
[275] M. J. Hope, M. B. Bally, G. Webb, P. R. Cullis, Production of large unilamellar 
vesicles by a rapid extrusion procedure. Characterization of size distribution, 
trapped volume and ability to maintain a membrane potential, Biochim Biophys Acta 





I would like to thank my supervisor Prof. Dr. Ulf Diederichsen for giving me the 
opportunity to work in an interesting scientific field in his group. I was granted freedom in 
my scientific research as well as in my self-development and was supported by you with 
trust in my capabilities.  
I am grateful for my second supervisor Prof. Dr. Claudia Steinem for helpful scientific 
discussions and advices. Particularly all SFB 803 related colloquia and conferences were 
well organized by you and your team and I am thankful to be a part of this scientific group. 
 
Furthermore, I would like to thank Prof. Dr. Kai Tittmann, Prof. Dr. Michael Meinecke, 
Prof. Dr. Jörg Enderlein and Dr. Holm Frauendorf for being part of my examination board. 
Moreover, I would like to thank Dr. Frauendorf and his team of the MS analytical 
department for swiftly measuring all my peptide mass spectra. 
 
I thank the whole Diederichsen group for a pleasant time during the last four years, 
especially Lab 102. I really enjoyed sharing my lab with Brigitte Worbs who stands out 
with her admirable work ethic and was always an enjoyable conversational partner. Dr. 
Barbara Hubrich, Dr. Jan-Dirk Wehland, Robert Schrimacher and Viktoria Mrden Debono 
with whom I had a great time in lab 102 as well. 
The sessions at the foosball table were essential for our good group dynamic and were a 
bright spot in dark times during my PhD time. For this I want to thank Pirajeev 
Selvachandran, Benedikt Kugler, Tobias Schmidt, Dr. Matthias Krull and Mathis Rink. 
 
I am very grateful for Martin Kloos, Pirajeev Selvachandran, Clara Bosbach and Tobias 
Schmidt for reading and correcting my work. 
I thank my bachelor student Fehmke Reichardt, who performed exceptionally well in all 
tasks she did during her bachelor thesis and her uplifting spirit during our time together. 
 
I would also like to thank Jun.-Prof. Dr. Franziska Thomas and her work group for support 
in scientific problems. Especially Vanessa Reusche who helped me in the BIN with the 
peptide synthesizer. 




I would also like to thank my friends and fellow chemistry students Valentin Müller, 
Marcus Thater and Jerome Spyra who fought valiantly with me during the bachelor, master 
and PhD time. 
 
I am very grateful for my wife Anika Groth, who supported me throughout my bachelor, 
master and PhD time in every way imaginable. Without you there would not be much 
happiness in my life. I am very lucky that you are by my side for the rest of my life.  
 
Ich bin sehr dankbar dafür, dass meine Eltern und mein Bruder mich mein Leben lang 
begleitet und immer unterstützt haben. Ihr habt immer an mich geglaubt und habt mich nie 
im Stich gelassen 
